{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 171390, "items": [{"indexed": {"date-parts": [[2018, 5, 3]], "date-time": "2018-05-03T21:09:35Z", "timestamp": 1525381775899}, "reference-count": 54, "publisher": "Elsevier BV", "license": [{"URL": "http://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2003, 8, 1]], "date-time": "2003-08-01T00:00:00Z", "timestamp": 1059696000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["International Congress Series"], "published-print": {"date-parts": [[2003, 8]]}, "DOI": "10.1016/s0531-5131(03)00610-1", "type": "journal-article", "created": {"date-parts": [[2003, 9, 12]], "date-time": "2003-09-12T14:50:46Z", "timestamp": 1063378246000}, "page": "101-117", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Differential ligand efficacy at h5-HT1A receptor-coupled G-protein subtypes: a commentary"], "prefix": "10.1016", "volume": "1249", "author": [{"given": "Adrian", "family": "Newman-Tancredi", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["International Congress Series"], "language": "en", "link": [{"URL": "http://api.elsevier.com/content/article/PII:S0531513103006101?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://api.elsevier.com/content/article/PII:S0531513103006101?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 3, 8]], "date-time": "2018-03-08T17:15:11Z", "timestamp": 1520529311000}, "score": 31.190943, "issued": {"date-parts": [[2003, 8]]}, "references-count": 54, "alternative-id": ["S0531513103006101"], "URL": "http://dx.doi.org/10.1016/s0531-5131(03)00610-1", "ISSN": ["0531-5131"], "issn-type": [{"value": "0531-5131", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 12, 21]], "date-time": "2018-12-21T22:42:38Z", "timestamp": 1545432158150}, "reference-count": 135, "publisher": "OMICS Publishing Group", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Neuropsychiatry"], "published-print": {"date-parts": [[2011, 4]]}, "DOI": "10.2217/npy.11.12", "type": "journal-article", "created": {"date-parts": [[2012, 3, 12]], "date-time": "2012-03-12T14:19:49Z", "timestamp": 1331561989000}, "page": "149-164", "source": "Crossref", "is-referenced-by-count": 33, "title": ["Biased agonism at serotonin 5-HT1A receptors: preferential postsynaptic activity for improved therapy of CNS disorders"], "prefix": "10.4172", "volume": "1", "author": [{"given": "Adrian", "family": "Newman-Tancredi", "sequence": "first", "affiliation": []}], "member": "2674", "container-title": ["Neuropsychiatry"], "language": "en", "deposited": {"date-parts": [[2017, 4, 27]], "date-time": "2017-04-27T14:40:26Z", "timestamp": 1493304026000}, "score": 31.190943, "issued": {"date-parts": [[2011, 4]]}, "references-count": 135, "journal-issue": {"published-print": {"date-parts": [[2011, 4]]}, "issue": "2"}, "alternative-id": ["10.2217/npy.11.12"], "URL": "http://dx.doi.org/10.2217/npy.11.12", "ISSN": ["1758-2008"], "issn-type": [{"value": "1758-2008", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 12, 21]], "date-time": "2018-12-21T22:42:38Z", "timestamp": 1545432158170}, "reference-count": 0, "publisher": "Bentham Science Publishers Ltd.", "issue": "26", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["CPD"], "published-print": {"date-parts": [[2015, 8, 27]]}, "DOI": "10.2174/1381612821666150605105215", "type": "journal-article", "created": {"date-parts": [[2015, 9, 2]], "date-time": "2015-09-02T05:30:52Z", "timestamp": 1441171852000}, "page": "3725-3731", "source": "Crossref", "is-referenced-by-count": 10, "title": ["Serotonin 5-HT<sub>1A</sub> Receptors and Antipsychotics - An Update in Light of New Concepts and Drugs"], "prefix": "10.2174", "volume": "21", "author": [{"given": "Andrew", "family": "McCreary", "sequence": "first", "affiliation": []}, {"given": "Adrian", "family": "Newman-Tancredi", "sequence": "additional", "affiliation": []}], "member": "965", "container-title": ["Current Pharmaceutical Design"], "language": "en", "link": [{"URL": "http://eurekaselect.com/article/download/132017", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2015, 11, 18]], "date-time": "2015-11-18T12:59:27Z", "timestamp": 1447851567000}, "score": 29.032433, "issued": {"date-parts": [[2015, 8, 27]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2015, 8, 27]]}, "issue": "26"}, "alternative-id": ["LiveAll1"], "URL": "http://dx.doi.org/10.2174/1381612821666150605105215", "ISSN": ["1381-6128"], "issn-type": [{"value": "1381-6128", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 10, 7]], "date-time": "2018-10-07T11:40:38Z", "timestamp": 1538912438874}, "reference-count": 121, "publisher": "Elsevier BV", "content-domain": {"domain": ["elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Neurobiology of Learning and Memory"], "published-print": {"date-parts": [[2014, 4]]}, "DOI": "10.1016/j.nlm.2013.12.015", "type": "journal-article", "created": {"date-parts": [[2014, 1, 11]], "date-time": "2014-01-11T15:45:35Z", "timestamp": 1389455135000}, "page": "72-80", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 28, "title": ["Improving cognition in schizophrenia with antipsychotics that elicit neurogenesis through 5-HT1A receptor activation"], "prefix": "10.1016", "volume": "110", "author": [{"given": "Rudy", "family": "Schreiber", "sequence": "first", "affiliation": []}, {"given": "Adrian", "family": "Newman-Tancredi", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Neurobiology of Learning and Memory"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1074742713002712?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1074742713002712?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 10, 7]], "date-time": "2018-10-07T10:59:54Z", "timestamp": 1538909994000}, "score": 29.032433, "issued": {"date-parts": [[2014, 4]]}, "references-count": 121, "alternative-id": ["S1074742713002712"], "URL": "http://dx.doi.org/10.1016/j.nlm.2013.12.015", "ISSN": ["1074-7427"], "issn-type": [{"value": "1074-7427", "type": "print"}], "subject": ["Experimental and Cognitive Psychology", "Cognitive Neuroscience", "Behavioral Neuroscience"], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "Improving cognition in schizophrenia with antipsychotics that elicit neurogenesis through 5-HT1A receptor activation", "name": "articletitle", "label": "Article Title"}, {"value": "Neurobiology of Learning and Memory", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.nlm.2013.12.015", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "Copyright \u00a9 2014 Elsevier Inc. All rights reserved.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2018, 5, 7]], "date-time": "2018-05-07T17:42:24Z", "timestamp": 1525714944465}, "reference-count": 0, "publisher": "Portland Press Ltd.", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Biochm. Soc. Trans."], "published-print": {"date-parts": [[1991, 4]]}, "DOI": "10.1042/bst019144s", "type": "journal-article", "created": {"date-parts": [[2015, 8, 11]], "date-time": "2015-08-11T12:35:16Z", "timestamp": 1439296516000}, "page": "144S-144S", "source": "Crossref", "is-referenced-by-count": 0, "title": ["High level expression of serotonin (5HT-1a) receptor in animal cells"], "prefix": "10.1042", "volume": "19", "author": [{"given": "ADRIAN", "family": "NEWMAN-TANCREDI", "sequence": "first", "affiliation": []}, {"given": "PHILIP G.", "family": "STRANGE", "sequence": "additional", "affiliation": []}], "member": "288", "published-online": {"date-parts": [[1991, 4, 1]]}, "container-title": ["Biochemical Society Transactions"], "language": "en", "deposited": {"date-parts": [[2015, 8, 11]], "date-time": "2015-08-11T12:35:56Z", "timestamp": 1439296556000}, "score": 26.235138, "issued": {"date-parts": [[1991, 4]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[1991, 4, 1]]}, "published-print": {"date-parts": [[1991, 4]]}, "issue": "2"}, "alternative-id": ["10.1042/bst019144s"], "URL": "http://dx.doi.org/10.1042/bst019144s", "ISSN": ["0300-5127", "1470-8752"], "issn-type": [{"value": "0300-5127", "type": "print"}, {"value": "1470-8752", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 8, 29]], "date-time": "2018-08-29T22:02:28Z", "timestamp": 1535580148728}, "reference-count": 228, "publisher": "Springer Nature", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Psychopharmacology"], "published-print": {"date-parts": [[2011, 8]]}, "DOI": "10.1007/s00213-011-2247-y", "type": "journal-article", "created": {"date-parts": [[2011, 3, 10]], "date-time": "2011-03-10T09:55:41Z", "timestamp": 1299750941000}, "page": "451-473", "source": "Crossref", "is-referenced-by-count": 82, "title": ["Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties"], "prefix": "10.1007", "volume": "216", "author": [{"given": "Adrian", "family": "Newman-Tancredi", "sequence": "first", "affiliation": []}, {"given": "Mark S.", "family": "Kleven", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2011, 3, 11]]}, "reference": [{"key": "2247_CR1", "doi-asserted-by": "crossref", "first-page": "3251", "DOI": "10.1517/14656560802532707", "volume": "9", "author": "A Abbas", "year": "2008", "unstructured": "Abbas A, Roth BL (2008) Pimavanserin tartrate: a 5-HT2A inverse agonist with potential for treating various neuropsychiatric disorders. Expert Opin Pharmacother 9:3251\u20133259", "journal-title": "Expert Opin Pharmacother"}, {"key": "2247_CR2", "doi-asserted-by": "crossref", "first-page": "119", "DOI": "10.1007/s00213-009-1521-8", "volume": "205", "author": "AI Abbas", "year": "2009", "unstructured": "Abbas AI, Hedlund PB, Huang XP, Tran TB, Meltzer HY, Roth BL (2009) Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo. Psychopharmacol (Berl) 205:119\u2013128", "journal-title": "Psychopharmacol (Berl)"}, {"key": "2247_CR3", "doi-asserted-by": "crossref", "first-page": "57", "DOI": "10.1177/0269881103017001700", "volume": "17", "author": "Z Abdul-Monim", "year": "2003", "unstructured": "Abdul-Monim Z, Reynolds GP, Neill JC (2003) The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat. J Psychopharmacol 17:57\u201365", "journal-title": "J Psychopharmacol"}, {"issue": "Suppl 1", "key": "2247_CR4", "doi-asserted-by": "crossref", "first-page": "S1", "DOI": "10.1017/S1461145704004110", "volume": "7", "author": "A Abi-Dargham", "year": "2004", "unstructured": "Abi-Dargham A (2004) Do we still believe in the dopamine hypothesis? New data bring new evidence. Int J Neuropsychopharmacol 7(Suppl 1):S1\u2013S5", "journal-title": "Int J Neuropsychopharmacol"}, {"issue": "10", "key": "2247_CR5", "doi-asserted-by": "crossref", "first-page": "1383", "DOI": "10.1017/S1461145710000787", "volume": "13", "author": "B Aggernaes", "year": "2010", "unstructured": "Aggernaes B, Glenthoj BY, Ebdrup BH, Rasmussen H, Lublin H, Oranje B (2010) Sensorimotor gating and habituation in antipsychotic-naive, first-episode schizophrenia patients before and after 6\u00a0months\u2019 treatment with quetiapine. Int J Neuropsychopharmacol 13(10):1383\u20131395", "journal-title": "Int J Neuropsychopharmacol"}, {"key": "2247_CR6", "doi-asserted-by": "crossref", "first-page": "1879", "DOI": "10.1016/j.pnpbp.2008.08.020", "volume": "32", "author": "S Akhondzadeh", "year": "2008", "unstructured": "Akhondzadeh S, Malek-Hosseini M, Ghoreishi A, Raznahan M, Rezazadeh SA (2008) Effect of ritanserin, a 5HT2A/2\u00a0C antagonist, on negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study. Prog Neuropsychopharmacol Biol Psychiatry 32:1879\u20131883", "journal-title": "Prog Neuropsychopharmacol Biol Psychiatry"}, {"key": "2247_CR7", "doi-asserted-by": "crossref", "first-page": "627", "DOI": "10.1016/j.biopsych.2009.03.012", "volume": "66", "author": "E Akimova", "year": "2009", "unstructured": "Akimova E, Lanzenberger R, Kasper S (2009) The serotonin-1A receptor in anxiety disorders. Biol Psychiatry 66:627\u2013635", "journal-title": "Biol Psychiatry"}, {"key": "2247_CR8", "first-page": "35", "volume": "4", "author": "PR Albert", "year": "2010", "unstructured": "Albert PR, Francois BL (2010) Modifying 5-HT1A receptor gene expression as a new target for antidepressant therapy. Front Neurosci 4:35", "journal-title": "Front Neurosci"}, {"key": "2247_CR9", "doi-asserted-by": "crossref", "first-page": "281", "DOI": "10.1093/cercor/bhg128", "volume": "14", "author": "M Amargos-Bosch", "year": "2004", "unstructured": "Amargos-Bosch M, Bortolozzi A, Puig MV, Serrats J, Adell A, Celada P, Toth M, Mengod G, Artigas F (2004) Co-expression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex. Cereb Cortex 14:281\u2013299", "journal-title": "Cereb Cortex"}, {"key": "2247_CR10", "doi-asserted-by": "crossref", "first-page": "106", "DOI": "10.1016/S0165-0173(99)00027-2", "volume": "31", "author": "NC Andreasen", "year": "2000", "unstructured": "Andreasen NC (2000) Schizophrenia: the fundamental questions. Brain Res Brain Res Rev 31:106\u2013112", "journal-title": "Brain Res Brain Res Rev"}, {"key": "2247_CR11", "doi-asserted-by": "crossref", "first-page": "777", "DOI": "10.1358/dof.2008.033.09.1236966", "volume": "33", "author": "J Arnt", "year": "2008", "unstructured": "Arnt J, Bang-Andersen B, Dias R, Boges\u00f8 KP (2008) Strategies or pharmacotherapy of schizophrenia. Drugs Future 33:777\u2013791", "journal-title": "Drugs Future"}, {"key": "2247_CR12", "doi-asserted-by": "crossref", "first-page": "15", "DOI": "10.1016/0014-2999(96)00086-6", "volume": "304", "author": "MB Assie", "year": "1996", "unstructured": "Assie MB, Koek W (1996) Effects of 5-HT1A receptor antagonists on hippocampal 5-hydroxytryptamine levels: (S)-WAY100135, but not WAY100635, has partial agonist properties. Eur J Pharmacol 304:15\u201321", "journal-title": "Eur J Pharmacol"}, {"key": "2247_CR13", "doi-asserted-by": "crossref", "first-page": "441", "DOI": "10.1007/s00210-006-0092-z", "volume": "373", "author": "MB Assie", "year": "2006", "unstructured": "Assie MB, Dominguez H, Consul-Denjean N, Newman-Tancredi A (2006) In vivo occupancy of dopamine D2 receptors by antipsychotic drugs and novel compounds in the mouse striatum and olfactory tubercles. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 373:441\u2013450", "journal-title": "Naunyn-Schmiedeberg\u2019s Arch Pharmacol"}, {"key": "2247_CR14", "doi-asserted-by": "crossref", "first-page": "160", "DOI": "10.1016/j.ejphar.2008.06.105", "volume": "592", "author": "MB Assie", "year": "2008", "unstructured": "Assie MB, Carilla-Durand E, Bardin L, Maraval M, Aliaga M, Malfetes N, Barbara M, Newman-Tancredi A (2008) The antipsychotics clozapine and olanzapine increase plasma glucose and corticosterone levels in rats: comparison with aripiprazole, ziprasidone, bifeprunox and F15063. Eur J Pharmacol 592:160\u2013166", "journal-title": "Eur J Pharmacol"}, {"key": "2247_CR15", "doi-asserted-by": "crossref", "first-page": "141", "DOI": "10.1016/S0014-2999(97)01207-7", "volume": "334", "author": "MB Assi\u00e9", "year": "1997", "unstructured": "Assi\u00e9 MB, Cosi C, Koek W (1997) 5-HT1A receptor agonist properties of the antipsychotic, nemonapride: comparison with bromerguride and clozapine. Eur J Pharmacol 334:141\u2013147", "journal-title": "Eur J Pharmacol"}, {"key": "2247_CR16", "doi-asserted-by": "crossref", "first-page": "265", "DOI": "10.1124/jpet.105.087163", "volume": "315", "author": "MB Assi\u00e9", "year": "2005", "unstructured": "Assi\u00e9 MB, Ravailhe V, Faucillon V, Newman-Tancredi A (2005) Contrasting contribution of 5-hydroxytryptamine 1A receptor activation to neurochemical profile of novel antipsychotics: frontocortical dopamine and hippocampal serotonin release in rat brain. J Pharmacol Exp Ther 315:265\u2013272", "journal-title": "J Pharmacol Exp Ther"}, {"key": "2247_CR17", "doi-asserted-by": "crossref", "first-page": "74", "DOI": "10.1016/j.ejphar.2009.02.001", "volume": "607", "author": "MB Assi\u00e9", "year": "2009", "unstructured": "Assi\u00e9 MB, Mnie-Filali O, Ravailhe V, Benas C, Marien M, Betry C, Zimmer L, Haddjeri N, Newman-Tancredi A (2009) F15063, a potential antipsychotic with dopamine D2/D3 receptor antagonist, 5-HT1A receptor agonist and dopamine D4 receptor partial agonist properties: influence on neuronal firing and neurotransmitter release. Eur J Pharmacol 607:74\u201383", "journal-title": "Eur J Pharmacol"}, {"key": "2247_CR18", "unstructured": "Auclair A, Newman-Tancredi A, Depoortere R (2006a) Comparative analysis of typical, atypical, and novel antipsychotics with preferential D2/D3 and 5-HT1A affinity in rodent models of cognitive flexibility and sensory gating: II The reversal learning task and PPI of the startle reflex. 25th Congress of International NeuroPsychopharmacology. Int J Neuropsychopharm, Chicago, pp P01.167"}, {"key": "2247_CR19", "doi-asserted-by": "crossref", "first-page": "1900", "DOI": "10.1038/sj.npp.1301015", "volume": "31", "author": "AL Auclair", "year": "2006", "unstructured": "Auclair AL, Kleven MS, Besnard J, Depoortere R, Newman-Tancredi A (2006b) Actions of novel antipsychotic agents on apomorphine-induced PPI disruption: influence of combined serotonin 5-HT1A receptor activation and dopamine D2 receptor blockade. Neuropsychopharmacology 31:1900\u20131909", "journal-title": "Neuropsychopharmacology"}, {"key": "2247_CR20", "doi-asserted-by": "crossref", "first-page": "45", "DOI": "10.1007/s00213-007-0762-7", "volume": "193", "author": "AL Auclair", "year": "2007", "unstructured": "Auclair AL, Galinier A, Besnard J, Newman-Tancredi A, Depoortere R (2007) Putative antipsychotics with pronounced agonism at serotonin 5-HT1A and partial agonist activity at dopamine D2 receptors disrupt basal PPI of the startle reflex in rats. Psychopharmacol Berl 193:45\u201354", "journal-title": "Psychopharmacol Berl"}, {"key": "2247_CR21", "unstructured": "Auclair AL, Galinier A, Besnard J, Newman-Tancredi ARD (2008) Effects of antipsychotics on working memory and attentional performance in Delayed non-matching to position test and in 5 choice serial reaction time task. Society for Neuroscience 38th Annual Meeting, Washington D.C., pp 155.10"}, {"key": "2247_CR22", "doi-asserted-by": "crossref", "first-page": "288", "DOI": "10.1016/j.bbr.2009.05.015", "volume": "203", "author": "AL Auclair", "year": "2009", "unstructured": "Auclair AL, Kleven MS, Barret-Grevoz C, Barreto M, Newman-Tancredi A, Depoortere R (2009) Differences among conventional, atypical and novel putative D2/5-HT1A antipsychotics on catalepsy-associated behaviour in cynomolgus monkeys. Behav Brain Res 203:288\u2013295", "journal-title": "Behav Brain Res"}, {"issue": "5", "key": "2247_CR23", "first-page": "1323", "volume": "114", "author": "AL Auclair", "year": "2010", "unstructured": "Auclair AL, Cathala A, Sarrazin F, Depoortere R, Piazza PV, Newman-Tancredi A, Spampinato U (2010) The central serotonin(2B) receptor: a new pharmacological target to modulate the mesoaccumbens dopaminergic pathway activity. J Neurochem 114(5):1323\u20131332", "journal-title": "J Neurochem"}, {"key": "2247_CR24", "doi-asserted-by": "crossref", "first-page": "37", "DOI": "10.1177/026988110101500108", "volume": "15", "author": "RA Bantick", "year": "2001", "unstructured": "Bantick RA, Deakin JF, Grasby PM (2001) The 5-HT1A receptor in schizophrenia: a promising target for novel atypical neuroleptics? J Psychopharmacol 15:37\u201346", "journal-title": "J Psychopharmacol"}, {"key": "2247_CR25", "doi-asserted-by": "crossref", "first-page": "346", "DOI": "10.1177/026988110401800304", "volume": "18", "author": "RA Bantick", "year": "2004", "unstructured": "Bantick RA, Montgomery AJ, Bench CJ, Choudhry T, Malek N, McKenna PJ, Quested DJ, Deakin JF, Grasby PM (2004a) A positron emission tomography study of the 5-HT1A receptor in schizophrenia and during clozapine treatment. J Psychopharmacol 18:346\u2013354", "journal-title": "J Psychopharmacol"}, {"key": "2247_CR26", "doi-asserted-by": "crossref", "first-page": "847", "DOI": "10.1038/sj.npp.1300390", "volume": "29", "author": "RA Bantick", "year": "2004", "unstructured": "Bantick RA, Rabiner EA, Hirani E, de Vries MH, Hume SP, Grasby PM (2004b) Occupancy of agonist drugs at the 5-HT1A receptor. Neuropsychopharmacology 29:847\u2013859", "journal-title": "Neuropsychopharmacology"}, {"key": "2247_CR27", "unstructured": "Barak S, Weiner I (2011) The M1/M4 preferring agonist xanomeline reverses amphetamine-, MK801- and scopolamine-induced abnormalities of latent inhibition: putative efficacy against positive, negative and cognitive symptoms in schizophrenia. Int J Neuropsychopharmacol 1\u201314 (in press)"}, {"key": "2247_CR28", "doi-asserted-by": "crossref", "first-page": "1869", "DOI": "10.1038/sj.npp.1300940", "volume": "31", "author": "L Bardin", "year": "2006", "unstructured": "Bardin L, Kleven MS, Barret-Grevoz C, Depoortere R, Newman-Tancredi A (2006a) Antipsychotic-like vs cataleptogenic actions in mice of novel antipsychotics having D2 antagonist and 5-HT1A agonist properties. Neuropsychopharmacology 31:1869\u20131879", "journal-title": "Neuropsychopharmacology"}, {"key": "2247_CR29", "unstructured": "Bardin L, Newman-Tancredi A, Depoort\u00e8re R (2006b) Comparative analysis of typical, atypical, and novel antipsychotics with preferential D2/D3 and 5-HT1A affinity in rodent models of cognition and memory deficits: I The hole-board and the social recognition tests. 25th Congress of International NeuroPsychopharmacology. Int J Neuropsychopharm Chicago, pp P01.166"}, {"key": "2247_CR30", "doi-asserted-by": "crossref", "first-page": "103", "DOI": "10.1097/FBP.0b013e3280ae6c96", "volume": "18", "author": "L Bardin", "year": "2007", "unstructured": "Bardin L, Auclair A, Kleven MS, Prinssen EP, Koek W, Newman-Tancredi A, Depoortere R (2007) Pharmacological profiles in rats of novel antipsychotics with combined dopamine D2/serotonin 5-HT1A activity: comparison with typical and atypical conventional antipsychotics. Behav Pharmacol 18:103\u2013118", "journal-title": "Behav Pharmacol"}, {"key": "2247_CR31", "doi-asserted-by": "crossref", "first-page": "1083", "DOI": "10.1016/S0028-3908(99)00010-6", "volume": "38", "author": "NM Barnes", "year": "1999", "unstructured": "Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38:1083\u20131152", "journal-title": "Neuropharmacology"}, {"key": "2247_CR32", "doi-asserted-by": "crossref", "first-page": "1645", "DOI": "10.1016/S0028-3908(96)00110-4", "volume": "35", "author": "GD Bartoszyk", "year": "1996", "unstructured": "Bartoszyk GD, Roos C, Ziegler H (1996) 5-HT1A receptors are not involved in clozapine\u2019s lack of cataleptogenic potential. Neuropharmacology 35:1645\u20131646", "journal-title": "Neuropharmacology"}, {"key": "2247_CR33", "doi-asserted-by": "crossref", "first-page": "4807", "DOI": "10.1523/JNEUROSCI.5113-03.2004", "volume": "24", "author": "JC Beique", "year": "2004", "unstructured": "Beique JC, Campbell B, Perring P, Hamblin MW, Walker P, Mladenovic L, Andrade R (2004) Serotonergic regulation of membrane potential in developing rat prefrontal cortex: coordinated expression of 5-hydroxytryptamine (5-HT)1A, 5-HT2A, and 5-HT7 receptors. J Neurosci 24:4807\u20134817", "journal-title": "J Neurosci"}, {"issue": "Suppl", "key": "2247_CR34", "doi-asserted-by": "crossref", "first-page": "43", "DOI": "10.1016/0924-977X(95)00022-H", "volume": "5", "author": "O Benkert", "year": "1995", "unstructured": "Benkert O, Muller-Siecheneder F, Wetzel H (1995) Dopamine agonists in schizophrenia: a review. Eur Neuropsychopharmacol 5(Suppl):43\u201353", "journal-title": "Eur Neuropsychopharmacol"}, {"key": "2247_CR35", "doi-asserted-by": "crossref", "first-page": "379", "DOI": "10.1111/j.1527-3458.2005.tb00055.x", "volume": "11", "author": "AC Berends", "year": "2005", "unstructured": "Berends AC, Luiten PG, Nyakas C (2005) A review of the neuroprotective properties of the 5-HT1A receptor agonist repinotan HCl (BAYx3702) in ischemic stroke. CNS Drug Rev 11:379\u2013402", "journal-title": "CNS Drug Rev"}, {"key": "2247_CR36", "doi-asserted-by": "crossref", "first-page": "193", "DOI": "10.1016/S0006-3223(02)01643-8", "volume": "53", "author": "P Blier", "year": "2003", "unstructured": "Blier P, Ward NM (2003) Is there a role for 5-HT1A agonists in the treatment of depression? Biol Psychiatry 53:193\u2013203", "journal-title": "Biol Psychiatry"}, {"key": "2247_CR37", "doi-asserted-by": "crossref", "first-page": "745", "DOI": "10.1007/s00213-007-0698-y", "volume": "191", "author": "A Bortolozzi", "year": "2007", "unstructured": "Bortolozzi A, Diaz-Mataix L, Toth M, Celada P, Artigas F (2007) In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain. Psychopharmacol Berl 191:745\u2013758", "journal-title": "Psychopharmacol Berl"}, {"issue": "10", "key": "2247_CR38", "doi-asserted-by": "crossref", "first-page": "1299", "DOI": "10.1017/S146114571000009X", "volume": "13", "author": "A Bortolozzi", "year": "2010", "unstructured": "Bortolozzi A, Masana M, Diaz-Mataix L, Cortes R, Scorza MC, Gingrich JA, Toth M, Artigas F (2010) Dopamine release induced by atypical antipsychotics in prefrontal cortex requires 5-HT1A receptors but not 5-HT2A receptors. Int J Neuropsychopharmacol 13(10):1299\u20131314", "journal-title": "Int J Neuropsychopharmacol"}, {"key": "2247_CR39", "doi-asserted-by": "crossref", "first-page": "1121", "DOI": "10.1016/j.neuropharm.2004.02.008", "volume": "46", "author": "D Boulay", "year": "2004", "unstructured": "Boulay D, Depoortere R, Louis C, Perrault G, Griebel G, Soubrie P (2004) SSR181507, a putative atypical antipsychotic with dopamine D2 antagonist and 5-HT1A agonist activities: improvement of social interaction deficits induced by phencyclidine in rats. Neuropharmacology 46:1121\u20131129", "journal-title": "Neuropharmacology"}, {"key": "2247_CR40", "doi-asserted-by": "crossref", "first-page": "416", "DOI": "10.1038/npp.2009.144", "volume": "35", "author": "D Boulay", "year": "2010", "unstructured": "Boulay D, Bergis O, Avenet P, Griebel G (2010) The glycine transporter-1 inhibitor SSR103800 displays a selective and specific antipsychotic-like profile in normal and transgenic mice. Neuropsychopharmacology 35:416\u2013427", "journal-title": "Neuropsychopharmacology"}, {"key": "2247_CR41", "doi-asserted-by": "crossref", "first-page": "155", "DOI": "10.1007/s00213-010-1938-0", "volume": "212", "author": "AM Bradford", "year": "2010", "unstructured": "Bradford AM, Savage KM, Jones DN, Kalinichev M (2010) Validation and pharmacological characterisation of MK-801-induced locomotor hyperactivity in BALB/C mice as an assay for detection of novel antipsychotics. Psychopharmacol Berl 212:155\u2013170", "journal-title": "Psychopharmacol Berl"}, {"key": "2247_CR42", "doi-asserted-by": "crossref", "first-page": "229", "DOI": "10.1358/dnp.2010.23.4.1416977", "volume": "23", "author": "TM Bridges", "year": "2010", "unstructured": "Bridges TM, LeBois EP, Hopkins CR, Wood MR, Jones CK, Conn PJ, Lindsley CW (2010) The antipsychotic potential of muscarinic allosteric modulation. Drug News Perspect 23:229\u2013240", "journal-title": "Drug News Perspect"}, {"key": "2247_CR43", "doi-asserted-by": "crossref", "first-page": "21", "DOI": "10.1161/CIRCHEARTFAILURE.109.885962", "volume": "3", "author": "MR Bristow", "year": "2010", "unstructured": "Bristow MR, Murphy GA, Krause-Steinrauf H, Anderson JL, Carlquist JF, Thaneemit-Chen S, Krishnan V, Abraham WT, Lowes BD, Port JD, Davis GW, Lazzeroni LC, Robertson AD, Lavori PW, Liggett SB (2010) An alpha2C-adrenergic receptor polymorphism alters the norepinephrine-lowering effects and therapeutic response of the beta-blocker bucindolol in chronic heart failure. Circ Heart Fail 3:21\u201328", "journal-title": "Circ Heart Fail"}, {"key": "2247_CR44", "doi-asserted-by": "crossref", "first-page": "996", "DOI": "10.1016/j.neuropharm.2005.05.013", "volume": "49", "author": "LA Bruins Slot", "year": "2005", "unstructured": "Bruins Slot LA, Kleven MS, Newman-Tancredi A (2005) Effects of novel antipsychotics with mixed D(2) antagonist/5-HT(1A) agonist properties on PCP-induced social interaction deficits in the rat. Neuropharmacology 49:996\u20131006", "journal-title": "Neuropharmacology"}, {"key": "2247_CR45", "doi-asserted-by": "crossref", "first-page": "63", "DOI": "10.1016/j.ejphar.2006.01.027", "volume": "534", "author": "LA Bruins Slot", "year": "2006", "unstructured": "Bruins Slot LA, De Vries L, Newman-Tancredi A, Cussac D (2006) Differential profile of antipsychotics at serotonin 5-HT1A and dopamine D2S receptors coupled to extracellular signal-regulated kinase. Eur J Pharmacol 534:63\u201370", "journal-title": "Eur J Pharmacol"}, {"key": "2247_CR46", "doi-asserted-by": "crossref", "first-page": "565", "DOI": "10.1016/S0197-0186(96)00124-6", "volume": "30", "author": "PW Burnet", "year": "1997", "unstructured": "Burnet PW, Eastwood SL, Harrison PJ (1997) [3\u00a0H]WAY-100635 for 5-HT1A receptor autoradiography in human brain: a comparison with [3\u00a0H]8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia. Neurochem Int 30:565\u2013574", "journal-title": "Neurochem Int"}, {"key": "2247_CR47", "doi-asserted-by": "crossref", "first-page": "139", "DOI": "10.1016/0893-133X(94)00071-7", "volume": "12", "author": "SB Caine", "year": "1995", "unstructured": "Caine SB, Geyer MA, Swerdlow NR (1995) Effects of D3/D2 dopamine receptor agonists and antagonists on prepulse inhibition of acoustic startle in the rat. Neuropsychopharmacology 12:139\u2013145", "journal-title": "Neuropsychopharmacology"}, {"key": "2247_CR48", "doi-asserted-by": "crossref", "first-page": "853", "DOI": "10.1111/j.1471-4159.2005.03600.x", "volume": "96", "author": "E Calcagno", "year": "2006", "unstructured": "Calcagno E, Carli M, Invernizzi RW (2006) The 5-HT(1A) receptor agonist 8-OH-DPAT prevents prefrontocortical glutamate and serotonin release in response to blockade of cortical NMDA receptors. J Neurochem 96:853\u2013860", "journal-title": "J Neurochem"}, {"key": "2247_CR49", "unstructured": "Carilla-Durand E, Assi\u00e9 MB, Maraval M, Newman-Tancredi A (2004a) Effects on plasma prolactin and corticosterone levels of antipsychotics with diverse dopamine D2 and serotonin 5-HT1A properties 24th Congress of International NeuroPsychopharmacology, Paris, pp P02.507"}, {"key": "2247_CR50", "unstructured": "Carilla-Durand E, Assi\u00e9 MB, Maraval M, Newman-Tancredi A (2004b) Effects on plasma prolactin and corticosterone levels of antipsychotics with diverse dopamine D2 and serotonin 5-HT1A properties. 24th Congress of International NeuroPsychopharmacology, Paris, pp Poster P02.507"}, {"key": "2247_CR51", "doi-asserted-by": "crossref", "first-page": "317", "DOI": "10.1007/s00213-008-1207-7", "volume": "200", "author": "DE Casey", "year": "2008", "unstructured": "Casey DE, Sands EE, Heisterberg J, Yang HM (2008) Efficacy and safety of bifeprunox in patients with an acute exacerbation of schizophrenia: results from a randomized, double-blind, placebo-controlled, multicenter, dose-finding study. Psychopharmacol Berl 200:317\u2013331", "journal-title": "Psychopharmacol Berl"}, {"key": "2247_CR52", "unstructured": "Chessick CA, Allen MH, Thase M, Batista Miralha da Cunha AB, Kapczinski FF, de Lima MS, dos Santos Souza JJ (2006) Azapirones for generalized anxiety disorder. Cochrane Database Syst Rev 3: CD006115"}, {"key": "2247_CR53", "doi-asserted-by": "crossref", "first-page": "234", "DOI": "10.1007/s00213-002-1256-2", "volume": "166", "author": "YH Chou", "year": "2003", "unstructured": "Chou YH, Halldin C, Farde L (2003) Occupancy of 5-HT1A receptors by clozapine in the primate brain: a PET study. Psychopharmacol Berl 166:234\u2013240", "journal-title": "Psychopharmacol Berl"}, {"key": "2247_CR54", "doi-asserted-by": "crossref", "first-page": "878", "DOI": "10.1126/science.1094987", "volume": "304", "author": "HF Clarke", "year": "2004", "unstructured": "Clarke HF, Dalley JW, Crofts HS, Robbins TW, Roberts AC (2004) Cognitive inflexibility after prefrontal serotonin depletion. Science 304:878\u2013880", "journal-title": "Science"}, {"key": "2247_CR55", "doi-asserted-by": "crossref", "first-page": "18", "DOI": "10.1093/cercor/bhj120", "volume": "17", "author": "HF Clarke", "year": "2007", "unstructured": "Clarke HF, Walker SC, Dalley JW, Robbins TW, Roberts AC (2007) Cognitive inflexibility after prefrontal serotonin depletion is behaviorally and neurochemically specific. Cereb Cortex 17:18\u201327", "journal-title": "Cereb Cortex"}, {"key": "2247_CR56", "doi-asserted-by": "crossref", "first-page": "91", "DOI": "10.1016/j.pnpbp.2004.10.010", "volume": "29", "author": "I Corripio", "year": "2005", "unstructured": "Corripio I, Catafau AM, Perez V, Puigdemont D, Mena E, Aguilar Y, Carrio I, Alvarez E (2005) Striatal dopaminergic D2 receptor occupancy and clinical efficacy in psychosis exacerbation: a 123I-IBZM study with ziprasidone and haloperidol. Prog Neuropsychopharmacol Biol Psychiatry 29:91\u201396", "journal-title": "Prog Neuropsychopharmacol Biol Psychiatry"}, {"key": "2247_CR57", "doi-asserted-by": "crossref", "first-page": "135", "DOI": "10.1016/j.ejphar.2006.01.051", "volume": "535", "author": "C Cosi", "year": "2006", "unstructured": "Cosi C, Carilla-Durand E, Assi\u00e9 MB, Ormiere AM, Maraval M, Leduc N, Newman-Tancredi A (2006) Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release. Eur J Pharmacol 535:135\u2013144", "journal-title": "Eur J Pharmacol"}, {"key": "2247_CR58", "doi-asserted-by": "crossref", "first-page": "178", "DOI": "10.1016/j.tips.2005.02.007", "volume": "26", "author": "P Csermely", "year": "2005", "unstructured": "Csermely P, Agoston V, Pongor S (2005) The efficiency of multi-target drugs: the network approach might help drug design. Trends Pharmacol Sci 26:178\u2013182", "journal-title": "Trends Pharmacol Sci"}, {"key": "2247_CR59", "doi-asserted-by": "crossref", "first-page": "168", "DOI": "10.1007/s00213-002-1043-0", "volume": "162", "author": "D Cussac", "year": "2002", "unstructured": "Cussac D, Duqueyroix D, Newman-Tancredi A, Millan MJ (2002) Stimulation by antipsychotic agents of mitogen-activated protein kinase (MAPK) coupled to cloned, human (h)serotonin (5-HT)(1A) receptors. Psychopharmacol Berl 162:168\u2013177", "journal-title": "Psychopharmacol Berl"}, {"key": "2247_CR60", "unstructured": "Cussac D, Martel JC, Assi\u00e9 MB, Heusler P, Rauly-Lestienne I, Ailhaud MC, Danty N, Leduc N, Ormi\u00e8re AM, Pulou G, Tardif S, Newman-Tancredi A (2008) Distinctive affinity profile of novel antipsychotics possessing combined D2 and 5-HT1A receptor properties compared with conventional and atypical antipsychotics. Society for Neuroscience\u201438th Annual Meeting, Washington DC, pp 155.9"}, {"key": "2247_CR61", "doi-asserted-by": "crossref", "first-page": "42", "DOI": "10.1016/S0006-8993(03)03352-3", "volume": "989", "author": "A Czyrak", "year": "2003", "unstructured": "Czyrak A, Czepiel K, Mackowiak M, Chocyk A, Wedzony K (2003) Serotonin 5-HT1A receptors might control the output of cortical glutamatergic neurons in rat cingulate cortex. Brain Res 989:42\u201351", "journal-title": "Brain Res"}, {"key": "2247_CR62", "doi-asserted-by": "crossref", "first-page": "177", "DOI": "10.1177/0269881108089586", "volume": "23", "author": "L Dahan", "year": "2009", "unstructured": "Dahan L, Husum H, Mnie-Filali O, Arnt J, Hertel P, Haddjeri N (2009) Effects of bifeprunox and aripiprazole on rat serotonin and dopamine neuronal activity and anxiolytic behaviour. J Psychopharmacol 23:177\u2013189", "journal-title": "J Psychopharmacol"}, {"key": "2247_CR63", "doi-asserted-by": "crossref", "first-page": "553", "DOI": "10.1001/archpsyc.60.6.553", "volume": "60", "author": "JM Davis", "year": "2003", "unstructured": "Davis JM, Chen N, Glick ID (2003) A meta-analysis of the efficacy of second-generation antipsychotics. Arch Gen Psychiatry 60:553\u2013564", "journal-title": "Arch Gen Psychiatry"}, {"key": "2247_CR64", "first-page": "112", "volume": "110", "author": "J Delay", "year": "1952", "unstructured": "Delay J, Deniker P, Harl JM (1952) Utilisation en th\u00e9rapeutique psychiatrique d\u2019une ph\u00e9nothiazine d\u2019action centrale \u00e9lective (4560 RP). Ann Med Psychol (Paris) 110:112\u2013117", "journal-title": "Ann Med Psychol (Paris)"}, {"key": "2247_CR65", "doi-asserted-by": "crossref", "first-page": "1889", "DOI": "10.1038/sj.npp.1300261", "volume": "28", "author": "R Depoortere", "year": "2003", "unstructured": "Depoortere R, Boulay D, Perrault G, Bergis O, Decobert M, Francon D, Jung M, Simiand J, Soubrie P, Scatton B (2003) SSR181507, a dopamine D2 receptor antagonist and 5-HT1A receptor agonistII: Behavioral profile predictive of an atypical antipsychotic activity. Neuropsychopharmacology 28:1889\u20131902", "journal-title": "Neuropsychopharmacology"}, {"key": "2247_CR66", "doi-asserted-by": "crossref", "first-page": "266", "DOI": "10.1038/sj.bjp.0707160", "volume": "151", "author": "R Depoortere", "year": "2007", "unstructured": "Depoortere R, Auclair AL, Bardin L, Bruins Slot L, Kleven MS, Colpaert F, Vacher B, Newman-Tancredi A (2007a) F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. III. Activity in models of cognition and negative symptoms. Br J Pharmacol 151:266\u2013277", "journal-title": "Br J Pharmacol"}, {"key": "2247_CR67", "doi-asserted-by": "crossref", "first-page": "253", "DOI": "10.1038/sj.bjp.0707159", "volume": "151", "author": "R Depoortere", "year": "2007", "unstructured": "Depoortere R, Bardin L, Auclair AL, Kleven MS, Prinssen E, Colpaert F, Vacher B, Newman-Tancredi A (2007b) F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. II. Activity in models of positive symptoms of schizophrenia. Br J Pharmacol 151:253\u2013265", "journal-title": "Br J Pharmacol"}, {"key": "2247_CR68", "doi-asserted-by": "crossref", "first-page": "34", "DOI": "10.1016/j.ejphar.2008.08.011", "volume": "597", "author": "R Depoortere", "year": "2008", "unstructured": "Depoortere R, Barret-Grevoz C, Bardin L, Newman-Tancredi A (2008) Apomorphine-induced emesis in dogs: differential sensitivity to established and novel dopamine D2/5-HT1A antipsychotic compounds. Eur J Pharmacol 597:34\u201338", "journal-title": "Eur J Pharmacol"}, {"key": "2247_CR69", "doi-asserted-by": "crossref", "first-page": "2933", "DOI": "10.1523/JNEUROSCI.5723-07.2008", "volume": "28", "author": "S Doly", "year": "2008", "unstructured": "Doly S, Valjent E, Setola V, Callebert J, Herve D, Launay JM, Maroteaux L (2008) Serotonin 5-HT2B receptors are required for 3,4-methylenedioxymethamphetamine-induced hyperlocomotion and 5-HT release in vivo and in vitro. J Neurosci 28:2933\u20132940", "journal-title": "J Neurosci"}, {"key": "2247_CR70", "doi-asserted-by": "crossref", "first-page": "313", "DOI": "10.1016/S0014-2999(99)00788-8", "volume": "386", "author": "J Elliott", "year": "1999", "unstructured": "Elliott J, Reynolds GP (1999) Agonist-stimulated GTPgamma[35\u00a0S] binding to 5-HT(1A) receptors in human post-mortem brain. Eur J Pharmacol 386:313\u2013315", "journal-title": "Eur J Pharmacol"}, {"key": "2247_CR71", "doi-asserted-by": "crossref", "first-page": "323", "DOI": "10.1034/j.1600-0447.2003.00053.x", "volume": "107", "author": "K Evans", "year": "2003", "unstructured": "Evans K, McGrath J, Milns R (2003) Searching for schizophrenia in ancient Greek and Roman literature: a systematic review. Acta Psychiatr Scand 107:323\u2013330", "journal-title": "Acta Psychiatr Scand"}, {"key": "2247_CR72", "doi-asserted-by": "crossref", "first-page": "439", "DOI": "10.1038/nrd1108", "volume": "2", "author": "B Fermini", "year": "2003", "unstructured": "Fermini B, Fossa AA (2003) The impact of drug-induced QT interval prolongation on drug discovery and development. Nat Rev Drug Discov 2:439\u2013447", "journal-title": "Nat Rev Drug Discov"}, {"key": "2247_CR73", "unstructured": "Fitzgerald LW, Probert AW, Borosky SA, Evans L, Whisman T, Donovan CM, Knauer CS, Akunne H, Johnson DS, White AD, Serpa KA (2009) In vitro pharmacological profile of PF-00217830, a novel dopamine D2 and 5-HT1A partial agonist/5-HT2A antagonist targeting the treatment of positive and negative symptoms of schizophrenia Society for Neuroscience, Chicago, IL, USA, pp 646.23"}, {"key": "2247_CR74", "first-page": "193", "volume": "11", "author": "DC Goff", "year": "1991", "unstructured": "Goff DC, Midha KK, Brotman AW, McCormick S, Waites M, Amico ET (1991) An open trial of buspirone added to neuroleptics in schizophrenic patients. J Clin Psychopharmacol 11:193\u2013197", "journal-title": "J Clin Psychopharmacol"}, {"key": "2247_CR75", "doi-asserted-by": "crossref", "first-page": "885", "DOI": "10.1038/sj.npp.1300933", "volume": "31", "author": "A Gogos", "year": "2006", "unstructured": "Gogos A, Nathan PJ, Guille V, Croft RJ, van den Buuse M (2006) Estrogen prevents 5-HT1A receptor-induced disruptions of prepulse inhibition in healthy women. Neuropsychopharmacology 31:885\u2013889", "journal-title": "Neuropsychopharmacology"}, {"key": "2247_CR76", "doi-asserted-by": "crossref", "first-page": "548", "DOI": "10.1097/FBP.0b013e32830cd822", "volume": "19", "author": "A Gogos", "year": "2008", "unstructured": "Gogos A, Bogeski M, van den Buuse M (2008) Role of serotonin-1A receptors in the action of antipsychotic drugs: comparison of prepulse inhibition studies in mice and rats and relevance for human pharmacology. Behav Pharmacol 19:548\u2013561", "journal-title": "Behav Pharmacol"}, {"key": "2247_CR77", "doi-asserted-by": "crossref", "first-page": "167", "DOI": "10.1097/00004850-199300830-00005", "volume": "8", "author": "P Grof", "year": "1993", "unstructured": "Grof P, Joffe R, Kennedy S, Persad E, Syrotiuk J, Bradford D (1993) An open study of oral flesinoxan, a 5-HT1A receptor agonist, in treatment-resistant depression. Int Clin Psychopharmacol 8:167\u2013172", "journal-title": "Int Clin Psychopharmacol"}, {"key": "2247_CR78", "first-page": "823", "volume": "11", "author": "G Grunder", "year": "2010", "unstructured": "Grunder G (2010) Cariprazine, an orally active D2/D3 receptor antagonist, for the potential treatment of schizophrenia, bipolar mania and depression. Curr Opin Investig Drugs 11:823\u2013832", "journal-title": "Curr Opin Investig Drugs"}, {"key": "2247_CR79", "doi-asserted-by": "crossref", "first-page": "171", "DOI": "10.1016/j.ejphar.2007.06.035", "volume": "572", "author": "I Gyertyan", "year": "2007", "unstructured": "Gyertyan I, Saghy K (2007) The selective dopamine D3 receptor antagonists, SB 277011-A and S 33084 block haloperidol-induced catalepsy in rats. Eur J Pharmacol 572:171\u2013174", "journal-title": "Eur J Pharmacol"}, {"key": "2247_CR80", "doi-asserted-by": "crossref", "first-page": "214", "DOI": "10.1016/j.biopsych.2009.02.033", "volume": "66", "author": "MR Hadjighassem", "year": "2009", "unstructured": "Hadjighassem MR, Austin MC, Szewczyk B, Daigle M, Stockmeier CA, Albert PR (2009) Human Freud-2/CC2D1B: a novel repressor of postsynaptic serotonin-1A receptor expression. Biol Psychiatry 66:214\u2013222", "journal-title": "Biol Psychiatry"}, {"key": "2247_CR81", "doi-asserted-by": "crossref", "first-page": "448", "DOI": "10.1016/j.euroneuro.2007.11.005", "volume": "18", "author": "H Hagiwara", "year": "2008", "unstructured": "Hagiwara H, Fujita Y, Ishima T, Kunitachi S, Shirayama Y, Iyo M, Hashimoto K (2008) Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antipsychotic drug perospirone: role of serotonin 5-HT1A receptors. Eur Neuropsychopharmacol 18:448\u2013454", "journal-title": "Eur Neuropsychopharmacol"}, {"key": "2247_CR82", "doi-asserted-by": "crossref", "first-page": "355", "DOI": "10.1016/0024-3205(91)90556-Q", "volume": "48", "author": "T Hashimoto", "year": "1991", "unstructured": "Hashimoto T, Nishino N, Nakai H, Tanaka C (1991) Increase in serotonin 5-HT1A receptors in prefrontal and temporal cortices of brains from patients with chronic schizophrenia. Life Sci 48:355\u2013363", "journal-title": "Life Sci"}, {"key": "2247_CR83", "doi-asserted-by": "crossref", "first-page": "49", "DOI": "10.1016/j.schres.2009.05.030", "volume": "113", "author": "K Hatta", "year": "2009", "unstructured": "Hatta K, Sato K, Hamakawa H, Takebayashi H, Kimura N, Ochi S, Sudo Y, Asukai N, Nakamura H, Usui C, Kawabata T, Hirata T, Sawa Y (2009) Effectiveness of second-generation antipsychotics with acute-phase schizophrenia. Schizophr Res 113:49\u201355", "journal-title": "Schizophr Res"}, {"key": "2247_CR84", "doi-asserted-by": "crossref", "first-page": "1106", "DOI": "10.1016/j.neuropharm.2006.11.008", "volume": "52", "author": "P Heusler", "year": "2007", "unstructured": "Heusler P, Newman-Tancredi A, Castro-Fernandez A, Cussac D (2007) Differential agonist and inverse agonist profile of antipsychotics at D2L receptors coupled to GIRK potassium channels. Neuropharmacology 52:1106\u20131113", "journal-title": "Neuropharmacology"}, {"key": "2247_CR85", "doi-asserted-by": "crossref", "first-page": "37", "DOI": "10.1016/j.ejphar.2007.11.046", "volume": "581", "author": "P Heusler", "year": "2008", "unstructured": "Heusler P, Newman-Tancredi A, Loock T, Cussac D (2008) Antipsychotics differ in their ability to internalise human dopamine D2S and human serotonin 5-HT1A receptors in HEK293 cells. Eur J Pharmacol 581:37\u201346", "journal-title": "Eur J Pharmacol"}, {"key": "2247_CR86", "doi-asserted-by": "crossref", "first-page": "13432", "DOI": "10.1073/pnas.96.23.13432", "volume": "96", "author": "GD Honey", "year": "1999", "unstructured": "Honey GD, Bullmore ET, Soni W, Varatheesan M, Williams SC, Sharma T (1999) Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia. Proc Natl Acad Sci USA 96:13432\u201313437", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "2247_CR87", "unstructured": "Horiguchi M, Meltzer HY (2010) Interactions among the atypical antipsychotic drug (APD), lurasidone, 5-HT1A and metabotropic glutamate receptor 2/3 (mGluR2/3) agonism, and 5-HT2A antagonism, to attenuate phencyclidine (PCP)-induced deficit in rat novel object recognition (NOR) Society for Neuroscience\u201440th Annual Meeting, San Diego, CA, pp Program No. 610.12"}, {"key": "2247_CR88", "doi-asserted-by": "crossref", "first-page": "549", "DOI": "10.1093/schbul/sbp006", "volume": "35", "author": "OD Howes", "year": "2009", "unstructured": "Howes OD, Kapur S (2009) The dopamine hypothesis of schizophrenia: version III\u2014the final common pathway. Schizophr Bull 35:549\u2013562", "journal-title": "Schizophr Bull"}, {"issue": "Suppl 1", "key": "2247_CR89", "doi-asserted-by": "crossref", "first-page": "S7", "DOI": "10.1017/S1461145704004122", "volume": "7", "author": "OD Howes", "year": "2004", "unstructured": "Howes OD, McDonald C, Cannon M, Arseneault L, Boydell J, Murray RM (2004) Pathways to schizophrenia: the impact of environmental factors. Int J Neuropsychopharmacol 7(Suppl 1):S7\u2013S13", "journal-title": "Int J Neuropsychopharmacol"}, {"key": "2247_CR90", "doi-asserted-by": "crossref", "first-page": "621", "DOI": "10.1111/1469-8986.3560621", "volume": "35", "author": "WG Iacono", "year": "1998", "unstructured": "Iacono WG (1998) Identifying psychophysiological risk for psychopathology: examples from substance abuse and schizophrenia research. Psychophysiology 35:621\u2013637", "journal-title": "Psychophysiology"}, {"key": "2247_CR91", "doi-asserted-by": "crossref", "first-page": "252", "DOI": "10.1016/S0006-8993(99)02346-X", "volume": "858", "author": "J Ichikawa", "year": "2000", "unstructured": "Ichikawa J, Meltzer HY (2000) The effect of serotonin(1A) receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens. Brain Res 858:252\u2013263", "journal-title": "Brain Res"}, {"key": "2247_CR92", "doi-asserted-by": "crossref", "first-page": "1521", "DOI": "10.1046/j.1471-4159.2001.00154.x", "volume": "76", "author": "J Ichikawa", "year": "2001", "unstructured": "Ichikawa J, Ishii H, Bonaccorso S, Fowler WL, O\u2019Laughlin IA, Meltzer HY (2001) 5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release. J Neurochem 76:1521\u20131531", "journal-title": "J Neurochem"}, {"key": "2247_CR93", "doi-asserted-by": "crossref", "first-page": "325", "DOI": "10.1016/S0893-133X(01)00312-8", "volume": "26", "author": "J Ichikawa", "year": "2002", "unstructured": "Ichikawa J, Dai J, O\u2019Laughlin IA, Fowler WL, Meltzer HY (2002) Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum. Neuropsychopharmacology 26:325\u2013339", "journal-title": "Neuropsychopharmacology"}, {"key": "2247_CR94", "doi-asserted-by": "crossref", "first-page": "23", "DOI": "10.1007/s00213-009-1702-5", "volume": "208", "author": "N Idris", "year": "2010", "unstructured": "Idris N, Neill J, Grayson B, Bang-Andersen B, Witten LM, Brennum LT, Arnt J (2010) Sertindole improves sub-chronic PCP-induced reversal learning and episodic memory deficits in rodents: involvement of 5-HT(6) and 5-HT (2A) receptor mechanisms. Psychopharmacol Berl 208:23\u201336", "journal-title": "Psychopharmacol Berl"}, {"key": "2247_CR95", "unstructured": "Ikeda K, Murai T, Tsujimura T, Fukuoka T, Ikejiri M, Hoshino K, Ishiyama T, Kimura J, Taiji M (2010) A unique cognitive enhancing effect of lurasidone in object retrieval with detours, a test of executive function in non-human primates Society for Neuroscience\u201440th Annual Meeting, San Diego, CA, pp Program No. 506.23"}, {"key": "2247_CR96", "doi-asserted-by": "crossref", "first-page": "515", "DOI": "10.1016/0028-3908(88)90134-7", "volume": "27", "author": "RW Invernizzi", "year": "1988", "unstructured": "Invernizzi RW, Cervo L, Samanin R (1988) 8-Hydroxy-2-(di-n-propylamino) tetralin, a selective serotonin1A receptor agonist, blocks haloperidol-induced catalepsy by an action on raphe nuclei medianus and dorsalis. Neuropharmacology 27:515\u2013518", "journal-title": "Neuropharmacology"}, {"key": "2247_CR97", "doi-asserted-by": "crossref", "first-page": "171", "DOI": "10.1124/jpet.110.167346", "volume": "334", "author": "T Ishibashi", "year": "2010", "unstructured": "Ishibashi T, Horisawa T, Tokuda K, Ishiyama T, Ogasa M, Tagashira R, Matsumoto K, Nishikawa H, Ueda Y, Toma S, Oki H, Tanno N, Saji I, Ito A, Ohno Y, Nakamura M (2010) Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine 7 (5-HT7) and 5-HT1A receptor activity. J Pharmacol Exp Ther 334:171\u2013181", "journal-title": "J Pharmacol Exp Ther"}, {"key": "2247_CR98", "doi-asserted-by": "crossref", "first-page": "201", "DOI": "10.1016/S0893-133X(98)00060-8", "volume": "20", "author": "JD Jentsch", "year": "1999", "unstructured": "Jentsch JD, Roth RH (1999) The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 20:201\u2013225", "journal-title": "Neuropsychopharmacology"}, {"key": "2247_CR99", "doi-asserted-by": "crossref", "first-page": "1056", "DOI": "10.1016/j.neuropharm.2008.05.025", "volume": "55", "author": "CA Jones", "year": "2008", "unstructured": "Jones CA, McCreary AC (2008) Serotonergic approaches in the development of novel antipsychotics. Neuropharmacology 55:1056\u20131065", "journal-title": "Neuropharmacology"}, {"key": "2247_CR100", "doi-asserted-by": "crossref", "first-page": "137", "DOI": "10.1016/S0014-2999(02)01532-7", "volume": "441", "author": "S Jordan", "year": "2002", "unstructured": "Jordan S, Koprivica V, Chen R, Tottori K, Kikuchi T, Altar CA (2002) The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor. Eur J Pharmacol 441:137\u2013140", "journal-title": "Eur J Pharmacol"}, {"key": "2247_CR101", "doi-asserted-by": "crossref", "first-page": "45", "DOI": "10.1016/j.ejphar.2003.10.025", "volume": "483", "author": "S Jordan", "year": "2004", "unstructured": "Jordan S, Koprivica V, Dunn R, Tottori K, Kikuchi T, Altar CA (2004) In vivo effects of aripiprazole on cortical and striatal dopaminergic and serotonergic function. Eur J Pharmacol 483:45\u201353", "journal-title": "Eur J Pharmacol"}, {"key": "2247_CR102", "doi-asserted-by": "crossref", "first-page": "33", "DOI": "10.1016/S0014-2999(03)01308-6", "volume": "462", "author": "HO Kalkman", "year": "2003", "unstructured": "Kalkman HO, Loetscher E (2003) alpha2C-Adrenoceptor blockade by clozapine and other antipsychotic drugs. Eur J Pharmacol 462:33\u201340", "journal-title": "Eur J Pharmacol"}, {"key": "2247_CR103", "doi-asserted-by": "crossref", "first-page": "1081", "DOI": "10.1016/j.pnpbp.2003.09.004", "volume": "27", "author": "S Kapur", "year": "2003", "unstructured": "Kapur S, Mamo D (2003) Half a century of antipsychotics and still a central role for dopamine D2 receptors. Prog Neuropsychopharmacol Biol Psychiatry 27:1081\u20131090", "journal-title": "Prog Neuropsychopharmacol Biol Psychiatry"}, {"key": "2247_CR104", "doi-asserted-by": "crossref", "first-page": "79", "DOI": "10.1097/01.jcp.0000150221.53877.d9", "volume": "25", "author": "MB Keller", "year": "2005", "unstructured": "Keller MB, Ruwe FJ, Janssens CJ, Sitsen JM, Jokinen R, Janczewski J (2005) Relapse prevention with gepirone ER in outpatients with major depression. J Clin Psychopharmacol 25:79\u201384", "journal-title": "J Clin Psychopharmacol"}, {"issue": "2", "key": "2247_CR105", "doi-asserted-by": "crossref", "first-page": "296", "DOI": "10.1124/jpet.110.173948", "volume": "336", "author": "T Kenakin", "year": "2011", "unstructured": "Kenakin T (2011) Functional selectivity and biased receptor signaling. J Pharmacol Exp Ther 336(2):296\u2013302", "journal-title": "J Pharmacol Exp Ther"}, {"key": "2247_CR106", "first-page": "9", "volume": "14", "author": "A Khan", "year": "2001", "unstructured": "Khan A, Batool F, Haleem DJ (2001) Behavioral effects of 8-OH-DPAT in single and repeated haloperidol injected rats. Pak J Pharm Sci 14:9\u201317", "journal-title": "Pak J Pharm Sci"}, {"key": "2247_CR107", "doi-asserted-by": "crossref", "first-page": "119", "DOI": "10.1007/s00213-009-1639-8", "volume": "207", "author": "SL Kirk", "year": "2009", "unstructured": "Kirk SL, Glazebrook J, Grayson B, Neill JC, Reynolds GP (2009) Olanzapine-induced weight gain in the rat: role of 5-HT2C and histamine H1 receptors. Psychopharmacol Berl 207:119\u2013125", "journal-title": "Psychopharmacol Berl"}, {"key": "2247_CR108", "doi-asserted-by": "crossref", "first-page": "328", "DOI": "10.1124/jpet.109.160432", "volume": "333", "author": "B Kiss", "year": "2010", "unstructured": "Kiss B, Horvath A, Nemethy Z, Schmidt E, Laszlovszky I, Bugovics G, Fazekas K, Hornok K, Orosz S, Gyertyan I, Agai-Csongor E, Domany G, Tihanyi K, Adham N, Szombathelyi Z (2010) Cariprazine (RGH-188), a dopamine D(3) receptor-preferring, D(3)/D(2) dopamine receptor antagonist-partial agonist antipsychotic candidate: in vitro and neurochemical profile. J Pharmacol Exp Ther 333:328\u2013340", "journal-title": "J Pharmacol Exp Ther"}, {"key": "2247_CR109", "doi-asserted-by": "crossref", "first-page": "25", "DOI": "10.1016/0014-2999(96)00498-0", "volume": "313", "author": "M Kleven", "year": "1996", "unstructured": "Kleven M, Prinssen EP, Koek W (1996) Role of 5-HT1A receptors in the ability of mixed 5-HT1A receptor agonist/dopamine D2 receptor antagonists to inhibit methylphenidate-induced behaviors in rats. Eur J Pharmacol 313:25\u201334", "journal-title": "Eur J Pharmacol"}, {"key": "2247_CR110", "doi-asserted-by": "crossref", "first-page": "135", "DOI": "10.1016/j.neuropharm.2005.02.005", "volume": "49", "author": "MS Kleven", "year": "2005", "unstructured": "Kleven MS, Barret-Grevoz C, Bruins Slot L, Newman-Tancredi A (2005) Novel antipsychotic agents with 5-HT(1A) agonist properties: role of 5-HT(1A) receptor activation in attenuation of catalepsy induction in rats. Neuropharmacology 49:135\u2013143", "journal-title": "Neuropharmacology"}, {"key": "2247_CR111", "doi-asserted-by": "crossref", "first-page": "611", "DOI": "10.1016/S0091-3057(01)00464-6", "volume": "68", "author": "SH Kollins", "year": "2001", "unstructured": "Kollins SH, MacDonald EK, Rush CR (2001) Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review. Pharmacol Biochem Behav 68:611\u2013627", "journal-title": "Pharmacol Biochem Behav"}, {"key": "2247_CR112", "doi-asserted-by": "crossref", "first-page": "1128", "DOI": "10.1016/S0006-3223(98)00132-2", "volume": "44", "author": "WK Kroeze", "year": "1998", "unstructured": "Kroeze WK, Roth BL (1998) The molecular biology of serotonin receptors: therapeutic implications for the interface of mood and psychosis. Biol Psychiatry 44:1128\u20131142", "journal-title": "Biol Psychiatry"}, {"key": "2247_CR113", "doi-asserted-by": "crossref", "first-page": "519", "DOI": "10.1038/sj.npp.1300027", "volume": "28", "author": "WK Kroeze", "year": "2003", "unstructured": "Kroeze WK, Hufeisen SJ, Popadak BA, Renock SM, Steinberg S, Ernsberger P, Jayathilake K, Meltzer HY, Roth BL (2003) H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Neuropsychopharmacology 28:519\u2013526", "journal-title": "Neuropsychopharmacology"}, {"key": "2247_CR114", "doi-asserted-by": "crossref", "first-page": "215", "DOI": "10.1007/s00213-003-1582-z", "volume": "169", "author": "JH Krystal", "year": "2003", "unstructured": "Krystal JH, D\u2019Souza DC, Mathalon D, Perry E, Belger A, Hoffman R (2003) NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development. Psychopharmacol Berl 169:215\u2013233", "journal-title": "Psychopharmacol Berl"}, {"key": "2247_CR115", "doi-asserted-by": "crossref", "first-page": "669", "DOI": "10.2165/11533230-000000000-00000", "volume": "24", "author": "JH Krystal", "year": "2010", "unstructured": "Krystal JH, Mathew SJ, D\u2019Souza DC, Garakani A, Gunduz-Bruce H, Charney DS (2010) Potential psychiatric applications of metabotropic glutamate receptor agonists and antagonists. CNS Drugs 24:669\u2013693", "journal-title": "CNS Drugs"}, {"key": "2247_CR116", "doi-asserted-by": "crossref", "first-page": "748", "DOI": "10.1016/j.drudis.2007.07.008", "volume": "12", "author": "JS Kumar", "year": "2007", "unstructured": "Kumar JS, Mann JJ (2007) PET tracers for 5-HT(1A) receptors and uses thereof. Drug Discov Today 12:748\u2013756", "journal-title": "Drug Discov Today"}, {"key": "2247_CR117", "doi-asserted-by": "crossref", "first-page": "199", "DOI": "10.1016/S0079-6123(08)00910-2", "volume": "172", "author": "T Kuroki", "year": "2008", "unstructured": "Kuroki T, Nagao N, Nakahara T (2008) Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis. Prog Brain Res 172:199\u2013212", "journal-title": "Prog Brain Res"}, {"key": "2247_CR118", "doi-asserted-by": "crossref", "first-page": "161", "DOI": "10.1038/sj.bjp.0707164", "volume": "151", "author": "AJ Lawrence", "year": "2007", "unstructured": "Lawrence AJ (2007) Optimisation of anti-psychotic therapeutics: a balancing act? Br J Pharmacol 151:161\u2013162", "journal-title": "Br J Pharmacol"}, {"key": "2247_CR119", "doi-asserted-by": "crossref", "first-page": "977", "DOI": "10.1016/j.neuropharm.2008.06.046", "volume": "55", "author": "B Francois Le", "year": "2008", "unstructured": "Le Francois B, Czesak M, Steubl D, Albert PR (2008) Transcriptional regulation at a HTR1A polymorphism associated with mental illness. Neuropharmacology 55:977\u2013985", "journal-title": "Neuropharmacology"}, {"key": "2247_CR120", "doi-asserted-by": "crossref", "first-page": "594", "DOI": "10.1007/s00259-009-1274-y", "volume": "37", "author": "L Lemoine", "year": "2010", "unstructured": "Lemoine L, Verdurand M, Vacher B, Blanc E, Le Bars D, Newman-Tancredi A, Zimmer L (2010) [18\u00a0F]F15599, a novel 5-HT1A receptor agonist, as a radioligand for PET neuroimaging. Eur J Nucl Med Mol Imaging 37:594\u2013605", "journal-title": "Eur J Nucl Med Mol Imaging"}, {"key": "2247_CR121", "first-page": "8788", "volume": "23", "author": "S Lemonde", "year": "2003", "unstructured": "Lemonde S, Turecki G, Bakish D, Du L, Hrdina PD, Bown CD, Sequeira A, Kushwaha N, Morris SJ, Basak A, Ou XM, Albert PR (2003) Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J Neurosci 23:8788\u20138799", "journal-title": "J Neurosci"}, {"key": "2247_CR122", "doi-asserted-by": "crossref", "first-page": "1581", "DOI": "10.1016/S0140-6736(03)13306-5", "volume": "361", "author": "S Leucht", "year": "2003", "unstructured": "Leucht S, Wahlbeck K, Hamann J, Kissling W (2003) New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis. Lancet 361:1581\u20131589", "journal-title": "Lancet"}, {"key": "2247_CR123", "first-page": "102", "volume": "29", "author": "R Lewis", "year": "2004", "unstructured": "Lewis R (2004) Should cognitive deficit be a diagnostic criterion for schizophrenia? J Psychiatry Neurosci 29:102\u2013113", "journal-title": "J Psychiatry Neurosci"}, {"key": "2247_CR124", "author": "J Leysen", "first-page": "57", "year": "2000", "unstructured": "Leysen J (2000) Receptor profile of antipsychotics. In: Ellenbroek BA, Cools AR (eds) Atypical antipsychotics. Birkh\u00e4user, Basel, Switzerland, pp 57\u201381", "volume-title": "Atypical antipsychotics", "DOI": "10.1007/978-3-0348-8448-8_4", "doi-asserted-by": "crossref"}, {"key": "2247_CR125", "doi-asserted-by": "crossref", "first-page": "S40", "DOI": "10.1007/BF02245006", "volume": "112", "author": "JE Leysen", "year": "1993", "unstructured": "Leysen JE, Janssen PM, Schotte A, Luyten WH, Megens AA (1993) Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors. Psychopharmacol Berl 112:S40\u2013S54", "journal-title": "Psychopharmacol Berl"}, {"key": "2247_CR126", "doi-asserted-by": "crossref", "first-page": "75", "DOI": "10.1016/j.ejphar.2004.04.028", "volume": "493", "author": "Z Li", "year": "2004", "unstructured": "Li Z, Ichikawa J, Dai J, Meltzer HY (2004) Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain. Eur J Pharmacol 493:75\u201383", "journal-title": "Eur J Pharmacol"}, {"key": "2247_CR127", "doi-asserted-by": "crossref", "first-page": "1986", "DOI": "10.1038/sj.npp.1300768", "volume": "30", "author": "Z Li", "year": "2005", "unstructured": "Li Z, Huang M, Ichikawa J, Dai J, Meltzer HY (2005) N-desmethylclozapine, a major metabolite of clozapine, increases cortical acetylcholine and dopamine release in vivo via stimulation of M1 muscarinic receptors. Neuropsychopharmacology 30:1986\u20131995", "journal-title": "Neuropsychopharmacology"}, {"key": "2247_CR128", "doi-asserted-by": "crossref", "first-page": "633", "DOI": "10.1176/ajp.141.12.1633", "volume": "141", "author": "JA Lieberman", "year": "1984", "unstructured": "Lieberman JA, Kane JM, Gadaleta D, Brenner R, Lesser MS, Kinon B (1984) Methylphenidate challenge as a predictor of relapse in schizophrenia. Am J Psychiatry 141:633\u2013638", "journal-title": "Am J Psychiatry"}, {"key": "2247_CR129", "doi-asserted-by": "crossref", "first-page": "415", "DOI": "10.1007/BF00216006", "volume": "91", "author": "JA Lieberman", "year": "1987", "unstructured": "Lieberman JA, Kane JM, Alvir J (1987) Provocative tests with psychostimulant drugs in schizophrenia. Psychopharmacol Berl 91:415\u2013433", "journal-title": "Psychopharmacol Berl"}, {"key": "2247_CR130", "doi-asserted-by": "crossref", "first-page": "1929", "DOI": "10.1111/j.1476-5381.2010.00738.x", "volume": "160", "author": "L Llado-Pelfort", "year": "2010", "unstructured": "Llado-Pelfort L, Assie MB, Newman-Tancredi A, Artigas F, Celada P (2010) Preferential in vivo action of F15599, a novel 5-HT1A receptor agonist, at postsynaptic 5-HT1A receptors. Br J Pharmacol 160:1929\u20131940", "journal-title": "Br J Pharmacol"}, {"key": "2247_CR131", "doi-asserted-by": "crossref", "first-page": "23", "DOI": "10.1016/j.euroneuro.2008.07.012", "volume": "19", "author": "F Loiseau", "year": "2009", "unstructured": "Loiseau F, Millan MJ (2009) Blockade of dopamine D(3) receptors in frontal cortex, but not in sub-cortical structures, enhances social recognition in rats: similar actions of D(1) receptor agonists, but not of D(2) antagonists. Eur Neuropsychopharmacol 19:23\u201333", "journal-title": "Eur Neuropsychopharmacol"}, {"key": "2247_CR132", "doi-asserted-by": "crossref", "first-page": "488", "DOI": "10.2174/138161210790361461", "volume": "16", "author": "RB Mailman", "year": "2010", "unstructured": "Mailman RB, Murthy V (2010) Third generation antipsychotic drugs: partial agonism or receptor functional selectivity? Curr Pharm Des 16:488\u2013501", "journal-title": "Curr Pharm Des"}, {"key": "2247_CR133", "doi-asserted-by": "crossref", "first-page": "1013", "DOI": "10.1124/mol.106.022756", "volume": "70", "author": "C Mannoury la Cour", "year": "2006", "unstructured": "Mannoury la Cour C, El Mestikawy S, Hanoun N, Hamon M, Lanfumey L (2006) Regional differences in the coupling of 5-hydroxytryptamine-1A receptors to G proteins in the rat brain. Mol Pharmacol 70:1013\u20131021", "journal-title": "Mol Pharmacol"}, {"key": "2247_CR134", "doi-asserted-by": "crossref", "first-page": "891", "DOI": "10.1017/S1461145709990794", "volume": "13", "author": "MM Marcus", "year": "2010", "unstructured": "Marcus MM, Wiker C, Franberg O, Konradsson-Geuken A, Langlois X, Jardemark K, Svensson TH (2010) Adjunctive alpha2-adrenoceptor blockade enhances the antipsychotic-like effect of risperidone and facilitates cortical dopaminergic and glutamatergic, NMDA receptor-mediated transmission. Int J Neuropsychopharmacol 13:891\u2013903", "journal-title": "Int J Neuropsychopharmacol"}, {"key": "2247_CR135", "unstructured": "Martel J-C, Cussac D, Assi\u00e9 M-B, Rauly-Lestienne I, Newman-Tancredi A (2006) Antagonism of serotonin 5-HT2B receptors: activity of atypical benzamide antipsychotics in comparison with 5-HT2A, 5-HT2C and dopamine D2 receptors. Society for Neuroscience\u201436th Annual Meeting, Atlanta, Georgia, pp Program number 93.8"}, {"key": "2247_CR136", "doi-asserted-by": "crossref", "first-page": "365", "DOI": "10.1007/s007020050064", "volume": "105", "author": "P Martin", "year": "1998", "unstructured": "Martin P, Waters N, Schmidt CJ, Carlsson A, Carlsson ML (1998) Rodent data and general hypothesis: antipsychotic action exerted through 5-Ht2A receptor antagonism is dependent on increased serotonergic tone. J Neural Transm 105:365\u2013396", "journal-title": "J Neural Transm"}, {"key": "2247_CR137", "doi-asserted-by": "crossref", "first-page": "150", "DOI": "10.1016/S0006-8993(00)03074-2", "volume": "888", "author": "F Mauler", "year": "2001", "unstructured": "Mauler F, Fahrig T, Horvath E, Jork R (2001) Inhibition of evoked glutamate release by the neuroprotective 5-HT(1A) receptor agonist BAY x 3702 in vitro and in vivo. Brain Res 888:150\u2013157", "journal-title": "Brain Res"}, {"key": "2247_CR138", "first-page": "1826", "volume": "35", "author": "PN McCormick", "year": "2010", "unstructured": "McCormick PN, Kapur S, Graff-Guerrero A, Raymond R, Nobrega JN, Wilson AA (2010) The antipsychotics olanzapine, risperidone, clozapine, and haloperidol are D2-selective ex vivo but not in vitro. Neuropsychopharmacology 35:1826\u20131835", "journal-title": "Neuropsychopharmacology"}, {"key": "2247_CR139", "doi-asserted-by": "crossref", "first-page": "78", "DOI": "10.1038/sj.npp.1301098", "volume": "32", "author": "AC McCreary", "year": "2007", "unstructured": "McCreary AC, Glennon JC, Ashby CR Jr, Meltzer HY, Li Z, Reinders JH, Hesselink MB, Long SK, Herremans AH, van Stuivenberg H, Feenstra RW, Kruse CG (2007) SLV313 (1-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-4- [5-(4-fluoro-phenyl)-pyridin-3-ylmethyl]-piperazine monohydrochloride): a novel dopamine D2 receptor antagonist and 5-HT1A receptor agonist potential antipsychotic drug. Neuropsychopharmacology 32:78\u201394", "journal-title": "Neuropsychopharmacology"}, {"key": "2247_CR140", "doi-asserted-by": "crossref", "first-page": "885", "DOI": "10.1111/j.2042-7158.1988.tb06295.x", "volume": "40", "author": "BA McMillen", "year": "1988", "unstructured": "McMillen BA, Scott SM, Davanzo EA (1988) Reversal of neuroleptic-induced catalepsy by novel aryl-piperazine anxiolytic drugs. J Pharm Pharmacol 40:885\u2013887", "journal-title": "J Pharm Pharmacol"}, {"key": "2247_CR141", "doi-asserted-by": "crossref", "first-page": "233", "DOI": "10.1016/j.euroneuro.2005.10.006", "volume": "16", "author": "R Medori", "year": "2006", "unstructured": "Medori R, Mannaert E, Grunder G (2006) Plasma antipsychotic concentration and receptor occupancy, with special focus on risperidone long-acting injectable. Eur Neuropsychopharmacol 16:233\u2013240", "journal-title": "Eur Neuropsychopharmacol"}, {"key": "2247_CR142", "doi-asserted-by": "crossref", "first-page": "701", "DOI": "10.2165/00003495-200464070-00003", "volume": "64", "author": "K Melkersson", "year": "2004", "unstructured": "Melkersson K, Dahl ML (2004) Adverse metabolic effects associated with atypical antipsychotics: literature review and clinical implications. Drugs 64:701\u2013723", "journal-title": "Drugs"}, {"key": "2247_CR143", "doi-asserted-by": "crossref", "first-page": "98", "DOI": "10.1016/j.bbr.2008.05.016", "volume": "195", "author": "HY Meltzer", "year": "2008", "unstructured": "Meltzer HY, Sumiyoshi T (2008) Does stimulation of 5-HT(1A) receptors improve cognition in schizophrenia? Behav Brain Res 195:98\u2013102", "journal-title": "Behav Brain Res"}, {"key": "2247_CR144", "doi-asserted-by": "crossref", "first-page": "13591", "DOI": "10.1073/pnas.96.24.13591", "volume": "96", "author": "HY Meltzer", "year": "1999", "unstructured": "Meltzer HY, Park S, Kessler R (1999) Cognition, schizophrenia, and the atypical antipsychotic drugs. Proc Natl Acad Sci USA 96:13591\u201313593", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "2247_CR145", "doi-asserted-by": "crossref", "first-page": "1159", "DOI": "10.1016/j.pnpbp.2003.09.010", "volume": "27", "author": "HY Meltzer", "year": "2003", "unstructured": "Meltzer HY, Li Z, Kaneda Y, Ichikawa J (2003) Serotonin receptors: their key role in drugs to treat schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 27:1159\u20131172", "journal-title": "Prog Neuropsychopharmacol Biol Psychiatry"}, {"issue": "2\u20133", "key": "2247_CR146", "doi-asserted-by": "crossref", "first-page": "289", "DOI": "10.1007/s00213-010-2137-8", "volume": "213", "author": "HY Meltzer", "year": "2011", "unstructured": "Meltzer HY, Horiguchi M, Massey BW (2011) The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment. Psychopharmacology (Berl) 213(2\u20133):289\u2013305", "journal-title": "Psychopharmacology (Berl)"}, {"key": "2247_CR147", "first-page": "833", "volume": "11", "author": "M Mezler", "year": "2010", "unstructured": "Mezler M, Geneste H, Gault L, Marek GJ (2010) LY-2140023, a prodrug of the group II metabotropic glutamate receptor agonist LY-404039 for the potential treatment of schizophrenia. Curr Opin Investig Drugs 11:833\u2013845", "journal-title": "Curr Opin Investig Drugs"}, {"key": "2247_CR148", "doi-asserted-by": "crossref", "first-page": "829", "DOI": "10.1586/14737175.7.7.829", "volume": "7", "author": "JW Michelsen", "year": "2007", "unstructured": "Michelsen JW, Meyer JM (2007) Cardiovascular effects of antipsychotics. Expert Rev Neurother 7:829\u2013839", "journal-title": "Expert Rev Neurother"}, {"key": "2247_CR149", "first-page": "853", "volume": "295", "author": "MJ Millan", "year": "2000", "unstructured": "Millan MJ (2000) Improving the treatment of schizophrenia: focus on serotonin (5-HT)(1A) receptors. J Pharmacol Exp Ther 295:853\u2013861", "journal-title": "J Pharmacol Exp Ther"}, {"key": "2247_CR150", "doi-asserted-by": "crossref", "first-page": "30", "DOI": "10.1007/s00213-005-2199-1", "volume": "179", "author": "MJ Millan", "year": "2005", "unstructured": "Millan MJ (2005) N-Methyl-D-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives. Psychopharmacol Berl 179:30\u201353", "journal-title": "Psychopharmacol Berl"}, {"key": "2247_CR151", "first-page": "1341", "volume": "286", "author": "MJ Millan", "year": "1998", "unstructured": "Millan MJ, Gobert A, Newman-Tancredi A, Audinot V, Lejeune F, Rivet JM, Cussac D, Nicolas JP, Muller O, Lavielle G (1998a) S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol. J Pharmacol Exp Ther 286:1341\u20131355", "journal-title": "J Pharmacol Exp Ther"}, {"key": "2247_CR152", "first-page": "1356", "volume": "286", "author": "MJ Millan", "year": "1998", "unstructured": "Millan MJ, Schreiber R, Dekeyne A, Rivet JM, Bervoets K, Mavridis M, Sebban C, Maurel-Remy S, Newman-Tancredi A, Spedding M, Muller O, Lavielle G, Brocco M (1998b) S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: II. Functional profile in comparison to clozapine and haloperidol. J Pharmacol Exp Ther 286:1356\u20131373", "journal-title": "J Pharmacol Exp Ther"}, {"key": "2247_CR153", "doi-asserted-by": "crossref", "first-page": "4419", "DOI": "10.1046/j.1460-9568.1999.00858.x", "volume": "11", "author": "MJ Millan", "year": "1999", "unstructured": "Millan MJ, Brocco M, Gobert A, Joly F, Bervoets K, Rivet J, Newman-Tancredi A, Audinot V, Maurel S (1999) Contrasting mechanisms of action and sensitivity to antipsychotics of phencyclidine versus amphetamine: importance of nucleus accumbens 5-HT2A sites for PCP-induced locomotion in the rat. Eur J Neurosci 11:4419\u20134432", "journal-title": "Eur J Neurosci"}, {"key": "2247_CR154", "first-page": "54", "volume": "292", "author": "MJ Millan", "year": "2000", "unstructured": "Millan MJ, Brocco M, Rivet JM, Audinot V, Newman-Tancredi A, Maiofiss L, Queriaux S, Despaux N, Peglion JL, Dekeyne A (2000) S18327 (1-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperid-1-yl]ethyl]3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1)- and alpha(2)-adrenergic receptors: II. Functional profile and a multiparametric comparison with haloperidol, clozapine, and 11 other antipsychotic agents. J Pharmacol Exp Ther 292:54\u201366", "journal-title": "J Pharmacol Exp Ther"}, {"key": "2247_CR155", "doi-asserted-by": "crossref", "first-page": "1047", "DOI": "10.1111/j.1471-4159.2006.04262.x", "volume": "100", "author": "MJ Millan", "year": "2007", "unstructured": "Millan MJ, Di Cara B, Dekeyne A, Panayi F, De Groote L, Sicard D, Cistarelli L, Billiras R, Gobert A (2007) Selective blockade of dopamine D(3) versus D(2) receptors enhances frontocortical cholinergic transmission and social memory in rats: a parallel neurochemical and behavioural analysis. J Neurochem 100:1047\u20131061", "journal-title": "J Neurochem"}, {"key": "2247_CR156", "doi-asserted-by": "crossref", "first-page": "1035", "DOI": "10.1017/S1461145710000775", "volume": "13", "author": "MJ Millan", "year": "2010", "unstructured": "Millan MJ, Buccafusco JJ, Loiseau F, Watson DJ, Decamp E, Fone KC, Thomasson-Perret N, Hill M, Mocaer E, Schneider JS (2010) The dopamine D(3) receptor antagonist, S33138, counters cognitive impairment in a range of rodent and primate procedures. Int J Neuropsychopharmacol 13:1035\u20131051", "journal-title": "Int J Neuropsychopharmacol"}, {"key": "2247_CR157", "doi-asserted-by": "crossref", "first-page": "519", "DOI": "10.1093/oxfordjournals.schbul.a007024", "volume": "29", "author": "R Mojtabai", "year": "2003", "unstructured": "Mojtabai R, Lavelle J, Gibson PJ, Bromet EJ (2003) Atypical antipsychotics in first admission schizophrenia: medication continuation and outcomes. Schizophr Bull 29:519\u2013530", "journal-title": "Schizophr Bull"}, {"key": "2247_CR158", "doi-asserted-by": "crossref", "first-page": "190", "DOI": "10.1007/s00406-005-0587-5", "volume": "255", "author": "HJ Moller", "year": "2005", "unstructured": "Moller HJ (2005) Antipsychotic and antidepressive effects of second generation antipsychotics: two different pharmacological mechanisms? Eur Arch Psychiatry Clin Neurosci 255:190\u2013201", "journal-title": "Eur Arch Psychiatry Clin Neurosci"}, {"key": "2247_CR159", "doi-asserted-by": "crossref", "first-page": "91", "DOI": "10.1097/FPC.0b013e328311a917", "volume": "19", "author": "R Mossner", "year": "2009", "unstructured": "Mossner R, Schuhmacher A, Kuhn KU, Cvetanovska G, Rujescu D, Zill P, Quednow BB, Rietschel M, Wolwer W, Gaebel W, Wagner M, Maier W (2009) Functional serotonin 1A receptor variant influences treatment response to atypical antipsychotics in schizophrenia. Pharmacogenet Genomics 19:91\u201394", "journal-title": "Pharmacogenet Genomics"}, {"key": "2247_CR160", "doi-asserted-by": "crossref", "first-page": "315", "DOI": "10.1007/s00213-008-1240-6", "volume": "202", "author": "T Nagai", "year": "2009", "unstructured": "Nagai T, Murai R, Matsui K, Kamei H, Noda Y, Furukawa H, Nabeshima T (2009) Aripiprazole ameliorates phencyclidine-induced impairment of recognition memory through dopamine D1 and serotonin 5-HT1A receptors. Psychopharmacol Berl 202:315\u2013328", "journal-title": "Psychopharmacol Berl"}, {"key": "2247_CR161", "doi-asserted-by": "crossref", "first-page": "39", "DOI": "10.1080/00207450601041989", "volume": "118", "author": "S Nakai", "year": "2008", "unstructured": "Nakai S, Hirose T, Mori T, Stark A, Araki H, Kikuchi T (2008) The effect of aripiprazole on prepulse inhibition of the startle response in normal and hyperdopaminergic states in rats. Int J Neurosci 118:39\u201357", "journal-title": "Int J Neurosci"}, {"key": "2247_CR162", "doi-asserted-by": "crossref", "first-page": "27", "DOI": "10.1038/sj.mp.4002066", "volume": "13", "author": "HA Nasrallah", "year": "2008", "unstructured": "Nasrallah HA (2008) Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry 13:27\u201335", "journal-title": "Mol Psychiatry"}, {"key": "2247_CR163", "unstructured": "Natesan S, Reckless GE, Barlow KB, Nobrega JN, Kapur S (2010) Partial agonists in schizophrenia\u2014why some work and others do not: insights from preclinical animal models. Int J Neuropsychopharmacol 1\u201314"}, {"key": "2247_CR164", "first-page": "519", "volume": "9", "author": "VS Naumenko", "year": "2010", "unstructured": "Naumenko VS, Bazovkina DV, Kondaurova EM, Zubkov EA, Kulikov AV (2010) The role of 5-HT2A receptor and 5-HT2A/5-HT1A receptor interaction in the suppression of catalepsy. Genes Brain Behav 9:519\u2013524", "journal-title": "Genes Brain Behav"}, {"key": "2247_CR165", "first-page": "802", "volume": "11", "author": "A Newman-Tancredi", "year": "2010", "unstructured": "Newman-Tancredi A (2010) The importance of 5-HT1A receptor agonism in antipsychotic drug action: rationale and perspectives. Curr Opin Investig Drugs 11:802\u2013812", "journal-title": "Curr Opin Investig Drugs"}, {"key": "2247_CR166", "doi-asserted-by": "crossref", "first-page": "341", "DOI": "10.1017/S1461145704005000", "volume": "8", "author": "A Newman-Tancredi", "year": "2005", "unstructured": "Newman-Tancredi A, Assi\u00e9 MB, Leduc N, Ormiere AM, Danty N, Cosi C (2005) Novel antipsychotics activate recombinant human and native rat serotonin 5-HT1A receptors: affinity, efficacy and potential implications for treatment of schizophrenia. Int J Neuropsychopharmacol 8:341\u2013356", "journal-title": "Int J Neuropsychopharmacol"}, {"key": "2247_CR167", "unstructured": "Newman-Tancredi A, Assi\u00e9 M-B, Martel J-C, Cosi C, Heusler P, Bruins Slot L, Carilla-Durand E, Cussac D (2006) F15063, a novel antipsychotic with D2/D3 antagonist, 5-HT1A agonist and D4 partial agonist properties: I. receptor affinity and efficacy in vitro and activity in neurochemical and neuroendocrine tests in rodents. 19th ECNP Congress Paris, France, pp Poster P.3.d.004"}, {"key": "2247_CR168", "doi-asserted-by": "crossref", "first-page": "237", "DOI": "10.1038/sj.bjp.0707158", "volume": "151", "author": "A Newman-Tancredi", "year": "2007", "unstructured": "Newman-Tancredi A, Assi\u00e9 MB, Martel JC, Cosi C, Slot LB, Palmier C, Rauly-Lestienne I, Colpaert F, Vacher B, Cussac D (2007a) F15063, a potential antipsychotic with D2/D3 antagonist, 5-HT1A agonist and D4 partial agonist properties. I. In vitro receptor affinity and efficacy profile. Br J Pharmacol 151:237\u2013252", "journal-title": "Br J Pharmacol"}, {"key": "2247_CR169", "first-page": "539", "volume": "8", "author": "A Newman-Tancredi", "year": "2007", "unstructured": "Newman-Tancredi A, Cussac D, Depoortere R (2007b) Neuropharmacological profile of bifeprunox: merits and limitations in comparison with other third-generation antipsychotics. Curr Opin Investig Drugs 8:539\u2013554", "journal-title": "Curr Opin Investig Drugs"}, {"key": "2247_CR170", "doi-asserted-by": "crossref", "first-page": "293", "DOI": "10.1017/S1461145707008061", "volume": "11", "author": "A Newman-Tancredi", "year": "2008", "unstructured": "Newman-Tancredi A, Heusler P, Martel JC, Ormiere AM, Leduc N, Cussac D (2008) Agonist and antagonist properties of antipsychotics at human dopamine D4.4 receptors: G-protein activation and K\u2009+\u2009channel modulation in transfected cells. Int J Neuropsychopharmacol 11:293\u2013307", "journal-title": "Int J Neuropsychopharmacol"}, {"key": "2247_CR171", "doi-asserted-by": "crossref", "first-page": "338", "DOI": "10.1111/j.1476-5381.2008.00001.x", "volume": "156", "author": "A Newman-Tancredi", "year": "2009", "unstructured": "Newman-Tancredi A, Martel JC, Assie MB, Buritova J, Lauressergues E, Cosi C, Heusler P, Bruins Slot L, Colpaert FC, Vacher B, Cussac D (2009) Signal transduction and functional selectivity of F15599, a preferential post-synaptic 5-HT1A receptor agonist. Br J Pharmacol 156:338\u2013353", "journal-title": "Br J Pharmacol"}, {"key": "2247_CR172", "doi-asserted-by": "crossref", "first-page": "787", "DOI": "10.1185/03007990903576953", "volume": "26", "author": "P Nuss", "year": "2010", "unstructured": "Nuss P, Tessier C (2010) Antipsychotic medication, functional outcome and quality of life in schizophrenia: focus on amisulpride. Curr Med Res Opin 26:787\u2013801", "journal-title": "Curr Med Res Opin"}, {"key": "2247_CR173", "doi-asserted-by": "crossref", "first-page": "54", "DOI": "10.1016/j.bbr.2008.02.023", "volume": "195", "author": "SO Ogren", "year": "2008", "unstructured": "Ogren SO, Eriksson TM, Elvander-Tottie E, D\u2019Addario C, Ekstrom JC, Svenningsson P, Meister B, Kehr J, Stiedl O (2008) The role of 5-HT1A receptors in learning and memory. Behav Brain Res 195:54\u201377", "journal-title": "Behav Brain Res"}, {"key": "2247_CR174", "doi-asserted-by": "crossref", "first-page": "130", "DOI": "10.1016/j.neulet.2004.05.021", "volume": "366", "author": "T Ojima", "year": "2004", "unstructured": "Ojima T, Ito C, Sakurai E, Watanabe T, Yanai K (2004) Effects of serotonin-dopamine antagonists on prepulse inhibition and neurotransmitter contents in the rat cortex. Neurosci Lett 366:130\u2013134", "journal-title": "Neurosci Lett"}, {"key": "2247_CR175", "doi-asserted-by": "crossref", "first-page": "S102", "DOI": "10.1192/bjp.184.47.s102", "volume": "47", "author": "M Peet", "year": "2004", "unstructured": "Peet M (2004) Diet, diabetes and schizophrenia: review and hypothesis. Br J Psychiatry Suppl 47:S102\u2013S105", "journal-title": "Br J Psychiatry Suppl"}, {"key": "2247_CR176", "doi-asserted-by": "crossref", "first-page": "632", "DOI": "10.1124/jpet.110.166710", "volume": "333", "author": "RD Porsolt", "year": "2010", "unstructured": "Porsolt RD, Moser PC, Castagne V (2010) Behavioral indices in antipsychotic drug discovery. J Pharmacol Exp Ther 333:632\u2013638", "journal-title": "J Pharmacol Exp Ther"}, {"key": "2247_CR177", "doi-asserted-by": "crossref", "first-page": "191", "DOI": "10.1007/s002130050124", "volume": "128", "author": "EP Prinssen", "year": "1996", "unstructured": "Prinssen EP, Kleven MS, Koek W (1996) Effects of dopamine antagonists in a two-way active avoidance procedure in rats: interactions with 8-OH-DPAT, ritanserin, and prazosin. Psychopharmacol Berl 128:191\u2013197", "journal-title": "Psychopharmacol Berl"}, {"key": "2247_CR178", "doi-asserted-by": "crossref", "first-page": "217", "DOI": "10.1016/S0014-2999(02)02430-5", "volume": "453", "author": "EP Prinssen", "year": "2002", "unstructured": "Prinssen EP, Colpaert FC, Koek W (2002) 5-HT1A receptor activation and anti-cataleptic effects: high-efficacy agonists maximally inhibit haloperidol-induced catalepsy. Eur J Pharmacol 453:217\u2013221", "journal-title": "Eur J Pharmacol"}, {"key": "2247_CR179", "doi-asserted-by": "crossref", "first-page": "431", "DOI": "10.1097/JCP.0b013e3181e69060", "volume": "30", "author": "TK Rajji", "year": "2010", "unstructured": "Rajji TK, Uchida H, Ismail Z, Ng W, Mamo DC, Remington G, Pollock BG, Mulsant BH (2010) Clozapine and global cognition in schizophrenia. J Clin Psychopharmacol 30:431\u2013436", "journal-title": "J Clin Psychopharmacol"}, {"key": "2247_CR180", "doi-asserted-by": "crossref", "first-page": "169", "DOI": "10.1016/j.pharmthera.2009.10.010", "volume": "125", "author": "GP Reynolds", "year": "2010", "unstructured": "Reynolds GP, Kirk SL (2010) Metabolic side effects of antipsychotic drug treatment\u2014pharmacological mechanisms. Pharmacol Ther 125:169\u2013179", "journal-title": "Pharmacol Ther"}, {"key": "2247_CR181", "doi-asserted-by": "crossref", "first-page": "1826", "DOI": "10.1176/appi.ajp.163.10.1826", "volume": "163", "author": "GP Reynolds", "year": "2006", "unstructured": "Reynolds GP, Arranz B, Templeman LA, Fertuzinhos S, San L (2006) Effect of 5-HT1A receptor gene polymorphism on negative and depressive symptom response to antipsychotic treatment of drug-naive psychotic patients. Am J Psychiatry 163:1826\u20131829", "journal-title": "Am J Psychiatry"}, {"key": "2247_CR182", "doi-asserted-by": "crossref", "first-page": "R3", "DOI": "10.1016/S0014-2999(97)81951-6", "volume": "338", "author": "H Rollema", "year": "1997", "unstructured": "Rollema H, Lu Y, Schmidt AW, Zorn SH (1997) Clozapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation. Eur J Pharmacol 338:R3\u2013R5", "journal-title": "Eur J Pharmacol"}, {"key": "2247_CR183", "doi-asserted-by": "crossref", "first-page": "229", "DOI": "10.1016/S0006-3223(00)00850-7", "volume": "48", "author": "H Rollema", "year": "2000", "unstructured": "Rollema H, Lu Y, Schmidt AW, Sprouse JS, Zorn SH (2000) 5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex. Biol Psychiatry 48:229\u2013237", "journal-title": "Biol Psychiatry"}, {"key": "2247_CR184", "doi-asserted-by": "crossref", "first-page": "399", "DOI": "10.1016/j.euroneuro.2005.04.009", "volume": "15", "author": "W Rossler", "year": "2005", "unstructured": "Rossler W, Salize HJ, van Os J, Riecher-Rossler A (2005) Size of burden of schizophrenia and psychotic disorders. Eur Neuropsychopharmacol 15:399\u2013409", "journal-title": "Eur Neuropsychopharmacol"}, {"key": "2247_CR185", "doi-asserted-by": "crossref", "first-page": "353", "DOI": "10.1038/nrd1346", "volume": "3", "author": "BL Roth", "year": "2004", "unstructured": "Roth BL, Sheffler DJ, Kroeze WK (2004) Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia. Nat Rev Drug Discov 3:353\u2013359", "journal-title": "Nat Rev Drug Discov"}, {"key": "2247_CR186", "doi-asserted-by": "crossref", "first-page": "59", "DOI": "10.1515/REVNEURO.1999.10.1.59", "volume": "10", "author": "F Sams-Dodd", "year": "1999", "unstructured": "Sams-Dodd F (1999) Phencyclidine in the social interaction test: an animal model of schizophrenia with face and predictive validity. Rev Neurosci 10:59\u201390", "journal-title": "Rev Neurosci"}, {"key": "2247_CR187", "doi-asserted-by": "crossref", "first-page": "1100", "DOI": "10.1093/cercor/bhh070", "volume": "14", "author": "N Santana", "year": "2004", "unstructured": "Santana N, Bortolozzi A, Serrats J, Mengod G, Artigas F (2004) Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. Cereb Cortex 14:1100\u20131109", "journal-title": "Cereb Cortex"}, {"key": "2247_CR188", "doi-asserted-by": "crossref", "first-page": "191", "DOI": "10.1016/0006-8993(93)91535-Z", "volume": "631", "author": "A Schotte", "year": "1993", "unstructured": "Schotte A, Janssen PF, Megens AA, Leysen JE (1993) Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography. Brain Res 631:191\u2013202", "journal-title": "Brain Res"}, {"key": "2247_CR189", "doi-asserted-by": "crossref", "first-page": "1400", "DOI": "10.1038/sj.npp.1300203", "volume": "28", "author": "DA Shapiro", "year": "2003", "unstructured": "Shapiro DA, Renock S, Arrington E, Chiodo LA, Liu LX, Sibley DR, Roth BL, Mailman R (2003) Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology. Neuropsychopharmacology 28:1400\u20131411", "journal-title": "Neuropsychopharmacology"}, {"key": "2247_CR190", "doi-asserted-by": "crossref", "first-page": "88", "DOI": "10.3928/0048-5713-19960201-09", "volume": "26", "author": "RP Sharma", "year": "1996", "unstructured": "Sharma RP, Shapiro LE (1996) The 5-HT1A receptor system: possible implications for schizophrenic negative symptomatology. Psychiatr Ann 26:88\u201393", "journal-title": "Psychiatr Ann"}, {"key": "2247_CR191", "doi-asserted-by": "crossref", "first-page": "583", "DOI": "10.1016/S0893-133X(01)00400-6", "volume": "26", "author": "S Shirazi-Southall", "year": "2002", "unstructured": "Shirazi-Southall S, Rodriguez DE, Nomikos GG (2002) Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat. Neuropsychopharmacology 26:583\u2013594", "journal-title": "Neuropsychopharmacology"}, {"key": "2247_CR192", "doi-asserted-by": "crossref", "first-page": "114", "DOI": "10.1254/jphs.93.114", "volume": "93", "author": "T Shiwa", "year": "2003", "unstructured": "Shiwa T, Amano T, Matsubayashi H, Seki T, Sasa M, Sakai N (2003) Perospirone, a novel antipsychotic agent, hyperpolarizes rat dorsal raphe neurons via 5-HT1A receptor. J Pharmacol Sci 93:114\u2013117", "journal-title": "J Pharmacol Sci"}, {"key": "2247_CR193", "doi-asserted-by": "crossref", "first-page": "1809", "DOI": "10.1176/appi.ajp.160.10.1809", "volume": "160", "author": "H Silver", "year": "2003", "unstructured": "Silver H, Feldman P, Bilker W, Gur RC (2003) Working memory deficit as a core neuropsychological dysfunction in schizophrenia. Am J Psychiatry 160:1809\u20131816", "journal-title": "Am J Psychiatry"}, {"key": "2247_CR194", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1007/BF00426687", "volume": "53", "author": "RC Smith", "year": "1977", "unstructured": "Smith RC, Davis JM (1977) Comparative effects of d-amphetamine, l-amphetamine, and methylphenidate on mood in man. Psychopharmacol Berl 53:1\u201312", "journal-title": "Psychopharmacol Berl"}, {"key": "2247_CR195", "doi-asserted-by": "crossref", "first-page": "26", "DOI": "10.1016/j.bbr.2008.03.018", "volume": "191", "author": "S Snigdha", "year": "2008", "unstructured": "Snigdha S, Neill JC (2008) Improvement of phencyclidine-induced social behaviour deficits in rats: involvement of 5-HT1A receptors. Behav Brain Res 191:26\u201331", "journal-title": "Behav Brain Res"}, {"key": "2247_CR196", "doi-asserted-by": "crossref", "first-page": "61", "DOI": "10.1097/00004714-198902000-00021", "volume": "9", "author": "R Sovner", "year": "1989", "unstructured": "Sovner R, Parnell-Sovner N (1989) Use of buspirone in the treatment of schizophrenia. J Clin Psychopharmacol 9:61\u201362", "journal-title": "J Clin Psychopharmacol"}, {"key": "2247_CR197", "first-page": "589", "volume": "6", "author": "A Spiros", "year": "2010", "unstructured": "Spiros A, Carr R, Geerts H (2010) Not all partial dopamine D(2) receptor agonists are the same in treating schizophrenia. Exploring the effects of bifeprunox and aripiprazole using a computer model of a primate striatal dopaminergic synapse. Neuropsychiatr Dis Treat 6:589\u2013603", "journal-title": "Neuropsychiatr Dis Treat"}, {"key": "2247_CR198", "doi-asserted-by": "crossref", "first-page": "373", "DOI": "10.1007/s00213-006-0621-y", "volume": "190", "author": "AD Stark", "year": "2007", "unstructured": "Stark AD, Jordan S, Allers KA, Bertekap RL, Chen R, Mistry Kannan T, Molski TF, Yocca FD, Sharp T, Kikuchi T, Burris KD (2007) Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT 2A receptors: functional receptor-binding and in vivo electrophysiological studies. Psychopharmacol Berl 190:373\u2013382", "journal-title": "Psychopharmacol Berl"}, {"key": "2247_CR199", "doi-asserted-by": "crossref", "first-page": "209", "DOI": "10.1016/0006-8993(95)01361-X", "volume": "708", "author": "T Sumiyoshi", "year": "1996", "unstructured": "Sumiyoshi T, Stockmeier CA, Overholser JC, Dilley GE, Meltzer HY (1996) Serotonin1A receptors are increased in postmortem prefrontal cortex in schizophrenia. Brain Res 708:209\u2013214", "journal-title": "Brain Res"}, {"key": "2247_CR200", "doi-asserted-by": "crossref", "first-page": "1722", "DOI": "10.1176/appi.ajp.158.10.1722", "volume": "158", "author": "T Sumiyoshi", "year": "2001", "unstructured": "Sumiyoshi T, Matsui M, Nohara S, Yamashita I, Kurachi M, Sumiyoshi C, Jayathilake K, Meltzer HY (2001a) Enhancement of cognitive performance in schizophrenia by addition of tandospirone to neuroleptic treatment. Am J Psychiatry 158:1722\u20131725", "journal-title": "Am J Psychiatry"}, {"key": "2247_CR201", "doi-asserted-by": "crossref", "first-page": "861", "DOI": "10.1016/S0006-3223(00)01025-8", "volume": "49", "author": "T Sumiyoshi", "year": "2001", "unstructured": "Sumiyoshi T, Matsui M, Yamashita I, Nohara S, Kurachi M, Uehara T, Sumiyoshi S, Sumiyoshi C, Meltzer HY (2001b) The effect of tandospirone, a serotonin(1A) agonist, on memory function in schizophrenia. Biol Psychiatry 49:861\u2013868", "journal-title": "Biol Psychiatry"}, {"key": "2247_CR202", "doi-asserted-by": "crossref", "first-page": "965", "DOI": "10.1016/j.pnpbp.2007.02.017", "volume": "31", "author": "T Sumiyoshi", "year": "2007", "unstructured": "Sumiyoshi T, Higuchi Y, Matsui M, Arai H, Takamiya C, Meltzer HY, Kurachi M (2007) Effective adjunctive use of tandospirone with perospirone for enhancing verbal memory and quality of life in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 31:965\u2013967", "journal-title": "Prog Neuropsychopharmacol Biol Psychiatry"}, {"key": "2247_CR203", "doi-asserted-by": "crossref", "first-page": "307", "DOI": "10.1007/s12325-010-0035-4", "volume": "27", "author": "T Sumiyoshi", "year": "2010", "unstructured": "Sumiyoshi T, Tsunoda M, Higuchi Y, Itoh T, Seo T, Itoh H, Suzuki M, Kurachi M (2010) Serotonin-1A receptor gene polymorphism and the ability of antipsychotic drugs to improve attention in schizophrenia. Adv Ther 27:307\u2013313", "journal-title": "Adv Ther"}, {"key": "2247_CR204", "doi-asserted-by": "crossref", "first-page": "155", "DOI": "10.1017/S1461145708009012", "volume": "12", "author": "B Szewczyk", "year": "2009", "unstructured": "Szewczyk B, Albert PR, Burns AM, Czesak M, Overholser JC, Jurjus GJ, Meltzer HY, Konick LC, Dieter L, Herbst N, May W, Rajkowska G, Stockmeier CA, Austin MC (2009) Gender-specific decrease in NUDR and 5-HT1A receptor proteins in the prefrontal cortex of subjects with major depressive disorder. Int J Neuropsychopharmacol 12:155\u2013168", "journal-title": "Int J Neuropsychopharmacol"}, {"key": "2247_CR205", "doi-asserted-by": "crossref", "first-page": "103", "DOI": "10.1016/j.ejphar.2007.07.031", "volume": "574", "author": "Y Tadori", "year": "2007", "unstructured": "Tadori Y, Kitagawa H, Forbes RA, McQuade RD, Stark A, Kikuchi T (2007) Differences in agonist/antagonist properties at human dopamine D(2) receptors between aripiprazole, bifeprunox and SDZ 208\u2013912. Eur J Pharmacol 574:103\u2013111", "journal-title": "Eur J Pharmacol"}, {"key": "2247_CR206", "doi-asserted-by": "crossref", "first-page": "35", "DOI": "10.1016/j.ejphar.2009.02.007", "volume": "607", "author": "Y Tadori", "year": "2009", "unstructured": "Tadori Y, Forbes RA, McQuade RD, Kikuchi T (2009) Receptor reserve-dependent properties of antipsychotics at human dopamine D2 receptors. Eur J Pharmacol 607:35\u201340", "journal-title": "Eur J Pharmacol"}, {"key": "2247_CR207", "first-page": "1749", "volume": "69", "author": "E Tanaka", "year": "1993", "unstructured": "Tanaka E, North RA (1993) Actions of 5-hydroxytryptamine on neurons of the rat cingulate cortex. J Neurophysiol 69:1749\u20131757", "journal-title": "J Neurophysiol"}, {"key": "2247_CR208", "doi-asserted-by": "crossref", "first-page": "514", "DOI": "10.1001/archpsyc.59.6.514", "volume": "59", "author": "J Tauscher", "year": "2002", "unstructured": "Tauscher J, Kapur S, Verhoeff NP, Hussey DF, Daskalakis ZJ, Tauscher-Wisniewski S, Wilson AA, Houle S, Kasper S, Zipursky RB (2002) Brain serotonin 5-HT(1A) receptor binding in schizophrenia measured by positron emission tomography and [11\u00a0C]WAY-100635. Arch Gen Psychiatry 59:514\u2013520", "journal-title": "Arch Gen Psychiatry"}, {"key": "2247_CR209", "doi-asserted-by": "crossref", "first-page": "35", "DOI": "10.2165/00002018-200528010-00003", "volume": "28", "author": "K Titier", "year": "2005", "unstructured": "Titier K, Girodet PO, Verdoux H, Molimard M, Begaud B, Haverkamp W, Lader M, Moore N (2005) Atypical antipsychotics: from potassium channels to torsade de pointes and sudden death. Drug Saf 28:35\u201351", "journal-title": "Drug Saf"}, {"key": "2247_CR210", "doi-asserted-by": "crossref", "first-page": "193", "DOI": "10.1016/S0924-977X(01)00076-1", "volume": "11", "author": "Y Tohyama", "year": "2001", "unstructured": "Tohyama Y, Yamane F, Merid MF, Diksic M (2001) Effects of selective 5-HT1A receptor antagonists on regional serotonin synthesis in the rat brain: an autoradiographic study with alpha-[14\u00a0C]methyl-L-tryptophan. Eur Neuropsychopharmacol 11:193\u2013202", "journal-title": "Eur Neuropsychopharmacol"}, {"key": "2247_CR211", "doi-asserted-by": "crossref", "first-page": "522", "DOI": "10.2174/138161210790361452", "volume": "16", "author": "GE Tsai", "year": "2010", "unstructured": "Tsai GE, Lin PY (2010) Strategies to enhance N-methyl-D-aspartate receptor-mediated neurotransmission in schizophrenia, a critical review and meta-analysis. Curr Pharm Des 16:522\u2013537", "journal-title": "Curr Pharm Des"}, {"key": "2247_CR212", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1124/jpet.106.104463", "volume": "320", "author": "JD Urban", "year": "2007", "unstructured": "Urban JD, Clarke WP, von Zastrow M, Nichols DE, Kobilka B, Weinstein H, Javitch JA, Roth BL, Christopoulos A, Sexton PM, Miller KJ, Spedding M, Mailman RB (2007a) Functional selectivity and classical concepts of quantitative pharmacology. J Pharmacol Exp Ther 320:1\u201313", "journal-title": "J Pharmacol Exp Ther"}, {"key": "2247_CR213", "doi-asserted-by": "crossref", "first-page": "67", "DOI": "10.1038/sj.npp.1301071", "volume": "32", "author": "JD Urban", "year": "2007", "unstructured": "Urban JD, Vargas GA, von Zastrow M, Mailman RB (2007b) Aripiprazole has functionally selective actions at dopamine D2 receptor-mediated signaling pathways. Neuropsychopharmacology 32:67\u201377", "journal-title": "Neuropsychopharmacology"}, {"key": "2247_CR214", "doi-asserted-by": "crossref", "first-page": "1224", "DOI": "10.1124/jpet.106.113084", "volume": "320", "author": "M Buuse van den", "year": "2007", "unstructured": "van den Buuse M, Gogos A (2007) Differential effects of antipsychotic drugs on serotonin-1A receptor-mediated disruption of prepulse inhibition. J Pharmacol Exp Ther 320:1224\u20131236", "journal-title": "J Pharmacol Exp Ther"}, {"issue": "suppl.3", "key": "2247_CR215", "first-page": "2.034", "volume": "10", "author": "BJ Vliet Van", "year": "2000", "unstructured": "Van Vliet BJ, Mos J, Van der Heijden JAM, Feenstra R, Kruse CG, Long SK (2000a) DU 127090: a highly potent, atypical dopamine receptor ligand\u2014a putative potent full spectrum antipsychotic with low EPS potential. Eur J Neuropsychopharmacology 10(suppl3):2.034", "journal-title": "Eur J Neuropsychopharmacology"}, {"issue": "suppl.3", "key": "2247_CR216", "first-page": "2.035", "volume": "10", "author": "BJ Vliet Van", "year": "2000", "unstructured": "Van Vliet BJ, Ronken E, Tulp M, Feenstra R, Kruse CG (2000b) DU 127090: a highly potent, atypical dopamine receptor ligand\u2014high potency but low efficacy at dopamine D2 receptors in vitro. Eur J Neuropsychopharmacology 10(suppl3):2.035", "journal-title": "Eur J Neuropsychopharmacology"}, {"key": "2247_CR217", "doi-asserted-by": "crossref", "first-page": "43", "DOI": "10.1007/BF01244451", "volume": "83", "author": "ML Wadenberg", "year": "1991", "unstructured": "Wadenberg ML, Ahlenius S (1991) Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat: enhancement of antipsychotic-like effects without catalepsy. J Neural Transm Gen Sect\u00a083:43\u201353", "journal-title": "J Neural Transm Gen Sect"}, {"key": "2247_CR218", "doi-asserted-by": "crossref", "first-page": "151", "DOI": "10.1016/S0028-3908(98)00162-2", "volume": "38", "author": "ML Wadenberg", "year": "1999", "unstructured": "Wadenberg ML, Young KA, Richter JT, Hicks PB (1999) Effects of local application of 5-hydroxytryptamine into the dorsal or median raphe nuclei on haloperidol-induced catalepsy in the rat. Neuropharmacology 38:151\u2013156", "journal-title": "Neuropharmacology"}, {"key": "2247_CR219", "doi-asserted-by": "crossref", "first-page": "904", "DOI": "10.1177/0269881107081522", "volume": "22", "author": "L Wang", "year": "2008", "unstructured": "Wang L, Fang C, Zhang A, Du J, Yu L, Ma J, Feng G, Xing Q, He L (2008) The \u20131019\u00a0C/G polymorphism of the 5-HT1A receptor gene is associated with negative symptom response to risperidone treatment in schizophrenia patients. J Psychopharmacol 22:904\u2013909", "journal-title": "J Psychopharmacol"}, {"key": "2247_CR220", "doi-asserted-by": "crossref", "first-page": "421", "DOI": "10.1016/j.euroneuro.2010.02.011", "volume": "20", "author": "M Weber", "year": "2010", "unstructured": "Weber M, Chang WL, Breier MR, Yang A, Millan MJ, Swerdlow NR (2010) The effects of the dopamine D2 agonist sumanirole on prepulse inhibition in rats. Eur Neuropsychopharmacol 20:421\u2013425", "journal-title": "Eur Neuropsychopharmacol"}, {"key": "2247_CR221", "doi-asserted-by": "crossref", "first-page": "84", "DOI": "10.1016/S0006-8993(97)00159-5", "volume": "756", "author": "K Wedzony", "year": "1997", "unstructured": "Wedzony K, Mackowiak M, Czyrak A, Fijal K, Michalska B (1997) Single doses of MK-801, a non-competitive antagonist of NMDA receptors, increase the number of 5-HT1A serotonin receptors in the rat brain. Brain Res 756:84\u201391", "journal-title": "Brain Res"}, {"key": "2247_CR222", "doi-asserted-by": "crossref", "first-page": "547", "DOI": "10.1016/S0893-133X(00)00150-0", "volume": "23", "author": "K Wedzony", "year": "2000", "unstructured": "Wedzony K, Mackowiak M, Zajaczkowski W, Fijal K, Chocyk A, Czyrak A (2000) WAY 100135, an antagonist of 5-HT1A serotonin receptors, attenuates psychotomimetic effects of MK-801. Neuropsychopharmacology 23:547\u2013559", "journal-title": "Neuropsychopharmacology"}, {"key": "2247_CR223", "first-page": "229", "volume": "59", "author": "K Wedzony", "year": "2008", "unstructured": "Wedzony K, Chocyk A, Mackowiak M (2008) A search for colocalization of serotonin 5-HT2A and 5-HT1A receptors in the rat medial prefrontal and entorhinal cortices\u2014immunohistochemical studies. J Physiol Pharmacol 59:229\u2013238", "journal-title": "J Physiol Pharmacol"}, {"key": "2247_CR224", "doi-asserted-by": "crossref", "first-page": "304", "DOI": "10.1007/s00213-003-1398-x", "volume": "167", "author": "CA Winstanley", "year": "2003", "unstructured": "Winstanley CA, Chudasama Y, Dalley JW, Theobald DE, Glennon JC, Robbins TW (2003) Intra-prefrontal 8-OH-DPAT and M100907 improve visuospatial attention and decrease impulsivity on the five-choice serial reaction time task in rats. Psychopharmacol Berl 167:304\u2013314", "journal-title": "Psychopharmacol Berl"}, {"key": "2247_CR225", "doi-asserted-by": "crossref", "first-page": "1269", "DOI": "10.1017/S1461145710000866", "volume": "13", "author": "EH Wong", "year": "2010", "unstructured": "Wong EH, Yocca F, Smith MA, Lee CM (2010) Challenges and opportunities for drug discovery in psychiatric disorders: the drug hunters\u2019 perspective. Int J Neuropsychopharmacol 13:1269\u20131284", "journal-title": "Int J Neuropsychopharmacol"}, {"key": "2247_CR226", "doi-asserted-by": "crossref", "first-page": "638", "DOI": "10.1038/npp.2010.195", "volume": "36", "author": "PN Yadav", "year": "2011", "unstructured": "Yadav PN, Abbas AI, Farrell MS, Setola V, Sciaky N, Huang XP, Kroeze WK, Crawford LK, Piel DA, Keiser MJ, Irwin JJ, Shoichet BK, Deneris ES, Gingrich J, Beck SG, Roth BL (2011) The presynaptic component of the serotonergic system is required for clozapine\u2019s efficacy. Neuropsychopharmacology 36:638\u2013651", "journal-title": "Neuropsychopharmacology"}, {"key": "2247_CR227", "doi-asserted-by": "crossref", "first-page": "17194", "DOI": "10.1074/jbc.M801713200", "volume": "283", "author": "EY Yuen", "year": "2008", "unstructured": "Yuen EY, Jiang Q, Chen P, Feng J, Yan Z (2008) Activation of 5-HT2A/C receptors counteracts 5-HT1A regulation of n-methyl-D-aspartate receptor channels in pyramidal neurons of prefrontal cortex. J Biol Chem 283:17194\u201317204", "journal-title": "J Biol Chem"}, {"key": "2247_CR228", "doi-asserted-by": "crossref", "first-page": "157", "DOI": "10.1016/j.neulet.2005.06.035", "volume": "387", "author": "A Zocchi", "year": "2005", "unstructured": "Zocchi A, Fabbri D, Heidbreder CA (2005) Aripiprazole increases dopamine but not noradrenaline and serotonin levels in the mouse prefrontal cortex. Neurosci Lett 387:157\u2013161", "journal-title": "Neurosci Lett"}], "container-title": ["Psychopharmacology"], "language": "en", "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/s00213-011-2247-y", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 19]], "date-time": "2017-06-19T20:54:49Z", "timestamp": 1497905689000}, "score": 26.235138, "issued": {"date-parts": [[2011, 3, 11]]}, "references-count": 228, "journal-issue": {"published-print": {"date-parts": [[2011, 8]]}, "issue": "4"}, "alternative-id": ["2247"], "URL": "http://dx.doi.org/10.1007/s00213-011-2247-y", "relation": {"cites": []}, "ISSN": ["0033-3158", "1432-2072"], "issn-type": [{"value": "0033-3158", "type": "print"}, {"value": "1432-2072", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 12, 12]], "date-time": "2018-12-12T02:02:42Z", "timestamp": 1544580162932}, "reference-count": 64, "publisher": "Springer Nature", "issue": "6", "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Psychopharmacology"], "published-print": {"date-parts": [[2016, 3]]}, "DOI": "10.1007/s00213-015-4173-x", "type": "journal-article", "created": {"date-parts": [[2015, 12, 22]], "date-time": "2015-12-22T23:22:01Z", "timestamp": 1450826521000}, "page": "937-947", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 5, "title": ["Anti-aggressive effects of the selective high-efficacy \u2018biased\u2019 5-HT1A receptor agonists F15599 and F13714 in male WTG rats"], "prefix": "10.1007", "volume": "233", "author": [{"given": "Sietse F.", "family": "de Boer", "sequence": "first", "affiliation": []}, {"given": "Adrian", "family": "Newman-Tancredi", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2015, 12, 23]]}, "reference": [{"key": "4173_CR1", "doi-asserted-by": "crossref", "first-page": "170", "DOI": "10.1038/sj.bjp.0706859", "volume": "149", "author": "MB Assi\u00e9", "year": "2006", "unstructured": "Assi\u00e9 MB, Lomenech H, Ravailhe V, Faucillon V, Newman-Tancredi A (2006) Rapid desensitization of somatodendritic 5-HT1A receptors by chronic administration of the high-efficacy 5-HT1A agonist, F13714: a microdialysis study in the rat. Br J Pharmacol 149:170\u2013178", "journal-title": "Br J Pharmacol"}, {"issue": "10", "key": "4173_CR2", "doi-asserted-by": "crossref", "first-page": "1285", "DOI": "10.1017/S1461145709991222", "volume": "13", "author": "MB Assi\u00e9", "year": "2010", "unstructured": "Assi\u00e9 MB, Bardin L, Auclair AL, Carilla-Durand E, Depoort\u00e8re R, Koek W, Kleven MS, Colpaert F, Vacher B, Newman-Tancredi A (2010) F15599, a highly selective post-synaptic 5-HT(1A) receptor agonist: in-vivo profile in behavioural models of antidepressant and serotonergic activity. Int J Neuropsychopharmacol 13(10):1285\u20131298", "journal-title": "Int J Neuropsychopharmacol"}, {"issue": "20", "key": "4173_CR3", "doi-asserted-by": "crossref", "first-page": "8678", "DOI": "10.1523/JNEUROSCI.2067-12.2013", "volume": "33", "author": "E Audero", "year": "2013", "unstructured": "Audero E, Mlinar B, Baccini G, Skachokova ZK, Corradetti R, Gross C (2013) Suppression of serotonin neuron firing increases aggression in mice. J Neurosci 33(20):8678\u20138688", "journal-title": "J Neurosci"}, {"issue": "10", "key": "4173_CR4", "doi-asserted-by": "crossref", "first-page": "2825", "DOI": "10.1111/j.1460-9568.2005.04107.x", "volume": "21", "author": "M Beekman", "year": "2005", "unstructured": "Beekman M, Flachskamm C, Linthorst AC (2005) Effects of exposure to a predator on behaviour and serotonergic neurotransmission in different brain regions of C57bl/6N mice. Eur J Neurosci 21(10):2825\u20132836", "journal-title": "Eur J Neurosci"}, {"key": "4173_CR5", "doi-asserted-by": "crossref", "first-page": "968", "DOI": "10.1126/science.122.3177.968", "volume": "122", "author": "BB Brodie", "year": "1955", "unstructured": "Brodie BB, Pletcher A, Shore PA (1955) Evidence that serotonin has a role in brain function. Science 122:968", "journal-title": "Science"}, {"key": "4173_CR6", "doi-asserted-by": "crossref", "first-page": "299", "DOI": "10.1097/00008877-199406000-00007", "volume": "3", "author": "AK Cadogan", "year": "1994", "unstructured": "Cadogan AK, Kendall DA, Fink H, Marsden CA (1994) Social interaction increases 5-HT release and cAMP efflux in the rat ventral hippocampus in vivo. Behav Pharmacol 3:299\u2013305", "journal-title": "Behav Pharmacol"}, {"key": "4173_CR7", "doi-asserted-by": "crossref", "first-page": "74", "DOI": "10.1016/j.neuropharm.2014.11.012", "volume": "90", "author": "F Calcagnoli", "year": "2015", "unstructured": "Calcagnoli F, Stubbendorff C, Meyer N, de Boer SF, Althaus M, Koolhaas JM (2015) Oxytocin microinjected into the central amygdaloid nuclei exerts anti-aggressive effects in male rats. Neuropharmacology 90:74\u201381", "journal-title": "Neuropharmacology"}, {"key": "4173_CR8", "doi-asserted-by": "crossref", "first-page": "263", "DOI": "10.1016/j.bbr.2008.01.003", "volume": "189", "author": "D Caramaschi", "year": "2008", "unstructured": "Caramaschi D, de Boer SF, Vries HD, Koolhaas JM (2008) Development of violence in mice through repeated victory along with changes in prefrontal cortex neurochemistry. Behav Brain Res 189:263\u2013272", "journal-title": "Behav Brain Res"}, {"issue": "6", "key": "4173_CR9", "doi-asserted-by": "crossref", "first-page": "1207", "DOI": "10.1038/sj.bjp.0702915", "volume": "128", "author": "M Carli", "year": "1999", "unstructured": "Carli M, Balducci C, Millan MJ, Bonalumi P, Samanin R (1999) S 15535, a benzodioxopiperazine acting as presynaptic agonist and postsynaptic 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal scopolamine. Br J Pharmacol 128(6):1207\u20131214", "journal-title": "Br J Pharmacol"}, {"issue": "3", "key": "4173_CR10", "doi-asserted-by": "crossref", "first-page": "349", "DOI": "10.1007/s00213-009-1543-2", "volume": "205", "author": "M Carrillo", "year": "2009", "unstructured": "Carrillo M, Ricci LA, Coppersmith GA, Melloni RH Jr (2009) The effect of increased serotonergic neurotransmission on aggression: a critical meta-analytical review of preclinical studies. Psychopharmacol 205(3):349\u2013368", "journal-title": "Psychopharmacol"}, {"key": "4173_CR11", "doi-asserted-by": "crossref", "first-page": "237", "DOI": "10.1007/s00213-008-1269-6", "volume": "201", "author": "LA Centenaro", "year": "2008", "unstructured": "Centenaro LA, Vieira K, Zimmermann N, Miczek KA, Lucion AB, de Almeida RMM (2008) Social instigation and aggressive behavior in mice: role of 5-HT1A and 5-HT1B receptors in the prefrontal cortex. Psychopharmacol 201:237\u2013248", "journal-title": "Psychopharmacol"}, {"issue": "1\u20132", "key": "4173_CR12", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/S0165-1781(97)00108-X", "volume": "73", "author": "EF Coccaro", "year": "1997", "unstructured": "Coccaro EF, Kavoussi RJ, Trestman RL, Gabriel SM, Cooper TB, Siever LJ (1997) Serotonin function in human subjects: intercorrelations among central 5-HT indices and aggressiveness. Psychiatry Res 73(1\u20132):1\u201314", "journal-title": "Psychiatry Res"}, {"issue": "3", "key": "4173_CR13", "doi-asserted-by": "crossref", "first-page": "295", "DOI": "10.1017/S1092852915000310", "volume": "20", "author": "EF Coccaro", "year": "2015", "unstructured": "Coccaro EF, Fanning JR, Phan KL, Lee R (2015) Serotonin and impulsive aggression. CNS Spectr 20(3):295\u2013302", "journal-title": "CNS Spectr"}, {"key": "4173_CR14", "doi-asserted-by": "crossref", "first-page": "425", "DOI": "10.1016/S0091-3057(97)00295-5", "volume": "58", "author": "A Cologer-Clifford", "year": "1997", "unstructured": "Cologer-Clifford A, Simon NG, Lu SF, Smoluk SA (1997) Serotonin agonist-induced decreases in intermale aggression are dependent on brain region and receptor subtype. Pharmacol Biochem Behav 58:425\u2013430", "journal-title": "Pharmacol Biochem Behav"}, {"key": "4173_CR15", "doi-asserted-by": "crossref", "first-page": "237", "DOI": "10.1097/JCP.0b013e31824929d6", "volume": "32", "author": "S Comai", "year": "2012", "unstructured": "Comai S, Tau M, Pavlovic Z, Gobbi G (2012) The psychopharmacology of aggressive behaviour: a translational approach. J Clin Psychopharmacol 32:237\u2013260", "journal-title": "J Clin Psychopharmacol"}, {"key": "4173_CR16", "doi-asserted-by": "crossref", "first-page": "392", "DOI": "10.1007/s002130050476", "volume": "134", "author": "RM Almeida De", "year": "1997", "unstructured": "De Almeida RM, Lucion AB (1997) 8-OH-DPAT in the median raphe, dorsal periaqueductal gray and corticomedial amygdala nucleus decreases, but in the medial septal area it can increase maternal aggressive behavior in rats. Psychopharmacol (Berl) 134:392\u2013400", "journal-title": "Psychopharmacol (Berl)"}, {"issue": "1\u20133", "key": "4173_CR17", "doi-asserted-by": "crossref", "first-page": "125", "DOI": "10.1016/j.ejphar.2005.09.065", "volume": "526", "author": "SF Boer De", "year": "2005", "unstructured": "De Boer SF, Koolhaas JM (2005) 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis. Eur J Pharmacol 526(1\u20133):125\u2013139", "journal-title": "Eur J Pharmacol"}, {"issue": "1", "key": "4173_CR18", "doi-asserted-by": "crossref", "first-page": "20", "DOI": "10.1016/S0893-133X(00)00092-0", "volume": "23", "author": "SF Boer De", "year": "2000", "unstructured": "De Boer SF, Lesourd M, Mocaer E, Koolhaas JM (2000) Somatodendritic 5-HT(1A) autoreceptors mediate the anti-aggressive actions of 5-HT(1A) receptor agonists in rats: an ethopharmacological study with S-15535, alnespirone, and WAY-100635. Neuropsychopharmacology 23(1):20\u201333", "journal-title": "Neuropsychopharmacology"}, {"issue": "5", "key": "4173_CR19", "doi-asserted-by": "crossref", "first-page": "481", "DOI": "10.1023/A:1025766415159", "volume": "33", "author": "SF Boer De", "year": "2003", "unstructured": "De Boer SF, van der Vegt BJ, Koolhaas JM (2003) Individual variation in aggression of feral rodent strains: a standard for the genetics of aggression and violence? Behav Genetics 33(5):481\u2013497", "journal-title": "Behav Genetics"}, {"key": "4173_CR20", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.3389/neuro.08.052.2009", "volume": "3", "author": "SF Boer De", "year": "2009", "unstructured": "De Boer SF, Caramaschi D, Natarajan D, Koolhaas JM (2009) The vicious cycle towards violence: focus on the negative feedback mechanisms of brain serotonin neurotransmission. Front Behav Neurosci 3:1\u20136", "journal-title": "Front Behav Neurosci"}, {"key": "4173_CR21", "doi-asserted-by": "crossref", "first-page": "111", "DOI": "10.1016/j.physbeh.2015.04.040", "volume": "146", "author": "SF Boer De", "year": "2015", "unstructured": "De Boer SF, Olivier B, Veening J, Koolhaas JM (2015) The neurobiology of aggression: revealing a modular view. Physiol Behav 146:111\u2013127", "journal-title": "Physiol Behav"}, {"issue": "5", "key": "4173_CR22", "doi-asserted-by": "crossref", "first-page": "1148", "DOI": "10.1037/a0031544", "volume": "139", "author": "AA Duke", "year": "2013", "unstructured": "Duke AA, Begue L, Bell R, Eisenlohr-Moul T (2013) Revisiting the serotonin-aggression relation in humans: a meta-analysis. Psychol Bull 139(5):1148\u20131172", "journal-title": "Psychol Bull"}, {"key": "4173_CR23", "doi-asserted-by": "crossref", "first-page": "111", "DOI": "10.1186/1471-2202-9-111", "volume": "9", "author": "CF Ferris", "year": "2008", "unstructured": "Ferris CF, Stolberg T, Kulkarni P, Murugavel M, Blanchard R, Blanchard DC, Febo M, Brevard M, Simon NG (2008) Imaging the neural circuitry and chemical control of aggressive motivation. BMC Neurosci 9:111", "journal-title": "BMC Neurosci"}, {"key": "4173_CR24", "doi-asserted-by": "crossref", "first-page": "623", "DOI": "10.1007/s00213-013-3389-x", "volume": "231", "author": "A Garcia-Garcia", "year": "2014", "unstructured": "Garcia-Garcia A, Newman-Tancredi A, Leonardo ED (2014) 5-HT1A receptors in mood and anxiety: recent insights into autoreceptor versus heteroreceptor function. Psychopharmacol (Berl) 231:623\u2013636", "journal-title": "Psychopharmacol (Berl)"}, {"issue": "7", "key": "4173_CR25", "doi-asserted-by": "crossref", "first-page": "1013", "DOI": "10.4088/JCP.v67n0702", "volume": "67", "author": "LE Goedhard", "year": "2006", "unstructured": "Goedhard LE, Stolker JJ, Heerdink ER, Nijman HLI, Olivier B, Egberts T (2006) Pharmacotherapy for the treatment of aggressive behaviour in general adult psychiatry: a systemic review. J Clin Psychiatry 67(7):1013\u20131024", "journal-title": "J Clin Psychiatry"}, {"issue": "1", "key": "4173_CR26", "doi-asserted-by": "crossref", "first-page": "88", "DOI": "10.1016/j.bbr.2005.01.006", "volume": "161", "author": "J Haller", "year": "2005", "unstructured": "Haller J, T\u00f3th M, Hal\u00e1sz J (2005) The activation of raphe serotonergic neurons in normal and hypoarousal-driven aggression: a double labeling study in rats. Behav Brain Res 161(1):88\u201394", "journal-title": "Behav Brain Res"}, {"issue": "1\u20132", "key": "4173_CR27", "doi-asserted-by": "crossref", "first-page": "173", "DOI": "10.1016/j.physbeh.2006.03.030", "volume": "88", "author": "J Haller", "year": "2006", "unstructured": "Haller J, T\u00f3th M, Halasz J, De Boer SF (2006) Patterns of violent aggression-induced brain c-fos expression in male mice selected for aggressiveness. Physiol Behav 88(1\u20132):173\u2013182", "journal-title": "Physiol Behav"}, {"key": "4173_CR28", "doi-asserted-by": "crossref", "first-page": "335", "DOI": "10.1016/j.expneurol.2015.05.021", "volume": "271", "author": "H Iderberg", "year": "2015", "unstructured": "Iderberg H, McCreary AC, Varney MA, Kleven MS, Koek W, Bardin L, Depoort\u00e8re R, Cenci MA, Newman-Tancredi A (2015) NLX-112, a novel 5-HT1A receptor agonist for the treatment of l-DOPA-induced dyskinesia: behavioral and neurochemical profile in rat. Exp Neurol 271:335\u2013350", "journal-title": "Exp Neurol"}, {"issue": "1\u20133", "key": "4173_CR29", "doi-asserted-by": "crossref", "first-page": "45", "DOI": "10.1016/S0165-0173(02)00187-X", "volume": "40", "author": "BL Jacobs", "year": "2002", "unstructured": "Jacobs BL, Martin-Cora FJ, Fornal CA (2002) Activity of medullary serotonergic neurons in freely moving animals. Brain Res Brain Res Rev 40(1\u20133):45\u201352", "journal-title": "Brain Res Brain Res Rev"}, {"key": "4173_CR30", "first-page": "77", "volume": "4", "author": "JM Koolhaas", "year": "2013", "unstructured": "Koolhaas JM, Coppens CM, de Boer SF, Buwalda B, Meerlo P, Timmermans PJA (2013) The resident-intruder paradigm: a standardized test for aggression, violence and social stress. J Vis Exp 4:77", "journal-title": "J Vis Exp"}, {"issue": "3530", "key": "4173_CR31", "doi-asserted-by": "crossref", "first-page": "621", "DOI": "10.1126/science.137.3530.621", "volume": "137", "author": "JW Maas", "year": "1962", "unstructured": "Maas JW (1962) Neurochemical differences between two strains of mice. Science 137(3530):621\u2013622", "journal-title": "Science"}, {"key": "4173_CR32", "author": "M Mak", "first-page": "289", "year": "1995", "unstructured": "Mak M, de Koning P, Mos J, Olivier B (1995) Preclinical and clinical studies on the role of 5-HT1 receptors in aggression. In: Hollander E, Stein DJ (eds) Impulsivity and aggression. John Wiley & Sons Ltd, Chichester, England, pp 289\u2013311", "volume-title": "Impulsivity and aggression"}, {"key": "4173_CR33", "author": "SB Manuck", "first-page": "65", "year": "2006", "unstructured": "Manuck SB, Kaplan JR, Lotrich FE (2006) Brain serotonin and aggressive disposition in humans and nonhuman primates. In: Nelson RJ (ed) Biology of Aggression. Oxford University Press, New York, pp 65\u2013113", "volume-title": "Biology of Aggression"}, {"key": "4173_CR34", "doi-asserted-by": "crossref", "first-page": "5024", "DOI": "10.1021/jm070714l", "volume": "50", "author": "JL Maurel", "year": "2007", "unstructured": "Maurel JL, Autin JM, Funes P (2007) High-efficacy 5-HT1A agonists for antidepressant treatment: a renewed opportunity. J Med Chem 50:5024\u20135033", "journal-title": "J Med Chem"}, {"issue": "11", "key": "4173_CR35", "doi-asserted-by": "crossref", "first-page": "1001", "DOI": "10.1001/archpsyc.1996.01830110037005", "volume": "53", "author": "CJ McDougle", "year": "1996", "unstructured": "McDougle CJ, Naylor ST, Cohen DJ, Volkmar FR, Heninger GR, Price LH (1996) A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Arch Gen Psychiatry 53(11):1001\u20131008", "journal-title": "Arch Gen Psychiatry"}, {"key": "4173_CR36", "doi-asserted-by": "crossref", "first-page": "336", "DOI": "10.1196/annals.1330.021", "volume": "1036", "author": "KA Miczek", "year": "2004", "unstructured": "Miczek KA, Faccidomo S, De Almeida RM, Bannai M, Fish EW, Debold JF (2004) Escalated aggressive behavior: new pharmacotherapeutic approaches and opportunities. Ann N Y Acad Sci 1036:336\u2013355", "journal-title": "Ann N Y Acad Sci"}, {"key": "4173_CR37", "doi-asserted-by": "crossref", "first-page": "90", "DOI": "10.1016/j.cobeha.2015.02.007", "volume": "3", "author": "KA Miczek", "year": "2015", "unstructured": "Miczek KA, Takahashi A, Gobrogge KL, Hwa LS, de Almeida RM (2015) Escalated aggression in animal models: shedding new light on mesocorticolimbic circuits. Curr Opin Behav Sci 3:90\u201395", "journal-title": "Curr Opin Behav Sci"}, {"issue": "1", "key": "4173_CR38", "first-page": "337", "volume": "268", "author": "MJ Millan", "year": "1994", "unstructured": "Millan MJ, Canton H, Gobert A et al (1994) Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists. J Pharmacol Exp Ther 268(1):337\u2013352", "journal-title": "J Pharmacol Exp Ther"}, {"issue": "1", "key": "4173_CR39", "first-page": "132", "volume": "282", "author": "MJ Millan", "year": "1997", "unstructured": "Millan MJ, Newman-Tancredi A, Rivet JM, Brocco M, Lacroix P, Audinot V, Cistarelli L, Gobert A (1997) S15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity. J Pharmacol Exp Ther 282(1):132\u2013147", "journal-title": "J Pharmacol Exp Ther"}, {"key": "4173_CR40", "doi-asserted-by": "crossref", "first-page": "295", "DOI": "10.1016/0014-2999(92)90348-8", "volume": "212", "author": "J Mos", "year": "1992", "unstructured": "Mos J, Olivier B, Poth M, van Aken H (1992) The effects of intraventricular administration of eltoprazine, 1-(3-trifluoromethylphenyl), piperazine, hydrochloride and 8-OH-DPAT on resident-intruder aggression in the rat. Eur J Pharmacol 212:295\u2013298", "journal-title": "Eur J Pharmacol"}, {"issue": "4", "key": "4173_CR41", "doi-asserted-by": "crossref", "first-page": "583", "DOI": "10.1007/s00221-012-3168-7", "volume": "230", "author": "T Nakazato", "year": "2013", "unstructured": "Nakazato T (2013) Dual modes of extracellular serotonin changes in the rat ventral striatum modulate adaptation to a social stress environment, studied with wireless voltammetry. Exp Brain Res 230(4):583\u2013596", "journal-title": "Exp Brain Res"}, {"issue": "2", "key": "4173_CR42", "doi-asserted-by": "crossref", "first-page": "149", "DOI": "10.2217/npy.11.12", "volume": "1", "author": "A Newman-Tancredi", "year": "2011", "unstructured": "Newman-Tancredi A (2011) Biased agonism at serotonin 5-HT1A receptors: preferential postsynaptic activity for improved therapy of CNS disorders. Neuropsychiatry 1(2):149\u2013164", "journal-title": "Neuropsychiatry"}, {"issue": "2", "key": "4173_CR43", "doi-asserted-by": "crossref", "first-page": "338", "DOI": "10.1111/j.1476-5381.2008.00001.x", "volume": "156", "author": "A Newman-Tancredi", "year": "2009", "unstructured": "Newman-Tancredi A, Martel JC, Assi\u00e9 MB, Buritova J, Lauressergues E, Cosi C, Heusler P, Bruins Slot L, Colpaert FC, Vacher B, Cussac D (2009) Signal transduction and functional selectivity of F15599, a preferential post-synaptic 5-HT1A receptor agonist. Br J Pharmacol 156(2):338\u2013353", "journal-title": "Br J Pharmacol"}, {"key": "4173_CR44", "doi-asserted-by": "crossref", "first-page": "382", "DOI": "10.1196/annals.1330.022", "volume": "1036", "author": "B Olivier", "year": "2004", "unstructured": "Olivier B (2004) Serotonin and aggression. Ann NY Acad Sci 1036:382\u2013392", "journal-title": "Ann NY Acad Sci"}, {"key": "4173_CR45", "doi-asserted-by": "crossref", "first-page": "1929", "DOI": "10.1111/j.1476-5381.2010.00738.x", "volume": "160", "author": "L Pelfort", "year": "2010", "unstructured": "Pelfort L, Assi\u00e9 MB, Newman-Tancredi A, Artigas F, Celada P (2010) Preferential in vivo action of F15599, a novel 5-HT1A receptor agonist, at postsynaptic 5-HT1A receptors. Br J Pharmacol 160:1929\u20131940", "journal-title": "Br J Pharmacol"}, {"issue": "3", "key": "4173_CR46", "doi-asserted-by": "crossref", "first-page": "145", "DOI": "10.1089/cap.1997.7.145", "volume": "7", "author": "CR Pfeffer", "year": "1997", "unstructured": "Pfeffer CR, Jiang H, Domeshek LJ (1997) Buspirone treatment of psychiatrically hospitalized prepubertal children with symptoms of anxiety and moderately severe aggression. J Child Adolesc Psychopharmacol 7(3):145\u2013155", "journal-title": "J Child Adolesc Psychopharmacol"}, {"issue": "4", "key": "4173_CR47", "first-page": "159", "volume": "52", "author": "J Ratey", "year": "1991", "unstructured": "Ratey J, Sovner R, Parks A, Rogentine K (1991) Buspirone treatment of aggression and anxiety in mentally retarded patients: a multiple-baseline, placebo lead-in study. J Clin Psychiatry 52(4):159\u2013162", "journal-title": "J Clin Psychiatry"}, {"issue": "2", "key": "4173_CR48", "doi-asserted-by": "crossref", "first-page": "270", "DOI": "10.1097/00004583-199402000-00017", "volume": "33", "author": "RW Ricketts", "year": "1994", "unstructured": "Ricketts RW, Goza AB, Ellis CR, Singh YN, Chambers S, Singh NN, Cooke JC (1994) Clinical effects of buspirone on intractable self-injury in adults with mental retardation. J Am Acad Child Adolesc Psychiatry 33(2):270\u2013276", "journal-title": "J Am Acad Child Adolesc Psychiatry"}, {"issue": "3", "key": "4173_CR49", "doi-asserted-by": "crossref", "first-page": "254", "DOI": "10.1017/S109285291500019X", "volume": "20", "author": "DR Rosell", "year": "2015", "unstructured": "Rosell DR, Siever LJ (2015) The neurobiology of aggression and violence. CNS Spectr 20(3):254\u2013279", "journal-title": "CNS Spectr"}, {"issue": "2", "key": "4173_CR50", "doi-asserted-by": "crossref", "first-page": "198", "DOI": "10.1016/S0006-8993(97)00433-2", "volume": "765", "author": "MB Shaikh", "year": "1997", "unstructured": "Shaikh MB, De Lanerolle NC, Siegel A (1997) Serotonin 5-HT1A and 5-HT2/1C receptors in the midbrain periaqueductal gray differentially modulate defensive rage behavior elicited from the medial hypothalamus of the cat. Brain Res 765(2):198\u2013207", "journal-title": "Brain Res"}, {"issue": "2", "key": "4173_CR51", "doi-asserted-by": "crossref", "first-page": "126", "DOI": "10.1097/00004714-199404000-00007", "volume": "14", "author": "SW Stanislav", "year": "1994", "unstructured": "Stanislav SW, Fabre T, Crismon ML, Childs A (1994) Buspirone\u2019s efficacy in organic-induced aggression. J Clin Psychopharmacol 14(2):126\u2013130", "journal-title": "J Clin Psychopharmacol"}, {"issue": "3", "key": "4173_CR52", "doi-asserted-by": "crossref", "first-page": "375", "DOI": "10.1007/s00213-013-3164-z", "volume": "230", "author": "DJ Stein", "year": "2013", "unstructured": "Stein DJ, Miczek KA, Lucion AB, de Almeida RM (2013) Aggression-reducing effects of F15599, a novel selective 5-HT1A receptor agonist, after microinjection into the ventral orbital prefrontal cortex, but not in infralimbic cortex in male mice. Psychopharmacology (Berl) 230(3):375\u2013387", "journal-title": "Psychopharmacology (Berl)"}, {"key": "4173_CR53", "doi-asserted-by": "crossref", "first-page": "3", "DOI": "10.1007/7854_2013_263", "volume": "17", "author": "A Takahashi", "year": "2014", "unstructured": "Takahashi A, Miczek KA (2014) Neurogenetics of aggressive behavior: studies in rodents. Curr Top Behav Neurosci 17:3\u201344", "journal-title": "Curr Top Behav Neurosci"}, {"issue": "2\u20133", "key": "4173_CR54", "doi-asserted-by": "crossref", "first-page": "183", "DOI": "10.1007/s00213-010-2000-y", "volume": "213", "author": "A Takahashi", "year": "2011", "unstructured": "Takahashi A, Quadros IM, de Almeida RM, Miczek KA (2011) Brain serotonin receptors and transporters: initiation vs. termination of escalated aggression. Psychopharmacology (Berl) 213(2\u20133):183\u2013212", "journal-title": "Psychopharmacology (Berl)"}, {"key": "4173_CR55", "doi-asserted-by": "crossref", "first-page": "73", "DOI": "10.1007/7854_2011_191", "volume": "12", "author": "A Takahashi", "year": "2012", "unstructured": "Takahashi A, Quadros IM, de Almeida RM, Miczek KA (2012) Behavioral and pharmacogenetics of aggressive behavior. Curr Top Behav Neurosci 12:73\u2013138", "journal-title": "Curr Top Behav Neurosci"}, {"issue": "16", "key": "4173_CR56", "doi-asserted-by": "crossref", "first-page": "6452", "DOI": "10.1523/JNEUROSCI.2450-14.2015", "volume": "35", "author": "A Takahashi", "year": "2015", "unstructured": "Takahashi A, Lee RX, Iwasato T, Itohara S, Arima H, Bettler B, Miczek KA, Koide T (2015) Glutamate input in the dorsal raphe nucleus as a determinant of escalated aggression in male mice. J Neurosci 35(16):6452\u20136463", "journal-title": "J Neurosci"}, {"issue": "5", "key": "4173_CR57", "doi-asserted-by": "crossref", "first-page": "181", "DOI": "10.1136/ebmed-2014-110016", "volume": "19", "author": "BR Underwood", "year": "2014", "unstructured": "Underwood BR, Fox C (2014) Citalopram decreases agitation in the context of Alzheimer\u2019s disease, but at doses higher than those commonly prescribed and at the expense of side effects. Evid Based Med 19(5):181", "journal-title": "Evid Based Med"}, {"issue": "3", "key": "4173_CR58", "doi-asserted-by": "crossref", "first-page": "259", "DOI": "10.1111/j.1471-4159.1968.tb06205.x", "volume": "15", "author": "L Valzelli", "year": "1968", "unstructured": "Valzelli L, Garattini S (1968) Biogenic amines in discrete brain areas after treatment with monoamineoxidase inhibitors. J Neurochem 15(3):259\u2013261", "journal-title": "J Neurochem"}, {"issue": "1\u20132", "key": "4173_CR59", "doi-asserted-by": "crossref", "first-page": "205", "DOI": "10.1016/S0031-9384(01)00565-0", "volume": "74", "author": "BJ Vegt Van der", "year": "2001", "unstructured": "Van der Vegt BJ, De Boer SF, Buwalda B, de Ruiter AJ, de Jong JG, Koolhaas JM (2001) Enhanced sensitivity of postsynaptic serotonin-1A receptors in rats and mice with high trait aggression. Physiol Behav 74(1\u20132):205\u2013211", "journal-title": "Physiol Behav"}, {"issue": "3", "key": "4173_CR60", "doi-asserted-by": "crossref", "first-page": "199", "DOI": "10.1016/S0018-506X(03)00132-6", "volume": "44", "author": "BJ Vegt Van der", "year": "2003", "unstructured": "Van der Vegt BJ, Lieuwes N, Cremers TI, de Boer SF, Koolhaas JM (2003) Cerebrospinal fluid monoamine and metabolite concentrations and aggression in rats. Horm Behav 44(3):199\u2013208", "journal-title": "Horm Behav"}, {"issue": "5", "key": "4173_CR61", "doi-asserted-by": "crossref", "first-page": "348", "DOI": "10.1111/j.1600-0447.1995.tb09793.x", "volume": "91", "author": "H Vartiainen", "year": "1995", "unstructured": "Vartiainen H, Tiihonen J, Putkonen A, Koponen H, Virkkunen M, Hakola P, Lehto H (1995) Citalopram, a selective serotonin reuptake inhibitor, in the treatment of aggression in schizophrenia. Acta Psychiatr Scand 91(5):348\u2013351", "journal-title": "Acta Psychiatr Scand"}, {"issue": "1\u20133", "key": "4173_CR62", "doi-asserted-by": "crossref", "first-page": "226", "DOI": "10.1016/j.ejphar.2005.09.041", "volume": "526", "author": "JG Veening", "year": "2005", "unstructured": "Veening JG, Coolen LM, de Jong TR, Joosten HW, de Boer SF, Koolhaas JM, Olivier B (2005) Do similar neural systems subserve aggressive and sexual behaviour in male rats? Insights from c-Fos and pharmacological studies. Eur J Pharmacol 526(1\u20133):226\u2013239", "journal-title": "Eur J Pharmacol"}, {"issue": "4", "key": "4173_CR63", "doi-asserted-by": "crossref", "first-page": "697", "DOI": "10.1016/0031-9384(82)90054-3", "volume": "28", "author": "H Walletschek", "year": "1982", "unstructured": "Walletschek H, Raab A (1982) Spontaneous activity of dorsal raphe neurons during defensive and offensive encounters in the tree-shrew. Physiol Behav 28(4):697\u2013705", "journal-title": "Physiol Behav"}, {"key": "4173_CR64", "unstructured": "Weintraub D, Drye LT, Porsteinsson AP, Rosenberg PB, Pollock BG, Devanand DP, Frangakis C, Ismail Z, Marano C, Meinert CL, Mintzer JE, Munro CA, Pelton G, Rabins PV, Schneider LS, Shade DM, Yesavage J, Lyketsos CG, CitAD Research Group (2015) Time to response to citalopram treatment for agitation in Alzheimer disease. Am J Geriatr Psychiatry S1064\u20137481", "DOI": "10.1016/j.jagp.2015.05.006", "doi-asserted-by": "crossref"}], "container-title": ["Psychopharmacology"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s00213-015-4173-x", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 7, 27]], "date-time": "2018-07-27T13:07:37Z", "timestamp": 1532696857000}, "score": 26.235138, "issued": {"date-parts": [[2015, 12, 23]]}, "references-count": 64, "journal-issue": {"published-print": {"date-parts": [[2016, 3]]}, "issue": "6"}, "alternative-id": ["4173"], "URL": "http://dx.doi.org/10.1007/s00213-015-4173-x", "relation": {"cites": []}, "ISSN": ["0033-3158", "1432-2072"], "issn-type": [{"value": "0033-3158", "type": "print"}, {"value": "1432-2072", "type": "electronic"}], "subject": ["Pharmacology"]}, {"indexed": {"date-parts": [[2018, 5, 3]], "date-time": "2018-05-03T00:22:58Z", "timestamp": 1525306978213}, "reference-count": 0, "publisher": "Springer Nature", "issue": "5", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1998, 5]]}, "DOI": "10.1016/s0893-133x(97)00169-3", "type": "journal-article", "created": {"date-parts": [[2002, 7, 25]], "date-time": "2002-07-25T22:56:43Z", "timestamp": 1027637803000}, "page": "395-398", "source": "Crossref", "is-referenced-by-count": 40, "title": ["Agonist and Antagonist Actions of (-)Pindolol at Recombinant, Human Serotonin1A (5-HT1A) Receptors"], "prefix": "10.1038", "volume": "18", "author": [{"given": "A", "family": "Newman-Tancredi, Ph.D.", "sequence": "first", "affiliation": []}], "member": "297", "container-title": ["Neuropsychopharmacology"], "deposited": {"date-parts": [[2011, 8, 8]], "date-time": "2011-08-08T12:17:39Z", "timestamp": 1312805859000}, "score": 22.779968, "issued": {"date-parts": [[1998, 5]]}, "references-count": 0, "journal-issue": {"issue": "5"}, "alternative-id": ["S0893-133X(97)00169-3"], "URL": "http://dx.doi.org/10.1016/s0893-133x(97)00169-3", "ISSN": ["0893-133X"], "issn-type": [{"value": "0893-133X", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 5, 2]], "date-time": "2018-05-02T22:23:00Z", "timestamp": 1525299780224}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "http://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1996, 12, 1]], "date-time": "1996-12-01T00:00:00Z", "timestamp": 849398400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1996, 12]]}, "DOI": "10.1016/s0361-9230(96)00150-5", "type": "journal-article", "created": {"date-parts": [[2002, 7, 25]], "date-time": "2002-07-25T16:05:14Z", "timestamp": 1027613114000}, "page": "93-96", "source": "Crossref", "is-referenced-by-count": 5, "title": ["Down-Regulation of Rat ? by Clenbuterol or Desipramine Does Not Require Chronic Treatment: [3H]CGP-12177 Binding Reveals Rapid (24 Hour) Modulation"], "prefix": "10.1016", "volume": "41", "author": [{"given": "A", "family": "Newman-Tancredi", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Brain Research Bulletin"], "link": [{"URL": "http://api.elsevier.com/content/article/PII:S0361-9230(96)00150-5?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://api.elsevier.com/content/article/PII:S0361-9230(96)00150-5?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2015, 9, 4]], "date-time": "2015-09-04T01:06:38Z", "timestamp": 1441328798000}, "score": 22.779968, "issued": {"date-parts": [[1996, 12]]}, "references-count": 0, "journal-issue": {"issue": "2"}, "alternative-id": ["S0361-9230(96)00150-5"], "URL": "http://dx.doi.org/10.1016/s0361-9230(96)00150-5", "ISSN": ["0361-9230"], "issn-type": [{"value": "0361-9230", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 5, 3]], "date-time": "2018-05-03T14:05:16Z", "timestamp": 1525356316206}, "reference-count": 0, "publisher": "American Society for Pharmacology & Experimental Therapeutics (ASPET)", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2002, 9, 1]]}, "DOI": "10.1124/mol.62.3.590", "type": "journal-article", "created": {"date-parts": [[2003, 1, 15]], "date-time": "2003-01-15T23:12:39Z", "timestamp": 1042672359000}, "page": "590-601", "source": "Crossref", "is-referenced-by-count": 37, "title": ["Antibody Capture Assay Reveals Bell-Shaped Concentration-Response Isotherms for h5-HT1A Receptor-Mediated Galpha i3 Activation: Conformational Selection by High-Efficacy Agonists, and Relationship to Trafficking of Receptor Signaling"], "prefix": "10.1124", "volume": "62", "author": [{"given": "A.", "family": "Newman-Tancredi", "sequence": "first", "affiliation": []}], "member": "36", "container-title": ["Molecular Pharmacology"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1124/mol.62.3.590", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T03:09:24Z", "timestamp": 1482462564000}, "score": 22.779968, "issued": {"date-parts": [[2002, 9, 1]]}, "references-count": 0, "journal-issue": {"issue": "3"}, "URL": "http://dx.doi.org/10.1124/mol.62.3.590", "ISSN": ["0026-895X"], "issn-type": [{"value": "0026-895X", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 12, 7]], "date-time": "2018-12-07T20:10:05Z", "timestamp": 1544213405819}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2010, 8, 1]], "date-time": "2010-08-01T00:00:00Z", "timestamp": 1280620800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Neuropsychopharmacology"], "published-print": {"date-parts": [[2010, 8]]}, "DOI": "10.1016/s0924-977x(10)70126-7", "type": "journal-article", "created": {"date-parts": [[2010, 9, 30]], "date-time": "2010-09-30T09:18:27Z", "timestamp": 1285838307000}, "page": "S164", "source": "Crossref", "is-referenced-by-count": 0, "title": ["S.03.02 Searching for an optimised pharmacological cocktail: focus on antipsychotics with combined D2 and serotonin 5-HT1A activity"], "prefix": "10.1016", "volume": "20", "author": [{"given": "A.", "family": "Newman-Tancredi", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["European Neuropsychopharmacology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0924977X10701267?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0924977X10701267?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 7]], "date-time": "2018-12-07T19:50:30Z", "timestamp": 1544212230000}, "score": 22.779968, "issued": {"date-parts": [[2010, 8]]}, "references-count": 0, "alternative-id": ["S0924977X10701267"], "URL": "http://dx.doi.org/10.1016/s0924-977x(10)70126-7", "ISSN": ["0924-977X"], "issn-type": [{"value": "0924-977X", "type": "print"}], "subject": ["Pharmacology (medical)", "Biological Psychiatry", "Pharmacology", "Neurology", "Psychiatry and Mental health", "Clinical Neurology"]}, {"indexed": {"date-parts": [[2018, 11, 20]], "date-time": "2018-11-20T01:10:06Z", "timestamp": 1542676206089}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2012, 10, 1]], "date-time": "2012-10-01T00:00:00Z", "timestamp": 1349049600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Neuropsychopharmacology"], "published-print": {"date-parts": [[2012, 10]]}, "DOI": "10.1016/s0924-977x(12)70154-2", "type": "journal-article", "created": {"date-parts": [[2012, 10, 23]], "date-time": "2012-10-23T06:56:59Z", "timestamp": 1350975419000}, "page": "S128", "source": "Crossref", "is-referenced-by-count": 0, "title": ["S.11.04 \u2018Biased agonism\u2019 at cortical post-synaptic 5-HT1A receptors for improved treatment of depressive disorders"], "prefix": "10.1016", "volume": "22", "author": [{"given": "A.", "family": "Newman-Tancredi", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["European Neuropsychopharmacology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0924977X12701542?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0924977X12701542?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 11, 20]], "date-time": "2018-11-20T00:52:09Z", "timestamp": 1542675129000}, "score": 22.779968, "issued": {"date-parts": [[2012, 10]]}, "references-count": 0, "alternative-id": ["S0924977X12701542"], "URL": "http://dx.doi.org/10.1016/s0924-977x(12)70154-2", "ISSN": ["0924-977X"], "issn-type": [{"value": "0924-977X", "type": "print"}], "subject": ["Pharmacology (medical)", "Biological Psychiatry", "Pharmacology", "Neurology", "Psychiatry and Mental health", "Clinical Neurology"]}, {"indexed": {"date-parts": [[2018, 9, 27]], "date-time": "2018-09-27T13:02:36Z", "timestamp": 1538053356891}, "reference-count": 0, "publisher": "American Society for Pharmacology & Experimental Therapeutics (ASPET)", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2002, 11, 1]]}, "DOI": "10.1124/jpet.102.039883", "type": "journal-article", "created": {"date-parts": [[2003, 1, 10]], "date-time": "2003-01-10T18:48:30Z", "timestamp": 1042224510000}, "page": "815-822", "source": "Crossref", "is-referenced-by-count": 123, "title": ["Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. III. Agonist and Antagonist Properties at Serotonin, 5-HT1 and 5-HT2, Receptor Subtypes"], "prefix": "10.1124", "volume": "303", "author": [{"given": "A.", "family": "Newman-Tancredi", "sequence": "first", "affiliation": []}], "member": "36", "container-title": ["Journal of Pharmacology and Experimental Therapeutics"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1124/jpet.102.039883", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 22]], "date-time": "2016-12-22T23:35:16Z", "timestamp": 1482449716000}, "score": 22.779968, "issued": {"date-parts": [[2002, 11, 1]]}, "references-count": 0, "journal-issue": {"issue": "2"}, "URL": "http://dx.doi.org/10.1124/jpet.102.039883", "ISSN": ["0022-3565", "1521-0103"], "issn-type": [{"value": "0022-3565", "type": "print"}, {"value": "1521-0103", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 1, 11]], "date-time": "2019-01-11T16:41:14Z", "timestamp": 1547224874050}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2006, 1, 1]], "date-time": "2006-01-01T00:00:00Z", "timestamp": 1136073600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Neuropsychopharmacology"], "published-print": {"date-parts": [[2006, 1]]}, "DOI": "10.1016/s0924-977x(06)70054-2", "type": "journal-article", "created": {"date-parts": [[2006, 11, 9]], "date-time": "2006-11-09T12:23:10Z", "timestamp": 1163074990000}, "page": "S178-S179", "source": "Crossref", "is-referenced-by-count": 0, "title": ["S.08.03 D2 antagonist/5-HT1A agonist interactions"], "prefix": "10.1016", "volume": "16", "author": [{"given": "A.", "family": "Newman-Tancredi", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["European Neuropsychopharmacology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0924977X06700542?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0924977X06700542?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 1, 11]], "date-time": "2019-01-11T16:21:37Z", "timestamp": 1547223697000}, "score": 22.779968, "issued": {"date-parts": [[2006, 1]]}, "references-count": 0, "alternative-id": ["S0924977X06700542"], "URL": "http://dx.doi.org/10.1016/s0924-977x(06)70054-2", "ISSN": ["0924-977X"], "issn-type": [{"value": "0924-977X", "type": "print"}], "subject": ["Pharmacology (medical)", "Biological Psychiatry", "Pharmacology", "Neurology", "Psychiatry and Mental health", "Clinical Neurology"]}, {"indexed": {"date-parts": [[2019, 1, 9]], "date-time": "2019-01-09T06:23:16Z", "timestamp": 1547014996204}, "reference-count": 0, "publisher": "American Society for Pharmacology & Experimental Therapeutics (ASPET)", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2002, 11, 1]]}, "DOI": "10.1124/jpet.102.039875", "type": "journal-article", "created": {"date-parts": [[2003, 1, 10]], "date-time": "2003-01-10T18:48:30Z", "timestamp": 1042224510000}, "page": "805-814", "source": "Crossref", "is-referenced-by-count": 92, "title": ["Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. II. Agonist and Antagonist Properties at Subtypes of Dopamine D2-Like Receptor and alpha 1/alpha 2-Adrenoceptor"], "prefix": "10.1124", "volume": "303", "author": [{"given": "A.", "family": "Newman-Tancredi", "sequence": "first", "affiliation": []}], "member": "36", "container-title": ["Journal of Pharmacology and Experimental Therapeutics"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1124/jpet.102.039875", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T00:46:39Z", "timestamp": 1482453999000}, "score": 22.779968, "issued": {"date-parts": [[2002, 11, 1]]}, "references-count": 0, "journal-issue": {"issue": "2"}, "URL": "http://dx.doi.org/10.1124/jpet.102.039875", "ISSN": ["0022-3565", "1521-0103"], "issn-type": [{"value": "0022-3565", "type": "print"}, {"value": "1521-0103", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 12]], "date-time": "2018-05-12T06:40:08Z", "timestamp": 1526107208632}, "reference-count": 61, "publisher": "Springer Nature", "issue": "5", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2018, 3, 23]], "date-time": "2018-03-23T00:00:00Z", "timestamp": 1521763200000}, "delay-in-days": 0, "content-version": "unspecified"}], "funder": [{"DOI": "10.13039/100000864", "name": "Michael J. Fox Foundation for Parkinson's Research", "doi-asserted-by": "publisher", "award": ["Research Grant"]}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Neurochem Res"], "published-print": {"date-parts": [[2018, 5]]}, "DOI": "10.1007/s11064-018-2514-y", "type": "journal-article", "created": {"date-parts": [[2018, 3, 23]], "date-time": "2018-03-23T06:28:19Z", "timestamp": 1521786499000}, "page": "1035-1046", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Effects of the Serotonin 5-HT1A Receptor Biased Agonists, F13714 and F15599, on Striatal Neurotransmitter Levels Following l-DOPA Administration in Hemi-Parkinsonian Rats"], "prefix": "10.1007", "volume": "43", "author": [{"ORCID": "http://orcid.org/0000-0002-2923-5714", "authenticated-orcid": false, "given": "Adrian", "family": "Newman-Tancredi", "sequence": "first", "affiliation": []}, {"given": "Mark A.", "family": "Varney", "sequence": "additional", "affiliation": []}, {"given": "Andrew C.", "family": "McCreary", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2018, 3, 23]]}, "reference": [{"issue": "Suppl 1", "key": "2514_CR1", "doi-asserted-by": "crossref", "first-page": "325", "DOI": "10.1111/jnc.13750", "volume": "139", "author": "W Oertel", "year": "2016", "unstructured": "Oertel W, Schulz JB (2016) Current and experimental treatments of Parkinson disease: a guide for neuroscientists. J Neurochem 139(Suppl 1):325\u2013337", "journal-title": "J Neurochem"}, {"key": "2514_CR2", "doi-asserted-by": "crossref", "first-page": "759", "DOI": "10.1007/s40265-016-0566-3", "volume": "76", "author": "D Vijayakumar", "year": "2016", "unstructured": "Vijayakumar D, Jankovic J (2016) Drug-induced dyskinesia, Part 1: treatment of levodopa-induced dyskinesia. Drugs 76:759\u2013777", "journal-title": "Drugs"}, {"key": "2514_CR3", "doi-asserted-by": "crossref", "first-page": "242", "DOI": "10.3389/fneur.2014.00242", "volume": "5", "author": "AM Cenci", "year": "2014", "unstructured": "Cenci AM (2014) Presynaptic mechanisms of l-DOPA-induced dyskinesia: the findings, the debate, and the therapeutic implications. Front Neurol 5:242", "journal-title": "Front Neurol"}, {"key": "2514_CR4", "doi-asserted-by": "crossref", "first-page": "283", "DOI": "10.1016/j.biopha.2015.01.029", "volume": "70", "author": "S Sharma", "year": "2015", "unstructured": "Sharma S, Singh S, Sharma V, Singh VP, Deshmukh R (2015) Neurobiology of l-DOPA induced dyskinesia and the novel therapeutic strategies. Biomed Pharmacother 70:283\u2013293", "journal-title": "Biomed Pharmacother"}, {"key": "2514_CR5", "doi-asserted-by": "crossref", "first-page": "2419", "DOI": "10.1093/brain/awt192", "volume": "136", "author": "JH Kordower", "year": "2013", "unstructured": "Kordower JH, Olanow CW, Dodiya HB, Chu Y, Beach TG, Adler CH, Halliday GM, Bartus RT (2013) Disease duration and the integrity of the nigrostriatal system in Parkinson\u2019s disease. Brain 136:2419\u20132431", "journal-title": "Brain"}, {"key": "2514_CR6", "doi-asserted-by": "crossref", "first-page": "2747", "DOI": "10.1093/brain/awh290", "volume": "127", "author": "R Fuente-Fernandez de la", "year": "2004", "unstructured": "de la Fuente-Fernandez R, Sossi V, Huang Z, Furtado S, Lu JQ, Calne DB, Ruth TJ, Stoessl AJ (2004) Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson\u2019s disease: implications for dyskinesias. Brain 127:2747\u20132754", "journal-title": "Brain"}, {"key": "2514_CR7", "doi-asserted-by": "crossref", "first-page": "1574", "DOI": "10.1093/brain/awn085", "volume": "131", "author": "J Lee", "year": "2008", "unstructured": "Lee J, Zhu WM, Stanic D, Finkelstein DI, Horne MH, Henderson J, Lawrence AJ, O\u2019Connor L, Tomas D, Drago J, Horne MK (2008) Sprouting of dopamine terminals and altered dopamine release and uptake in Parkinsonian dyskinaesia. Brain 131:1574\u20131587", "journal-title": "Brain"}, {"key": "2514_CR8", "first-page": "120", "volume": "131", "author": "SJ Kish", "year": "2008", "unstructured": "Kish SJ, Tong J, Hornykiewicz O, Rajput A, Chang LJ, Guttman M, Furukawa Y (2008) Preferential loss of serotonin markers in caudate versus putamen in Parkinson\u2019s disease. Brain 131:120\u2013131", "journal-title": "Brain"}, {"key": "2514_CR9", "doi-asserted-by": "crossref", "first-page": "619", "DOI": "10.1002/ana.22097", "volume": "68", "author": "D Rylander", "year": "2010", "unstructured": "Rylander D, Parent M, O\u2019Sullivan SS, Dovero S, Lees AJ, Bezard E, Descarries L, Cenci MA (2010) Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia. Ann Neurol 68:619\u2013628", "journal-title": "Ann Neurol"}, {"key": "2514_CR10", "doi-asserted-by": "crossref", "first-page": "343", "DOI": "10.1016/j.jocn.2011.09.008", "volume": "19", "author": "PA Cheshire", "year": "2012", "unstructured": "Cheshire PA, Williams DR (2012) Serotonergic involvement in levodopa-induced dyskinesias in Parkinson\u2019s disease. J Clin Neurosci 19:343\u2013348", "journal-title": "J Clin Neurosci"}, {"key": "2514_CR11", "doi-asserted-by": "crossref", "first-page": "796", "DOI": "10.1002/mds.26144", "volume": "30", "author": "P Cheshire", "year": "2015", "unstructured": "Cheshire P, Ayton S, Bertram KL, Ling H, Li A, McLean C, Halliday GM, O\u2019Sullivan SS, Revesz T, Finkelstein DI, Storey E, Williams DR (2015) Serotonergic markers in Parkinson\u2019s disease and levodopa-induced dyskinesias. Mov Disord 30:796\u2013804", "journal-title": "Mov Disord"}, {"key": "2514_CR12", "doi-asserted-by": "crossref", "first-page": "853", "DOI": "10.1212/WNL.0000000000001909", "volume": "85", "author": "JY Lee", "year": "2015", "unstructured": "Lee JY, Seo S, Lee JS, Kim HJ, Kim YK, Jeon BS (2015) Putaminal serotonergic innervation: monitoring dyskinesia risk in Parkinson disease. Neurology 85:853\u2013860", "journal-title": "Neurology"}, {"key": "2514_CR13", "author": "G Pagano", "year": "2017", "unstructured": "Pagano G, Niccolini F, Politis M (2017) The serotonergic system in Parkinson\u2019s patients with dyskinesia: evidence from imaging studies. J Neural Transm. https://doi.org/10.1007/s00702-017-1823-7", "journal-title": "J Neural Transm", "DOI": "10.1007/s00702-017-1823-7", "doi-asserted-by": "publisher"}, {"key": "2514_CR14", "doi-asserted-by": "crossref", "first-page": "1152", "DOI": "10.1212/WNL.0000000000002494", "volume": "86", "author": "AA Roussakis", "year": "2016", "unstructured": "Roussakis AA, Politis M, Towey D, Piccini P (2016) Serotonin-to-dopamine transporter ratios in Parkinson disease: relevance for dyskinesias. Neurology 86:1152\u20131158", "journal-title": "Neurology"}, {"key": "2514_CR15", "doi-asserted-by": "crossref", "first-page": "78", "DOI": "10.3389/fneur.2014.00078", "volume": "5", "author": "M Carta", "year": "2014", "unstructured": "Carta M, Tronci E (2014) Serotonin system implication in l-DOPA-induced dyskinesia: from animal models to clinical investigations. Front Neurol 5:78", "journal-title": "Front Neurol"}, {"key": "2514_CR16", "author": "K Lanza", "year": "2018", "unstructured": "Lanza K, Bishop C (2018) Serotonergic targets for the treatment of l-DOPA-induced dyskinesia. J Neural Transm. https://doi.org/10.1007/s00702-017-1837-1", "journal-title": "J Neural Transm", "DOI": "10.1007/s00702-017-1837-1", "doi-asserted-by": "publisher"}, {"key": "2514_CR17", "doi-asserted-by": "crossref", "first-page": "1110", "DOI": "10.1021/acschemneuro.5b00034", "volume": "6", "author": "R Andrade", "year": "2015", "unstructured": "Andrade R, Huereca D, Lyons JG, Andrade EM, McGregor KM (2015) 5-HT1A receptor-mediated autoinhibition and the control of serotonergic cell firing. ACS Chem Neurosci 6:1110\u20131115", "journal-title": "ACS Chem Neurosci"}, {"key": "2514_CR18", "doi-asserted-by": "crossref", "first-page": "1829", "DOI": "10.1212/WNL.57.10.1829", "volume": "57", "author": "F Bibbiani", "year": "2001", "unstructured": "Bibbiani F, Oh JD, Chase TN (2001) Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models. Neurology 57:1829\u20131834", "journal-title": "Neurology"}, {"key": "2514_CR19", "doi-asserted-by": "crossref", "first-page": "306", "DOI": "10.1016/j.pbb.2007.05.002", "volume": "87", "author": "KL Eskow", "year": "2007", "unstructured": "Eskow KL, Gupta V, Alam S, Park JY, Bishop C (2007) The partial 5-HT(1A) agonist buspirone reduces the expression and development of l-DOPA-induced dyskinesia in rats and improves l-DOPA efficacy. Pharmacol Biochem Behav 87:306\u2013314", "journal-title": "Pharmacol Biochem Behav"}, {"key": "2514_CR20", "doi-asserted-by": "crossref", "first-page": "463", "DOI": "10.1007/s00221-013-3621-2", "volume": "230", "author": "P Huot", "year": "2013", "unstructured": "Huot P, Fox SH (2013) The serotonergic system in motor and non-motor manifestations of Parkinson\u2019s disease. Exp Brain Res 230:463\u2013476", "journal-title": "Exp Brain Res"}, {"key": "2514_CR21", "doi-asserted-by": "crossref", "first-page": "2", "DOI": "10.1124/jpet.111.184093", "volume": "339", "author": "P Huot", "year": "2011", "unstructured": "Huot P, Fox SH, Newman-Tancredi A, Brotchie JM (2011) Anatomically selective serotonergic type 1A and serotonergic type 2A therapies for Parkinson\u2019s disease: an approach to reducing dyskinesia without exacerbating parkinsonism? J Pharmacol Exp Ther 339:2\u20138", "journal-title": "J Pharmacol Exp Ther"}, {"key": "2514_CR22", "doi-asserted-by": "crossref", "first-page": "306", "DOI": "10.1016/j.neuropharm.2015.05.033", "volume": "97", "author": "P Huot", "year": "2015", "unstructured": "Huot P, Johnston TH, Fox SH, Newman-Tancredi A, Brotchie JM (2015) The highly-selective 5-HT agonist F15599 reduces l-DOPA-induced dyskinesia without compromising anti-parkinsonian benefits in the MPTP-lesioned macaque. Neuropharmacology 97:306\u2013311", "journal-title": "Neuropharmacology"}, {"key": "2514_CR23", "doi-asserted-by": "crossref", "first-page": "52", "DOI": "10.1016/j.neuropharm.2015.01.012", "volume": "93", "author": "H Iderberg", "year": "2015", "unstructured": "Iderberg H, McCreary AC, Varney MA, Cenci MA, Newman-Tancredi A (2015) Activity of serotonin 5-HT1A receptor \u2018biased agonists\u2019 in rat models of Parkinson\u2019s disease and l-DOPA-induced dyskinesia. Neuropharmacology 93:52\u201367", "journal-title": "Neuropharmacology"}, {"key": "2514_CR24", "doi-asserted-by": "crossref", "first-page": "335", "DOI": "10.1016/j.expneurol.2015.05.021", "volume": "271", "author": "H Iderberg", "year": "2015", "unstructured": "Iderberg H, McCreary AC, Varney MA, Kleven MS, Koek W, Bardin L, Depoort\u00e8re R, Cenci MA, Newman-Tancredi A (2015) NLX-112, a novel 5-HT1A receptor agonist for the treatment of l-DOPA-induced dyskinesia: behavioral and neurochemical profile in rat. Exp Neurol 271:335\u2013350", "journal-title": "Exp Neurol"}, {"key": "2514_CR25", "doi-asserted-by": "crossref", "first-page": "168", "DOI": "10.1016/j.expneurol.2017.03.013", "volume": "292", "author": "SM Meadows", "year": "2017", "unstructured": "Meadows SM, Chambers NE, Conti MM, Bossert SC, Tasber C, Sheena E, Varney M, Newman-Tancredi A, Bishop C (2017) Characterizing the differential roles of striatal 5-HT1A auto- and hetero-receptors in the reduction of l-DOPA-induced dyskinesia. Exp Neurol 292:168\u2013178", "journal-title": "Exp Neurol"}, {"key": "2514_CR26", "doi-asserted-by": "crossref", "first-page": "651", "DOI": "10.1016/j.neuropharm.2016.01.013", "volume": "105", "author": "AC McCreary", "year": "2016", "unstructured": "McCreary AC, Varney MA, Newman-Tancredi A (2016) The novel 5-HT1A receptor agonist, NLX-112 reduces l-DOPA-induced abnormal involuntary movements in rat: a chronic administration study with microdialysis measurements. Neuropharmacology 105:651\u2013660", "journal-title": "Neuropharmacology"}, {"key": "2514_CR27", "doi-asserted-by": "crossref", "first-page": "1612", "DOI": "10.1212/01.wnl.0000242888.30755.5d", "volume": "67", "author": "N Pavese", "year": "2006", "unstructured": "Pavese N, Evans AH, Tai YF, Hotton G, Brooks DJ, Lees AJ, Piccini P (2006) Clinical correlates of levodopa-induced dopamine release in Parkinson disease: a PET study. Neurology 67:1612\u20131617", "journal-title": "Neurology"}, {"key": "2514_CR28", "doi-asserted-by": "crossref", "first-page": "170", "DOI": "10.1038/sj.bjp.0706859", "volume": "149", "author": "MB Assie", "year": "2006", "unstructured": "Assie MB, Lomenech H, Ravailhe V, Faucillon V, Newman-Tancredi A (2006) Rapid desensitization of somatodendritic 5-HT1A receptors by chronic administration of the high-efficacy 5-HT1A agonist, F13714: a microdialysis study in the rat. Br J Pharmacol 149:170\u2013178", "journal-title": "Br J Pharmacol"}, {"key": "2514_CR29", "doi-asserted-by": "crossref", "first-page": "149", "DOI": "10.2217/npy.11.12", "volume": "1", "author": "A Newman-Tancredi", "year": "2011", "unstructured": "Newman-Tancredi A (2011) Biased agonism at serotonin 5-HT1A receptors: preferential postsynaptic activity for improved therapy of CNS disorders. Neuropsychiatry 1:149\u2013164", "journal-title": "Neuropsychiatry"}, {"key": "2514_CR30", "doi-asserted-by": "crossref", "first-page": "1929", "DOI": "10.1111/j.1476-5381.2010.00738.x", "volume": "160", "author": "L Llado-Pelfort", "year": "2010", "unstructured": "Llado-Pelfort L, Assie MB, Newman-Tancredi A, Artigas F, Celada P (2010) Preferential in vivo action of F15599, a novel 5-HT1A receptor agonist, at postsynaptic 5-HT1A receptors. Br J Pharmacol 160:1929\u20131940", "journal-title": "Br J Pharmacol"}, {"key": "2514_CR31", "doi-asserted-by": "crossref", "first-page": "338", "DOI": "10.1111/j.1476-5381.2008.00001.x", "volume": "156", "author": "A Newman-Tancredi", "year": "2009", "unstructured": "Newman-Tancredi A, Martel JC, Assie MB, Buritova J, Lauressergues E, Cosi C, Heusler P, Bruins Slot L, Colpaert FC, Vacher B, Cussac D (2009) Signal transduction and functional selectivity of F15599, a preferential post-synaptic 5-HT1A receptor agonist. Br J Pharmacol 156:338\u2013353", "journal-title": "Br J Pharmacol"}, {"key": "2514_CR32", "doi-asserted-by": "crossref", "first-page": "195", "DOI": "10.1016/j.expneurol.2011.07.006", "volume": "231", "author": "P Huot", "year": "2011", "unstructured": "Huot P, Brotchie JM (2011) 5-HT(1A) receptor stimulation and l-DOPA-induced dyskinesia in Parkinson\u2019s disease: bridging the gap between serotonergic and glutamatergic mechanisms. Exp Neurol 231:195\u2013198", "journal-title": "Exp Neurol"}, {"key": "2514_CR33", "doi-asserted-by": "crossref", "first-page": "52", "DOI": "10.1016/j.neuropharm.2015.01.012", "volume": "93C", "author": "H Iderberg", "year": "2015", "unstructured": "Iderberg H, McCreary AC, Varney MA, Cenci MA, Newman-Tancredi A (2015) Activity of serotonin 5-HT receptor \u2018biased agonists\u2019 in rat models of Parkinson\u2019s disease and l-DOPA-induced dyskinesia. Neuropharmacology 93C:52\u201367", "journal-title": "Neuropharmacology"}, {"key": "2514_CR34", "author": "G Paxinos", "year": "2007", "unstructured": "Paxinos G, Watson C (2007) The rat brain in stereotaxic coordinates. Academic Press, Cambridge", "volume-title": "The rat brain in stereotaxic coordinates"}, {"key": "2514_CR35", "doi-asserted-by": "crossref", "first-page": "777", "DOI": "10.1016/0024-3205(76)90303-9", "volume": "19", "author": "BL Jacobs", "year": "1976", "unstructured": "Jacobs BL (1976) An animal behavior model for studying central serotonergic synapses. Life Sci 19:777\u2013785", "journal-title": "Life Sci"}, {"key": "2514_CR36", "doi-asserted-by": "crossref", "first-page": "141", "DOI": "10.1016/0091-3057(93)90330-V", "volume": "46", "author": "NA Moore", "year": "1993", "unstructured": "Moore NA, Rees G, Sanger G, Perrett L (1993) 5-HT1A-mediated lower lip retraction: effects of 5-HT1A agonists and antagonists. Pharmacol Biochem Behav 46:141\u2013143", "journal-title": "Pharmacol Biochem Behav"}, {"key": "2514_CR37", "doi-asserted-by": "crossref", "first-page": "631", "DOI": "10.1097/00001756-199902250-00034", "volume": "10", "author": "H Tanaka", "year": "1999", "unstructured": "Tanaka H, Kannari K, Maeda T, Tomiyama M, Suda T, Matsunaga M (1999) Role of serotonergic neurons in l-DOPA-derived extracellular dopamine in the striatum of 6-OHDA-lesioned rats. Neuroreport 10:631\u2013634", "journal-title": "Neuroreport"}, {"key": "2514_CR38", "doi-asserted-by": "crossref", "first-page": "806", "DOI": "10.1111/j.1471-4159.2011.07598.x", "volume": "120", "author": "A Nahimi", "year": "2012", "unstructured": "Nahimi A, Holtzermann M, Landau AM, Simonsen M, Jakobsen S, Alstrup AK, Vang K, Moller A, Wegener G, Gjedde A, Doudet DJ (2012) Serotonergic modulation of receptor occupancy in rats treated with l-DOPA after unilateral 6-OHDA lesioning. J Neurochem 120:806\u2013817", "journal-title": "J Neurochem"}, {"key": "2514_CR39", "doi-asserted-by": "crossref", "first-page": "1819", "DOI": "10.1093/brain/awm082", "volume": "130", "author": "M Carta", "year": "2007", "unstructured": "Carta M, Carlsson T, Kirik D, Bjorklund A (2007) Dopamine released from 5-HT terminals is the cause of l-DOPA-induced dyskinesia in parkinsonian rats. Brain 130:1819\u20131833", "journal-title": "Brain"}, {"key": "2514_CR40", "doi-asserted-by": "crossref", "first-page": "1346", "DOI": "10.1046/j.1471-4159.2001.00184.x", "volume": "76", "author": "K Kannari", "year": "2001", "unstructured": "Kannari K, Yamato H, Shen H, Tomiyama M, Suda T, Matsunaga M (2001) Activation of 5-HT(1A) but not 5-HT(1B) receptors attenuates an increase in extracellular dopamine derived from exogenously administered l-DOPA in the striatum with nigrostriatal denervation. J Neurochem 76:1346\u20131353", "journal-title": "J Neurochem"}, {"key": "2514_CR41", "doi-asserted-by": "crossref", "first-page": "610", "DOI": "10.1002/syn.20630", "volume": "63", "author": "KL Eskow", "year": "2009", "unstructured": "Eskow KL, Dupre KB, Barnum CJ, Dickinson SO, Park JY, Bishop C (2009) The role of the dorsal raphe nucleus in the development, expression, and treatment of l-DOPA-induced dyskinesia in hemiparkinsonian rats. Synapse 63:610\u2013620", "journal-title": "Synapse"}, {"key": "2514_CR42", "doi-asserted-by": "crossref", "first-page": "1406", "DOI": "10.1016/j.cellsig.2010.03.019", "volume": "22", "author": "AM Polter", "year": "2010", "unstructured": "Polter AM, Li X (2010) 5-HT1A receptor-regulated signal transduction pathways in brain. Cell Signal 22:1406\u20131412", "journal-title": "Cell Signal"}, {"key": "2514_CR43", "doi-asserted-by": "crossref", "first-page": "193", "DOI": "10.1002/syn.20195", "volume": "58", "author": "T Antonelli", "year": "2005", "unstructured": "Antonelli T, Fuxe K, Tomasini MC, Bartoszyk GD, Seyfried CA, Tanganelli S, Ferraro L (2005) Effects of sarizotan on the corticostriatal glutamate pathways. Synapse 58:193\u2013199", "journal-title": "Synapse"}, {"key": "2514_CR44", "doi-asserted-by": "crossref", "first-page": "699", "DOI": "10.1097/00001756-200505120-00009", "volume": "16", "author": "LJ Mignon", "year": "2005", "unstructured": "Mignon LJ, Wolf WA (2005) 8-hydroxy-2-(di-n-propylamino)tetralin reduces striatal glutamate in an animal model of Parkinson\u2019s disease. Neuroreport 16:699\u2013703", "journal-title": "Neuroreport"}, {"key": "2514_CR45", "doi-asserted-by": "crossref", "first-page": "288", "DOI": "10.1016/j.expneurol.2011.02.012", "volume": "229", "author": "KB Dupre", "year": "2011", "unstructured": "Dupre KB, Ostock CY, Eskow Jaunarajs KL, Button T, Savage LM, Wolf W, Bishop C (2011) Local modulation of striatal glutamate efflux by serotonin 1A receptor stimulation in dyskinetic, hemiparkinsonian rats. Exp Neurol 229:288\u2013299", "journal-title": "Exp Neurol"}, {"key": "2514_CR46", "doi-asserted-by": "crossref", "first-page": "753", "DOI": "10.1016/j.neuropharm.2011.05.021", "volume": "61", "author": "CY Ostock", "year": "2011", "unstructured": "Ostock CY, Dupre KB, Jaunarajs KL, Walters H, George J, Krolewski D, Walker PD, Bishop C (2011) Role of the primary motor cortex in l-Dopa-induced dyskinesia and its modulation by 5-HT1A receptor stimulation. Neuropharmacology 61:753\u2013760", "journal-title": "Neuropharmacology"}, {"key": "2514_CR47", "doi-asserted-by": "crossref", "first-page": "703", "DOI": "10.1007/s40263-013-0071-0", "volume": "27", "author": "P Celada", "year": "2013", "unstructured": "Celada P, Bortolozzi A, Artigas F (2013) Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research. CNS Drugs 27:703\u2013716", "journal-title": "CNS Drugs"}, {"key": "2514_CR48", "doi-asserted-by": "crossref", "first-page": "1100", "DOI": "10.1093/cercor/bhh070", "volume": "14", "author": "N Santana", "year": "2004", "unstructured": "Santana N, Bortolozzi A, Serrats J, Mengod G, Artigas F (2004) Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. Cereb Cortex 14:1100\u20131109", "journal-title": "Cereb Cortex"}, {"key": "2514_CR49", "doi-asserted-by": "crossref", "first-page": "155", "DOI": "10.1016/j.expneurol.2018.01.010", "volume": "302", "author": "I Brys", "year": "2018", "unstructured": "Brys I, Halje P, Scheffer-Teixeira R, Varney M, Newman-Tancredi A, Petersson P (2018) Neurophysiological effects in cortico-basal ganglia-thalamic circuits of antidyskinetic treatment with 5-HT1A receptor biased agonists. Exp Neurol 302:155\u2013168", "journal-title": "Exp Neurol"}, {"key": "2514_CR50", "doi-asserted-by": "crossref", "first-page": "241", "DOI": "10.1007/s00213-008-1452-9", "volume": "204", "author": "C Marin", "year": "2009", "unstructured": "Marin C, Aguilar E, Rodriguez-Oroz MC, Bartoszyk GD, Obeso JA (2009) Local administration of sarizotan into the subthalamic nucleus attenuates levodopa-induced dyskinesias in 6-OHDA-lesioned rats. Psychopharmacology 204:241\u2013250", "journal-title": "Psychopharmacology"}, {"key": "2514_CR51", "doi-asserted-by": "crossref", "first-page": "117", "DOI": "10.1146/annurev-neuro-071013-013916", "volume": "37", "author": "AB Nelson", "year": "2014", "unstructured": "Nelson AB, Kreitzer AC (2014) Reassessing models of basal ganglia function and dysfunction. Annu Rev Neurosci 37:117\u2013135", "journal-title": "Annu Rev Neurosci"}, {"key": "2514_CR52", "doi-asserted-by": "crossref", "first-page": "205", "DOI": "10.1097/01.wnf.0000177642.89888.85", "volume": "28", "author": "GK Isbister", "year": "2005", "unstructured": "Isbister GK, Buckley NA (2005) The pathophysiology of serotonin toxicity in animals and humans: implications for diagnosis and treatment. Clin Neuropharmacol 28:205\u2013214", "journal-title": "Clin Neuropharmacol"}, {"key": "2514_CR53", "doi-asserted-by": "crossref", "first-page": "237", "DOI": "10.1111/j.1749-6632.1990.tb16886.x", "volume": "600", "author": "AR Green", "year": "1990", "unstructured": "Green AR, Backus LI (1990) Animal models of serotonin behavior. Ann N Y Acad Sci 600:237\u2013248 discussion 248 \u2013 239", "journal-title": "Ann N Y Acad Sci"}, {"key": "2514_CR54", "first-page": "309", "volume": "62", "author": "D Bijl", "year": "2004", "unstructured": "Bijl D (2004) The serotonin syndrome. Neth J Med 62:309\u2013313", "journal-title": "Neth J Med"}, {"key": "2514_CR55", "doi-asserted-by": "crossref", "first-page": "921", "DOI": "10.1021/jm00140a002", "volume": "24", "author": "LE Arvidsson", "year": "1981", "unstructured": "Arvidsson LE, Hacksell U, Nilsson JL, Hjorth S, Carlsson A, Lindberg P, Sanchez D, Wikstrom H (1981) 8-Hydroxy-2-(di-n-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist. J Med Chem 24:921\u2013923", "journal-title": "J Med Chem"}, {"key": "2514_CR56", "doi-asserted-by": "crossref", "first-page": "271", "DOI": "10.1016/0014-2999(84)90714-3", "volume": "106", "author": "MD Tricklebank", "year": "1984", "unstructured": "Tricklebank MD, Forler C, Fozard JR (1984) The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat. Eur J Pharmacol 106:271\u2013282", "journal-title": "Eur J Pharmacol"}, {"key": "2514_CR57", "doi-asserted-by": "crossref", "first-page": "1285", "DOI": "10.1017/S1461145709991222", "volume": "13", "author": "MB Assie", "year": "2010", "unstructured": "Assie MB, Bardin L, Auclair AL, Carilla-Durand E, Depoortere R, Koek W, Kleven MS, Colpaert F, Vacher B, Newman-Tancredi A (2010) F15599, a highly selective post-synaptic 5-HT1A receptor agonist: in-vivo profile in behavioural models of antidepressant and serotonergic activity. Int J Neuropsychopharmacol 13:1285\u20131298", "journal-title": "Int J Neuropsychopharmacol"}, {"key": "2514_CR58", "doi-asserted-by": "crossref", "first-page": "315", "DOI": "10.1016/0014-2999(94)90728-5", "volume": "263", "author": "HH Berendsen", "year": "1994", "unstructured": "Berendsen HH, Bourgondien FG, Broekkamp CL (1994) Role of dorsal and median raphe nuclei in lower lip retraction in rats. Eur J Pharmacol 263:315\u2013318", "journal-title": "Eur J Pharmacol"}, {"key": "2514_CR59", "doi-asserted-by": "crossref", "first-page": "351", "DOI": "10.1016/0014-2999(91)90150-O", "volume": "193", "author": "GA Higgins", "year": "1991", "unstructured": "Higgins GA, Elliott PJ (1991) Differential behavioural activation following intra-raphe infusion of 5-HT1A receptor agonists. Eur J Pharmacol 193:351\u2013356", "journal-title": "Eur J Pharmacol"}, {"key": "2514_CR60", "unstructured": "Assi\u00e9 M-B, Ravailhe V, Benas C, Newman-Tancredi A (2008) Differential effects of 5-HT1A receptor agonists on extracellular levels of 5-HT in hippocampus and of dopamine in frontal cortex of freely moving rats. In: British Association for Psychopharmacology Summer Meeting. Harrogate, Poster ID 59"}, {"key": "2514_CR61", "doi-asserted-by": "crossref", "first-page": "26633", "DOI": "10.1038/srep26633", "volume": "6", "author": "G Becker", "year": "2016", "unstructured": "Becker G, Bolbos R, Costes N, Redoute J, Newman-Tancredi A, Zimmer L (2016) Selective serotonin 5-HT1A receptor biased agonists elicitdistinct brain activation patterns: a pharmacoMRI study. Sci Rep 6:26633", "journal-title": "Sci Rep"}], "container-title": ["Neurochemical Research"], "language": "en", "link": [{"URL": "http://link.springer.com/article/10.1007/s11064-018-2514-y/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s11064-018-2514-y.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s11064-018-2514-y.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 5, 12]], "date-time": "2018-05-12T06:26:05Z", "timestamp": 1526106365000}, "score": 22.620516, "issued": {"date-parts": [[2018, 3, 23]]}, "references-count": 61, "journal-issue": {"published-print": {"date-parts": [[2018, 5]]}, "issue": "5"}, "alternative-id": ["2514"], "URL": "http://dx.doi.org/10.1007/s11064-018-2514-y", "relation": {"cites": []}, "ISSN": ["0364-3190", "1573-6903"], "issn-type": [{"value": "0364-3190", "type": "print"}, {"value": "1573-6903", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 4]], "date-time": "2018-05-04T13:22:46Z", "timestamp": 1525440166578}, "reference-count": 37, "publisher": "Wiley", "issue": "2", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 5356, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2001, 1]]}, "DOI": "10.1038/sj.bjp.0703832", "type": "journal-article", "created": {"date-parts": [[2005, 1, 28]], "date-time": "2005-01-28T21:09:20Z", "timestamp": 1106946560000}, "page": "518-524", "source": "Crossref", "is-referenced-by-count": 18, "title": ["Differential modulation by GTP\u03b3S of agonist and inverse agonist binding to h5-HT1Areceptors revealed by [3H]-WAY100,635"], "prefix": "10.1111", "volume": "132", "author": [{"given": "Adrian", "family": "Newman-Tancredi", "sequence": "first", "affiliation": []}, {"given": "Laurence", "family": "Verri\u00e8le", "sequence": "additional", "affiliation": []}, {"given": "Mark J", "family": "Millan", "sequence": "additional", "affiliation": []}], "member": "311", "reference": [{"key": "10.1038/sj.bjp.0703832-BIB1", "first-page": "179", "article-title": "The 5-HT1A receptor antagonist (S)UH301 blocks (R)-8-OH-DPAT-induced inhibition of serotonergic dorsal raphe cell firing in the rat", "volume": "96", "author": "ARBORELIUS", "year": "1994", "journal-title": "J. Neural. Transm. Gen. Sect."}, {"key": "10.1038/sj.bjp.0703832-BIB2", "first-page": "97", "article-title": "Correlation between low/high affinity ratios for 5-HT1A receptors and intrinsic activity", "volume": "386", "author": "ASSI\u00c9", "year": "1999", "journal-title": "Eur. J. Pharmacol."}, {"key": "10.1038/sj.bjp.0703832-BIB3", "first-page": "213", "article-title": "Signal transduction by G-proteins: 1994 edition", "volume": "15", "author": "BIRNBAUMER", "year": "1995", "journal-title": "J. Receptor & Signal Transduction Res."}, {"key": "10.1038/sj.bjp.0703832-BIB4", "first-page": "275", "article-title": "Molecular biology of 5-HT receptors", "volume": "33", "author": "BOESS", "year": "1994", "journal-title": "Neuropharmacol."}, {"key": "10.1038/sj.bjp.0703832-BIB5", "first-page": "21", "article-title": "S 14506: a novel, potent, high-efficacy 5-HT1A agonist and potential anxiolytic agent", "volume": "26", "author": "COLPAERT", "year": "1992", "journal-title": "Drug Dev. Res."}, {"key": "10.1038/sj.bjp.0703832-BIB6", "first-page": "780", "article-title": "Intrinsic activity of enantiomers of 8-hydroxy-2-(di-n-propylamino)tetralin and its analogs at 5-hydroxytryptamine1A receptors that are negatively coupled to adenylate cyclase", "volume": "39", "author": "CORNFIELD", "year": "1991", "journal-title": "Mol. Pharmacol."}, {"key": "10.1038/sj.bjp.0703832-BIB7", "first-page": "9", "article-title": "The putative \u2018silent' 5-HT1A receptor antagonist, WAY100635, has inverse agonist properties at cloned human 5-HT1A receptors", "volume": "401", "author": "COSI", "year": "2000", "journal-title": "Eur. J. Pharmacol."}, {"key": "10.1038/sj.bjp.0703832-BIB8", "first-page": "73", "article-title": "Inverse agonism at heptahelical receptors: concept, experimental approach and therapeutic potential", "volume": "14", "author": "DAEFFLER", "year": "2000", "journal-title": "Fundam. Clin. Pharmacol."}, {"key": "10.1038/sj.bjp.0703832-BIB9", "first-page": "1", "article-title": "5-HT1A receptor agonists: recent developments and controversial issues", "volume": "121", "author": "DE VRY", "year": "1995", "journal-title": "Psychopharmacol."}, {"key": "10.1038/sj.bjp.0703832-BIB10", "first-page": "144", "article-title": "Agonist high and low affinity state ratios predict drug intrinsic activity and a revised ternary complex mechanism at serotonin 5-HT2A and 5-HT2C receptors", "volume": "35", "author": "EGAN", "year": "2000", "journal-title": "Synapse"}, {"key": "10.1038/sj.bjp.0703832-BIB11", "first-page": "337", "article-title": "Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist", "volume": "73", "author": "FLETCHER", "year": "1996", "journal-title": "Behav. Brain Res."}, {"key": "10.1038/sj.bjp.0703832-BIB12", "doi-asserted-by": "crossref", "first-page": "437", "DOI": "10.1111/j.1476-5381.1988.tb11451.x", "article-title": "Relative affinities of drugs acting at cholinoceptors in displacing agonist and antagonist radioligands: the NMS/Oxo-M ratio as an index of efficacy at cortical muscarinic receptors", "volume": "93", "author": "FREEDMAN", "year": "1988", "journal-title": "Br. J. Pharmacol."}, {"key": "10.1038/sj.bjp.0703832-BIB13", "first-page": "140", "article-title": "Identification of presynaptic serotonin autoreceptors using a new ligand: [3H]-PAT", "volume": "305", "author": "GOZLAN", "year": "1983", "journal-title": "Nature"}, {"key": "10.1038/sj.bjp.0703832-BIB14", "first-page": "173", "article-title": "The selective 5-HT1A antagonist radioligand [3H]-WAY100,635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes", "volume": "288", "author": "GOZLAN", "year": "1995", "journal-title": "Eur. J. Pharmacol."}, {"key": "10.1038/sj.bjp.0703832-BIB15", "unstructured": "HULME, E.C. & BIRDSALL, N.J.M. (1992). Strategy and tactics in receptor-binding studies. In: Receptor-Ligand Interactions: A Practical Approach. Ed.: Hulme EC. New York: Oxford University Press."}, {"key": "10.1038/sj.bjp.0703832-BIB16", "first-page": "561", "article-title": "A three binding site hypothesis for the interaction of ligands with monoamine G-protein-coupled receptors: implications for combinatorial drug design", "volume": "18", "author": "JACOBY", "year": "1999", "journal-title": "Quant. Struct.-Act. Relat."}, {"key": "10.1038/sj.bjp.0703832-BIB17", "unstructured": "KENAKIN, T. (1997). Pharmacologic analysis of drug-receptor interactions. Philadelphia: Lippincott-Raven."}, {"key": "10.1038/sj.bjp.0703832-BIB18", "first-page": "653", "article-title": "Pharmacological characterisation of recombinant human 5-hydroxytryptamine1A receptors using a novel antagonist radioligand, [3H]-WAY100,635", "volume": "60", "author": "KHAWAJA", "year": "1997", "journal-title": "Life Sciences"}, {"key": "10.1038/sj.bjp.0703832-BIB19", "first-page": "344", "article-title": "New 5-HT1A receptor antagonist: [3H]-p-MPPF", "volume": "23", "author": "KUNG", "year": "1996", "journal-title": "Synapse"}, {"key": "10.1038/sj.bjp.0703832-BIB20", "first-page": "432", "article-title": "Intrinsic activity determination at dopamine D2 G-protein-coupled receptor: utilization of receptor binding affinities", "volume": "42", "author": "LAHTI", "year": "1992", "journal-title": "Mol. Pharmacol."}, {"key": "10.1038/sj.bjp.0703832-BIB21", "first-page": "1059", "article-title": "Atypical in vitro and in vivo binding of [3H]-S14506 to brain 5-HT1A receptors", "volume": "104", "author": "LIMA", "year": "1997", "journal-title": "J. Neural. Transm."}, {"key": "10.1038/sj.bjp.0703832-BIB22", "first-page": "347", "article-title": "Mechanisms of agonism and inverse agonism at serotonin 5-HT1A receptors", "volume": "74", "author": "MCLOUGHLIN", "year": "2000", "journal-title": "J. Neurochem."}, {"key": "10.1038/sj.bjp.0703832-BIB23", "first-page": "148", "article-title": "S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties", "volume": "282", "author": "MILLAN", "year": "1997", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10.1038/sj.bjp.0703832-BIB24", "first-page": "132", "article-title": "S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h\u03b12A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity", "volume": "282", "author": "MILLAN", "year": "1997", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10.1038/sj.bjp.0703832-BIB25", "first-page": "451", "article-title": "S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors", "volume": "262", "author": "MILLAN", "year": "1992", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10.1038/sj.bjp.0703832-BIB26", "author": "MILLIGAN", "year": "2000", "article-title": "S14506, novel receptor coupling at 5-HT1A receptors", "journal-title": "Neuropharmacology"}, {"key": "10.1038/sj.bjp.0703832-BIB27", "first-page": "107", "article-title": "S15535 and WAY100,635 antagonise 5-HT-stimulated [35S]-GTP\u03b3S binding at cloned human 5-HT1A receptors", "volume": "307", "author": "NEWMAN-TANCREDI", "year": "1996", "journal-title": "Eur. J. Pharmacol."}, {"key": "10.1038/sj.bjp.0703832-BIB28", "first-page": "395", "article-title": "Agonist and antagonist actions of (\u2212)pindolol at recombinant, human serotinin1A (5-HT1A) receptors", "volume": "18", "author": "NEWMAN-TANCREDI", "year": "1998", "journal-title": "Neuropsychopharmacol."}, {"key": "10.1038/sj.bjp.0703832-BIB29", "first-page": "737", "article-title": "Inhibition of the constitutive activity of human 5-HT1A receptors by the inverse agonist, spiperone but not the neutral antagonist, WAY100,635", "volume": "120", "author": "NEWMAN-TANCREDI", "year": "1997", "journal-title": "Br. J. Pharmacol."}, {"key": "10.1038/sj.bjp.0703832-BIB30", "first-page": "245", "article-title": "Agonist and antagonist actions of antipsychotic agents at serotonin 5-HT1A receptors: a [35S]-GTP\u03b3S binding study", "volume": "355", "author": "NEWMAN-TANCREDI", "year": "1998", "journal-title": "Eur. J. Pharmacol."}, {"key": "10.1038/sj.bjp.0703832-BIB31", "first-page": "205", "article-title": "Labelling of recombinant human and native rat serotonin 5-HT1A receptors by a novel, selective radioligand, [3H]-S 15535: definition of its binding profile using agonists, antagonists and inverse agonists", "volume": "357", "author": "NEWMAN-TANCREDI", "year": "1998", "journal-title": "Naunyn-Schmiedeberg's Arch. Pharmacol."}, {"key": "10.1038/sj.bjp.0703832-BIB32", "first-page": "153", "article-title": "Development of 5-HT1A receptor antagonists", "volume": "73", "author": "ROUTLEDGE", "year": "1996", "journal-title": "Behav. Brain Res."}, {"key": "10.1038/sj.bjp.0703832-BIB33", "first-page": "537", "article-title": "The potent activity of the 5-HT1A receptor agonists S14506 and S14671, in the forced swim test is blocked by novel 5-HT1A receptor antagonists", "volume": "271", "author": "SCHREIBER", "year": "1994", "journal-title": "Eur. J. Pharmacol."}, {"key": "10.1038/sj.bjp.0703832-BIB34", "first-page": "267", "article-title": "Characterisation of a cloned human 5-HT1A receptor cell line using [35S]GTP\u03b3S binding", "volume": "320", "author": "STANTON", "year": "1997", "journal-title": "Eur. J. Pharmacol."}, {"key": "10.1038/sj.bjp.0703832-BIB35", "first-page": "1003", "article-title": "Characterisation of recombinant human serotonin 5-HT1A receptors expressed in Chinese Hamster Ovary cells: [3H]spiperone discriminates between the G-protein-coupled and uncoupled form", "volume": "45", "author": "SUNDARAM", "year": "1993", "journal-title": "Biochem. Pharmacol."}, {"key": "10.1038/sj.bjp.0703832-BIB36", "first-page": "1909", "article-title": "Characterisation of recombinant serotonin 5-HT1A receptors expressed in chinese hamster ovary cells: the agonist [3H]-lisuride labels free receptor and receptor coupled to G-protein", "volume": "65", "author": "SUNDARAM", "year": "1995", "journal-title": "J. Neurochem."}, {"key": "10.1038/sj.bjp.0703832-BIB37", "first-page": "1108", "article-title": "5-HT1A receptor agonist - antagonist binding difference as a measure of intrinsic activity in recombinant and native systems", "volume": "130", "author": "WATSON", "year": "2000", "journal-title": "Br. J. Pharmacol."}], "container-title": ["British Journal of Pharmacology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1038%2Fsj.bjp.0703832", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 16]], "date-time": "2017-06-16T15:14:51Z", "timestamp": 1497626091000}, "score": 22.620516, "issued": {"date-parts": [[2001, 1]]}, "references-count": 37, "journal-issue": {"published-print": {"date-parts": [[2001, 1]]}, "issue": "2"}, "URL": "http://dx.doi.org/10.1038/sj.bjp.0703832", "relation": {"cites": []}, "ISSN": ["0007-1188", "1476-5381"], "issn-type": [{"value": "0007-1188", "type": "print"}, {"value": "1476-5381", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 9, 16]], "date-time": "2018-09-16T08:41:07Z", "timestamp": 1537087267597}, "reference-count": 47, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2016, 6, 1]], "date-time": "2016-06-01T00:00:00Z", "timestamp": 1464739200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Neuropharmacology"], "published-print": {"date-parts": [[2016, 6]]}, "DOI": "10.1016/j.neuropharm.2016.01.013", "type": "journal-article", "created": {"date-parts": [[2016, 1, 9]], "date-time": "2016-01-09T02:46:43Z", "timestamp": 1452307603000}, "page": "651-660", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 13, "title": ["The novel 5-HT 1A receptor agonist, NLX-112 reduces l -DOPA-induced abnormal involuntary movements in rat: A chronic administration study with microdialysis measurements"], "prefix": "10.1016", "volume": "105", "author": [{"given": "Andrew C.", "family": "McCreary", "sequence": "first", "affiliation": []}, {"given": "Mark A.", "family": "Varney", "sequence": "additional", "affiliation": []}, {"ORCID": "http://orcid.org/0000-0002-2923-5714", "authenticated-orcid": false, "given": "Adrian", "family": "Newman-Tancredi", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Neuropharmacology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0028390816300132?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0028390816300132?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 9, 16]], "date-time": "2018-09-16T08:26:17Z", "timestamp": 1537086377000}, "score": 22.620516, "issued": {"date-parts": [[2016, 6]]}, "references-count": 47, "alternative-id": ["S0028390816300132"], "URL": "http://dx.doi.org/10.1016/j.neuropharm.2016.01.013", "ISSN": ["0028-3908"], "issn-type": [{"value": "0028-3908", "type": "print"}], "subject": ["Pharmacology", "Cellular and Molecular Neuroscience"], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "The novel 5-HT1A receptor agonist, NLX-112 reduces l-DOPA-induced abnormal involuntary movements in rat: A chronic administration study with microdialysis measurements", "name": "articletitle", "label": "Article Title"}, {"value": "Neuropharmacology", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.neuropharm.2016.01.013", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "\u00a9 2016 Elsevier Ltd. All rights reserved.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2018, 5, 7]], "date-time": "2018-05-07T17:42:33Z", "timestamp": 1525714953301}, "reference-count": 0, "publisher": "Portland Press Ltd.", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Biochm. Soc. Trans."], "published-print": {"date-parts": [[1992, 5]]}, "DOI": "10.1042/bst020145s", "type": "journal-article", "created": {"date-parts": [[2015, 8, 11]], "date-time": "2015-08-11T12:39:56Z", "timestamp": 1439296796000}, "page": "145S-145S", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Pharmacological characterisation of the 5-HT1Aserotonin receptor using the agonist [5H]8-OH-DPAT, and the antagonist [3H]spiperone"], "prefix": "10.1042", "volume": "20", "author": [{"given": "HARDY", "family": "SUNDARAM", "sequence": "first", "affiliation": []}, {"given": "ADRIAN", "family": "NEWMAN-TANCREDI", "sequence": "additional", "affiliation": []}, {"given": "PHILIP G", "family": "STRANGE", "sequence": "additional", "affiliation": []}], "member": "288", "published-online": {"date-parts": [[1992, 5, 1]]}, "container-title": ["Biochemical Society Transactions"], "language": "en", "deposited": {"date-parts": [[2015, 8, 11]], "date-time": "2015-08-11T12:40:42Z", "timestamp": 1439296842000}, "score": 22.620516, "issued": {"date-parts": [[1992, 5]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[1992, 5, 1]]}, "published-print": {"date-parts": [[1992, 5]]}, "issue": "2"}, "alternative-id": ["10.1042/bst020145s"], "URL": "http://dx.doi.org/10.1042/bst020145s", "ISSN": ["0300-5127", "1470-8752"], "issn-type": [{"value": "0300-5127", "type": "print"}, {"value": "1470-8752", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 3]], "date-time": "2018-05-03T08:39:30Z", "timestamp": 1525336770099}, "reference-count": 0, "publisher": "Springer Nature", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Psychopharmacology"], "published-print": {"date-parts": [[2002, 7]]}, "DOI": "10.1007/s00213-002-1043-0", "type": "journal-article", "created": {"date-parts": [[2003, 3, 5]], "date-time": "2003-03-05T19:14:55Z", "timestamp": 1046891695000}, "page": "168-177", "source": "Crossref", "is-referenced-by-count": 30, "title": ["Stimulation by antipsychotic agents of mitogen-activated protein kinase (MAPK) coupled to cloned, human (h)serotonin (5-HT)1A receptors"], "prefix": "10.1007", "volume": "162", "author": [{"given": "Didier", "family": "Cussac", "sequence": "first", "affiliation": []}, {"given": "Delphine", "family": "Duqueyroix", "sequence": "additional", "affiliation": []}, {"given": "Adrian", "family": "Newman-Tancredi", "sequence": "additional", "affiliation": []}, {"given": "Mark J.", "family": "Millan", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2002, 4, 30]]}, "container-title": ["Psychopharmacology"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s00213-002-1043-0", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2014, 2, 5]], "date-time": "2014-02-05T14:22:26Z", "timestamp": 1391610146000}, "score": 22.620516, "issued": {"date-parts": [[2002, 4, 30]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2002, 7]]}, "issue": "2"}, "alternative-id": ["1043"], "URL": "http://dx.doi.org/10.1007/s00213-002-1043-0", "ISSN": ["0033-3158", "1432-2072"], "issn-type": [{"value": "0033-3158", "type": "print"}, {"value": "1432-2072", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 2]], "date-time": "2018-05-02T22:54:28Z", "timestamp": 1525301668717}, "reference-count": 18, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "http://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1996, 6, 1]], "date-time": "1996-06-01T00:00:00Z", "timestamp": 833587200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Journal of Pharmacology"], "published-print": {"date-parts": [[1996, 6]]}, "DOI": "10.1016/0014-2999(96)00303-2", "type": "journal-article", "created": {"date-parts": [[2002, 7, 25]], "date-time": "2002-07-25T17:50:27Z", "timestamp": 1027619427000}, "page": "107-111", "source": "Crossref", "is-referenced-by-count": 30, "title": ["S 15535 and WAY 100,635 antagonise 5-HT-stimulated [35S]GTP\u03b3S binding at cloned human 5-HT1A receptors"], "prefix": "10.1016", "volume": "307", "author": [{"given": "Adrian", "family": "Newman-Tancredi", "sequence": "first", "affiliation": []}, {"given": "Christine", "family": "Chaput", "sequence": "additional", "affiliation": []}, {"given": "Laurence", "family": "Verri\u00e8le", "sequence": "additional", "affiliation": []}, {"given": "Mark J.", "family": "Millan", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Journal of Pharmacology"], "language": "en", "link": [{"URL": "http://api.elsevier.com/content/article/PII:0014299996003032?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://api.elsevier.com/content/article/PII:0014299996003032?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 14]], "date-time": "2017-06-14T23:09:41Z", "timestamp": 1497481781000}, "score": 22.620516, "issued": {"date-parts": [[1996, 6]]}, "references-count": 18, "journal-issue": {"published-print": {"date-parts": [[1996, 6]]}, "issue": "1"}, "alternative-id": ["0014299996003032"], "URL": "http://dx.doi.org/10.1016/0014-2999(96)00303-2", "ISSN": ["0014-2999"], "issn-type": [{"value": "0014-2999", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 5, 2]], "date-time": "2018-05-02T22:44:36Z", "timestamp": 1525301076463}, "reference-count": 30, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "http://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2001, 7, 1]], "date-time": "2001-07-01T00:00:00Z", "timestamp": 993945600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Journal of Pharmacology"], "published-print": {"date-parts": [[2001, 7]]}, "DOI": "10.1016/s0014-2999(01)01127-x", "type": "journal-article", "created": {"date-parts": [[2002, 7, 25]], "date-time": "2002-07-25T17:18:16Z", "timestamp": 1027617496000}, "page": "13-17", "source": "Crossref", "is-referenced-by-count": 12, "title": ["Agonist properties of pindolol at h5-HT1A receptors coupled to mitogen-activated protein kinase"], "prefix": "10.1016", "volume": "424", "author": [{"given": "Mark J", "family": "Millan", "sequence": "first", "affiliation": []}, {"given": "Adrian", "family": "Newman-Tancredi", "sequence": "additional", "affiliation": []}, {"given": "Delphine", "family": "Duqueyroix", "sequence": "additional", "affiliation": []}, {"given": "Didier", "family": "Cussac", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Journal of Pharmacology"], "language": "en", "link": [{"URL": "http://api.elsevier.com/content/article/PII:S001429990101127X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://api.elsevier.com/content/article/PII:S001429990101127X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 14]], "date-time": "2017-06-14T22:53:40Z", "timestamp": 1497480820000}, "score": 22.620516, "issued": {"date-parts": [[2001, 7]]}, "references-count": 30, "journal-issue": {"published-print": {"date-parts": [[2001, 7]]}, "issue": "1"}, "alternative-id": ["S001429990101127X"], "URL": "http://dx.doi.org/10.1016/s0014-2999(01)01127-x", "ISSN": ["0014-2999"], "issn-type": [{"value": "0014-2999", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 5, 2]], "date-time": "2018-05-02T22:02:54Z", "timestamp": 1525298574160}, "reference-count": 42, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "http://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2001, 1, 1]], "date-time": "2001-01-01T00:00:00Z", "timestamp": 978307200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Neuropharmacology"], "published-print": {"date-parts": [[2001, 1]]}, "DOI": "10.1016/s0028-3908(00)00104-0", "type": "journal-article", "created": {"date-parts": [[2002, 7, 25]], "date-time": "2002-07-25T14:57:27Z", "timestamp": 1027609047000}, "page": "57-64", "source": "Crossref", "is-referenced-by-count": 16, "title": ["Constitutive activity at serotonin 5-HT1D receptors: detection by homologous GTP\u03b3S versus [35S]-GTP\u03b3S binding isotherms"], "prefix": "10.1016", "volume": "40", "author": [{"given": "Val\u00e9rie", "family": "Audinot", "sequence": "first", "affiliation": []}, {"given": "Adrian", "family": "Newman-Tancredi", "sequence": "additional", "affiliation": []}, {"given": "Mark J.", "family": "Millan", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Neuropharmacology"], "language": "en", "link": [{"URL": "http://api.elsevier.com/content/article/PII:S0028390800001040?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://api.elsevier.com/content/article/PII:S0028390800001040?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 14]], "date-time": "2017-06-14T21:38:40Z", "timestamp": 1497476320000}, "score": 22.620516, "issued": {"date-parts": [[2001, 1]]}, "references-count": 42, "journal-issue": {"published-print": {"date-parts": [[2001, 1]]}, "issue": "1"}, "alternative-id": ["S0028390800001040"], "URL": "http://dx.doi.org/10.1016/s0028-3908(00)00104-0", "ISSN": ["0028-3908"], "issn-type": [{"value": "0028-3908", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 5, 2]], "date-time": "2018-05-02T21:16:31Z", "timestamp": 1525295791298}, "reference-count": 15, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "http://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1995, 7, 1]], "date-time": "1995-07-01T00:00:00Z", "timestamp": 804556800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Journal of Pharmacology"], "published-print": {"date-parts": [[1995, 7]]}, "DOI": "10.1016/0014-2999(95)00250-o", "type": "journal-article", "created": {"date-parts": [[2002, 7, 25]], "date-time": "2002-07-25T12:18:09Z", "timestamp": 1027599489000}, "page": "225-229", "source": "Crossref", "is-referenced-by-count": 10, "title": ["Evidence that dopamine D3 receptors participate in clozapine-induced hypothermia"], "prefix": "10.1016", "volume": "280", "author": [{"given": "Mark J.", "family": "Millan", "sequence": "first", "affiliation": []}, {"given": "Val\u00e9rie", "family": "Audinot", "sequence": "additional", "affiliation": []}, {"given": "Christophe", "family": "Melon", "sequence": "additional", "affiliation": []}, {"given": "Adrian", "family": "Newman-Tancredi", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Journal of Pharmacology"], "language": "en", "link": [{"URL": "http://api.elsevier.com/content/article/PII:001429999500250O?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://api.elsevier.com/content/article/PII:001429999500250O?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 14]], "date-time": "2017-06-14T20:19:05Z", "timestamp": 1497471545000}, "score": 22.620516, "issued": {"date-parts": [[1995, 7]]}, "references-count": 15, "journal-issue": {"published-print": {"date-parts": [[1995, 7]]}, "issue": "2"}, "alternative-id": ["001429999500250O"], "URL": "http://dx.doi.org/10.1016/0014-2999(95)00250-o", "ISSN": ["0014-2999"], "issn-type": [{"value": "0014-2999", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 5, 2]], "date-time": "2018-05-02T23:53:56Z", "timestamp": 1525305236017}, "reference-count": 43, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "http://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2001, 10, 1]], "date-time": "2001-10-01T00:00:00Z", "timestamp": 1001894400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Journal of Pharmacology"], "published-print": {"date-parts": [[2001, 10]]}, "DOI": "10.1016/s0014-2999(01)01344-9", "type": "journal-article", "created": {"date-parts": [[2002, 10, 14]], "date-time": "2002-10-14T15:56:01Z", "timestamp": 1034610961000}, "page": "177-184", "source": "Crossref", "is-referenced-by-count": 18, "title": ["Efficacy of antipsychotic agents at human 5-HT1A receptors determined by [3H]WAY100,635 binding affinity ratios: relationship to efficacy for G-protein activation"], "prefix": "10.1016", "volume": "428", "author": [{"given": "Adrian", "family": "Newman-Tancredi", "sequence": "first", "affiliation": []}, {"given": "Laurence", "family": "Verri\u00e8le", "sequence": "additional", "affiliation": []}, {"given": "Manuelle", "family": "Touzard", "sequence": "additional", "affiliation": []}, {"given": "Mark J.", "family": "Millan", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Journal of Pharmacology"], "language": "en", "link": [{"URL": "http://api.elsevier.com/content/article/PII:S0014299901013449?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://api.elsevier.com/content/article/PII:S0014299901013449?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 15]], "date-time": "2017-06-15T00:53:21Z", "timestamp": 1497488001000}, "score": 22.620516, "issued": {"date-parts": [[2001, 10]]}, "references-count": 43, "journal-issue": {"published-print": {"date-parts": [[2001, 10]]}, "issue": "2"}, "alternative-id": ["S0014299901013449"], "URL": "http://dx.doi.org/10.1016/s0014-2999(01)01344-9", "ISSN": ["0014-2999"], "issn-type": [{"value": "0014-2999", "type": "print"}]}], "items-per-page": 25, "query": {"start-index": 0, "search-terms": null}}, "custom_name_alias": "NEWMAN-TANCREDI ADRIAN"}